Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Defense Response To Virus (GO:0051607),44/189,4.48703661638377e-38,7.50681225921004e-35,0,0,20.8642059252064,1794.25997334768,IFITM3;RTP4;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;USP18;IFI44L;IFIT3;IFIT2;OASL;IFIH1;TRIM6;IFI16;TRIM5;DHX58;AZI2;MICA;GBP5;APOBEC3D;RSAD2;APOBEC3G;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;PML;BST2;NT5C3A;SLFN13;MOV10;PLSCR1;AIM2;OAS1;OAS2;OAS3;IRF7;SHFL;RIGI
Defense Response To Symbiont (GO:0140546),40/148,1.7368637852612e-37,1.45288655637099e-34,0,0,25.1594650205761,2129.58687261663,IFITM3;RTP4;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;IFI44L;IFIT3;IFIT2;OASL;IFIH1;IFI16;TRIM5;AZI2;MICA;GBP5;APOBEC3D;RSAD2;APOBEC3G;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;BST2;NT5C3A;SLFN13;MOV10;PLSCR1;AIM2;OAS1;OAS2;OAS3;IRF7;SHFL;RIGI
Negative Regulation Of Viral Process (GO:0048525),21/61,1.14936417452341e-22,5.74513353164343e-20,0,0,33.5726384364821,1696.01123952761,IFITM3;RSAD2;APOBEC3G;STAT1;MX1;IFIT5;EIF2AK2;ISG15;ZC3HAV1;IFIT1;OASL;IFIH1;BST2;TRIM6;PLSCR1;OAS1;IFI16;OAS2;OAS3;TRIM14;SHFL
Negative Regulation Of Viral Genome Replication (GO:0045071),20/53,1.37361232077548e-22,5.74513353164343e-20,0,0,38.6442345533255,1945.32866467485,IFITM3;APOBEC3D;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;ZC3HAV1;IFIT1;OASL;IFIH1;BST2;TRIM6;PLSCR1;OAS1;IFI16;OAS2;OAS3;SHFL
Regulation Of Viral Genome Replication (GO:0045069),20/67,3.19920133535159e-20,1.07045276680864e-17,0,0,27.1138436032053,1217.10792073722,IFITM3;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;ZC3HAV1;IFIT1;OASL;IFIH1;BST2;TRIM6;PLSCR1;LARP1;OAS1;IFI16;OAS2;OAS3;SHFL
Response To Interferon-Beta (GO:0035456),11/29,5.1918231464146e-13,1.44765335399194e-10,0,0,37.8888888888889,1071.74486231647,IFITM3;BST2;TRIM6;PLSCR1;PNPT1;AIM2;IFI16;OAS1;STAT1;XAF1;SHFL
Response To Cytokine (GO:0034097),17/125,2.39403276114311e-11,5.72173829913203e-09,0,0,9.90198880552578,242.157658786406,IFITM3;CD274;SP100;GCH1;STAT1;MX2;MX1;EIF2AK2;ISG15;ADAR;PML;BST2;NUB1;PLSCR1;LAMP3;XAF1;SHFL
Negative Regulation Of Innate Immune Response (GO:0045824),12/52,3.55235252480036e-11,7.42885721748875e-09,0,0,18.6379746835443,448.445065030899,OAS1;IFI16;OAS3;STAT2;TREX1;DHX58;NLRC5;TRAFD1;SERPING1;ISG15;SAMHD1;USP18
Antiviral Innate Immune Response (GO:0140374),11/46,1.56161066139475e-10,2.90286070723714e-08,0,0,19.4688598467778,439.60944793164,IFIH1;TRIM6;OAS1;DHX58;MX1;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2;RIGI
Interleukin-27-Mediated Signaling Pathway (GO:0070106),5/5,1.15092499307162e-09,1.92549751340882e-07,0,0,98360,2024514.35981117,OAS1;OAS2;STAT1;MX1;OASL
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),7/15,1.72072329716197e-09,2.61706370559271e-07,0,0,53.601246105919,1081.70107871877,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),11/59,2.70962379194593e-09,3.77766716993795e-07,0,0,14.1866456361725,279.852241409789,IL1RN;OAS1;OAS3;STAT2;NLRC5;ISG15;SAMHD1;PARP14;ZNF675;USP18;NAIP
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),8/33,4.66801743914608e-08,6.00737936591645e-06,0,0,19.647,331.640304831195,TRIM6;OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18
Regulation Of Innate Immune Response (GO:0045088),11/78,5.70800526841473e-08,6.53111386360185e-06,0,0,10.153726634964,169.352088722388,GBP5;TASL;PLSCR1;IFI16;TREX1;DHX58;TRAFD1;IFI35;PARP9;SAMHD1;FCGR2B
Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),7/23,5.85575062486717e-08,6.53111386360185e-06,0,0,26.7897196261682,446.136073910861,IFIH1;OAS3;DHX58;TIFA;IRF7;MAP2K6;RIGI
Response To Type II Interferon (GO:0034341),11/80,7.46761276991319e-08,7.80832260254047e-06,0,0,9.85840991176336,161.777545447776,IFITM3;GBP6;BST2;GBP5;NUB1;SP100;GCH1;STAT1;GBP1;SHFL;GBP4
Response To Type I Interferon (GO:0034340),5/9,1.37379308706636e-07,1.35197402038942e-05,0,0,76.1145510835913,1202.64949126582,SP100;MX1;ISG15;IFIT1;SHFL
Positive Regulation Of Defense Response To Virus By Host (GO:0002230),7/28,2.63569992657341e-07,2.44973665397629e-05,0,0,20.4060228452752,309.129756063196,TRIM6;APOBEC3G;DTX3L;STAT1;PARP9;TRIM22;RIGI
Regulation Of Ribonuclease Activity (GO:0060700),4/5,3.50582777826409e-07,3.08697361738728e-05,0,0,242.851851851852,3609.66953896785,OAS1;OAS2;OAS3;OASL
Positive Regulation Of Type I Interferon Production (GO:0032481),9/64,9.58766743984241e-07,8.02008381342818e-05,0,0,10.0628669136506,139.447365875739,IFIH1;OAS1;OAS2;STAT1;OAS3;DHX58;IRF7;ISG15;RIGI
Regulation Of Nuclease Activity (GO:0032069),4/6,1.03813698775371e-06,8.27049133577124e-05,0,0,121.41975308642,1672.93141269008,OAS1;OAS2;OAS3;OASL
Cellular Response To Interferon-Beta (GO:0035458),6/22,1.11118121187641e-06,8.45002803395103e-05,0,0,22.8913043478261,313.841773090196,TRIM6;PNPT1;AIM2;IFI16;OAS1;STAT1
Positive Regulation Of Interferon-Beta Production (GO:0032728),7/36,1.66027192092422e-06,0.000120766735813314,0,0,14.770759480073,196.577083273995,IFIH1;OAS1;OAS2;OAS3;IRF7;ISG15;RIGI
Regulation Of Defense Response To Virus By Host (GO:0050691),7/37,2.01906545591851e-06,0.000140745687822986,0,0,14.2776739356179,187.221365019083,TRIM6;APOBEC3G;DTX3L;STAT1;PARP9;TRIM22;RIGI
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),7/39,2.93272889043413e-06,0.000194272514866893,0,0,13.3839563862928,170.505945711082,TASL;RSAD2;DHX58;WDFY1;IFI35;DDX60;OASL
Defense Response To Protozoan (GO:0042832),5/15,3.01917835417766e-06,0.000194272514866893,0,0,30.4365325077399,386.864332668461,GBP6;BATF2;IRF4;GBP1;GBP4
Regulation Of Cytokine Production (GO:0001817),13/167,3.97921643939868e-06,0.000246564040856074,0,0,5.23055040197897,65.0388899908334,BTN2A2;BTN3A1;EIF2AK2;ISG15;BTN3A3;BTN3A2;IFIH1;IFI16;IRF7;IGF2BP3;FCGR2B;BTN2A3P;RIGI
Response To Interferon-Alpha (GO:0035455),5/17,6.05562560525284e-06,0.000361823629913857,0,0,25.3611971104231,304.702682588718,IFITM3;BST2;MX2;LAMP3;EIF2AK2
Regulation Of Interferon-Beta Production (GO:0032648),7/50,1.63189279787499e-05,0.000941433327877535,0,0,9.95457509237122,109.73112182585,IFIH1;OAS1;OAS2;OAS3;IRF7;ISG15;RIGI
Positive Regulation Of Cytokine Production (GO:0001819),17/320,2.36815430882417e-05,0.00132064071955428,0,0,3.49424299343118,37.2165342410184,GBP5;CD274;BTN3A1;EIF2AK2;ISG15;NOD1;BTN3A2;MMP8;IFIH1;C5;TRIM6;IFI16;IRF4;DHX58;IRF7;IL18R1;RIGI
Cellular Response To Type I Interferon (GO:0071357),6/38,3.29612004647047e-05,0.00177884156056294,0,0,11.4363354037267,118.025033407794,IFITM3;SP100;STAT1;OAS2;STAT2;IFIT1
Regulation Of Viral Life Cycle (GO:1903900),5/24,3.78499691978262e-05,0.00197884370212385,0,0,16.0118950627342,163.031200376046,TRIM6;TRIM5;LAMP3;TRIM38;TRIM22
Regulation Of Viral Entry Into Host Cell (GO:0046596),6/44,7.75970932745085e-05,0.00393393748631069,0,0,9.62765609676365,91.1159504200285,IFITM3;TRIM6;TRIM5;TRIM38;TRIM22;LY6E
Positive Regulation Of Innate Immune Response (GO:0045089),6/45,8.83116323719879e-05,0.00434545179289223,0,0,9.38031533683708,87.5618547686428,GBP5;TASL;TRIM6;PLSCR1;NLRC5;IFI35
Regulation Of Interleukin-10 Production (GO:0032653),6/46,0.000100170995943764,0.00478817360611193,0,0,9.14534161490683,84.2160842831755,CD274;IRF4;ISG15;MMP8;FCGR2B;TRIB2
Negative Regulation Of Interleukin-10 Production (GO:0032693),4/16,0.000110606868629393,0.00514014697824929,0,0,20.2263374485597,184.252394757563,CD274;MMP8;FCGR2B;TRIB2
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),13/232,0.000126652747735929,0.00572675802600566,0,0,3.66585489599188,32.8976072362841,STAT1;IFIT5;SHISA5;RHOH;NOD1;BST2;TRIM6;CASP10;TRIM5;TIFA;TNFSF10;TRIM38;TRIM22
Regulation Of Response To Biotic Stimulus (GO:0002831),5/31,0.000137717102499835,0.00606317664426905,0,0,11.6968325791855,103.988455468097,HERC5;TRIM5;DHX58;SAMHD1;FCGR2B
Defense Response To Bacterium (GO:0042742),12/204,0.000145784943870585,0.00625380028449972,0,0,3.85284810126582,34.0336636911099,GBP6;RNF213;OAS1;OAS2;OAS3;ISG15;NOD1;GBP1;NAIP;MICA;GBP4;GBP3
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),11/175,0.000153750485983298,0.00643061407625146,0,0,4.12764484111718,36.2414625776971,BST2;TRIM6;CASP10;TRIM5;TIFA;IFIT5;TNFSF10;SHISA5;NOD1;TRIM38;TRIM22
Cellular Response To Cytokine Stimulus (GO:0071345),15/308,0.000185909055722066,0.00758599634690283,0,0,3.16964529108375,27.2280548171172,GBP6;CCR1;GBP5;PNPT1;STAT1;IFIT1;MT2A;TRIM6;AIM2;OAS1;IFI16;ZNF675;GBP1;GBP4;GBP3
Protein poly-ADP-ribosylation (GO:0070212),3/8,0.000230249174350665,0.00917159211163483,0,0,36.3083076923077,304.131037540178,PARP10;ZC3HAV1;PARP9
Regulation Of Immune Response (GO:0050776),7/77,0.000269308810589271,0.0104779916306012,0,0,6.10654205607477,50.1936496597639,PLSCR1;RSAD2;IRF4;DHX58;IRF7;SAMHD1;FCGR2B
Negative Regulation Of Viral Life Cycle (GO:1903901),4/20,0.000279576788693857,0.0106302719882914,0,0,15.1666666666667,124.097209102033,IFITM3;BST2;TRIM5;LY6E
Pattern Recognition Receptor Signaling Pathway (GO:0002221),6/56,0.000302668896819391,0.0112525569861965,0,0,7.31254658385093,59.2526223795851,IFIH1;DHX58;TIFA;NOD1;NAIP;RIGI
Type I Interferon-Mediated Signaling Pathway (GO:0060337),5/37,0.00032599054383916,0.0116489104813073,0,0,9.50077399380805,76.27831486398,IFITM3;SP100;STAT1;OAS2;STAT2
Modulation By Symbiont Of Entry Into Host (GO:0052372),4/21,0.000340920424798978,0.0116489104813073,0,0,14.2737835875091,113.959910762245,TRIM6;TRIM5;TRIM38;TRIM22
Positive Regulation Of Interferon-Alpha Production (GO:0032727),4/21,0.000340920424798978,0.0116489104813073,0,0,14.2737835875091,113.959910762245,IFIH1;STAT1;IRF7;RIGI
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),3/9,0.000341181478532013,0.0116489104813073,0,0,30.2553846153846,241.531640722603,DHX58;DDX60;OASL
Protein auto-ADP-ribosylation (GO:0070213),3/10,0.000481490319246846,0.0161106660819995,0,0,25.9318681318681,198.083801488166,PARP10;PARP11;PARP12
Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),3/11,0.000654025259992787,0.0214545933327046,0,0,22.6892307692308,166.365712117142,NLRC5;PARP14;PARP9
Negative Regulation Of Cytokine Production (GO:0001818),10/178,0.000736845067642071,0.0228827173915592,0,0,3.65079365079365,26.3336598234778,CD274;CEACAM1;BTN2A2;DHX58;INHBA;XAF1;MMP8;FCGR2B;TRIB2;GBP1
Cellular Response To Type II Interferon (GO:0071346),6/66,0.000738593388609802,0.0228827173915592,0,0,6.09068322981366,43.9184733198708,GBP6;GBP5;SP100;STAT1;GBP1;GBP4
Negative Regulation Of Immune Response (GO:0050777),6/66,0.000738593388609802,0.0228827173915592,0,0,6.09068322981366,43.9184733198708,IFI16;TREX1;DHX58;RHBDF2;TRAFD1;FCGR2B
Regulation Of Interferon-Alpha Production (GO:0032647),4/26,0.000798330701342802,0.024283768424482,0,0,11.026936026936,78.6549983171779,IFIH1;STAT1;IRF7;RIGI
Positive Regulation Of mRNA Metabolic Process (GO:1903313),3/12,0.00086147302473498,0.0257365066139575,0,0,20.1671794871795,142.317099664332,MOV10;PNPT1;ZC3HAV1
Protein Ubiquitination (GO:0016567),17/434,0.00088184421576219,0.025882901280178,0,0,2.52403864689599,17.7528135653977,DTX3L;FANCA;UBE2L6;ISG15;BRCA2;TNFSF13B;HERC5;RNF144A;NUB1;TRIM6;RNF213;TRIM5;TRIM14;TRIM69;TRIM38;TRIM22;HERC6
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),9/152,0.000928129344512832,0.0267717309201718,0,0,3.85297147993073,26.9027547834163,TRIM6;AIM2;TRIM5;TRIM14;EIF2AK2;NOD1;TRIM38;TRIM22;IL18R1
Post-Translational Protein Modification (GO:0043687),5/48,0.00110547210219974,0.0308490893358706,0,0,7.06638346893225,48.1042838766369,PARP10;PARP11;ZC3HAV1;PARP9;PARP12
Regulation Of ERBB Signaling Pathway (GO:1901184),3/13,0.00110636303655244,0.0308490893358706,0,0,18.1495384615385,123.538049399421,CEACAM1;RHBDF2;IFI6
Interferon-Mediated Signaling Pathway (GO:0140888),5/49,0.00121478710924263,0.0333170300616872,0,0,6.90543202927104,46.3574526355045,IFITM3;SP100;OAS2;STAT1;STAT2
Negative Regulation Of Gene Expression (GO:0010629),14/336,0.00138913177162058,0.0358040738740178,0,0,2.67931320963722,17.627406176408,CCR1;PNPT1;SMAD3;BTN2A2;EIF2AK2;PARP14;PARP9;MMP8;PARP10;OCLN;TRIM6;LARP1;IGF2BP3;FCGR2B
Cellular Response To Exogenous dsRNA (GO:0071360),3/14,0.00139107280442986,0.0358040738740178,0,0,16.4987412587413,108.523440861087,IFIH1;IFIT1;RIGI
Negative Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001911),3/14,0.00139107280442986,0.0358040738740178,0,0,16.4987412587413,108.523440861087,CEACAM1;FCGR2B;MICA
Protein Localization To Vacuole (GO:0072665),3/14,0.00139107280442986,0.0358040738740178,0,0,16.4987412587413,108.523440861087,GLMP;KPTN;GBP1
mRNA Methylation (GO:0080009),3/15,0.00171783316036902,0.0435444678378388,0,0,15.1230769230769,96.2839664016107,METTL14;METTL4;CMTR1
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),6/78,0.00177255524005237,0.0442609689045913,0,0,5.07246376811594,32.1357477861959,IFIH1;OAS1;OAS2;OAS3;MMP8;RIGI
Regulation Of Gene Expression (GO:0010468),32/1127,0.00182441510487442,0.0448859775066897,0,0,1.83408614093546,11.5666566066315,BMPR2;BNC2;HNRNPLL;BRCA2;ACVR1B;AFF1;TRIM6;LARP1;IFI16;LAMP3;METTL4;IGF2BP3;BTN2A3P;TRIM22;CCR1;SMAD3;BTN3A1;BTN2A2;RHOH;BTN3A3;TDRD7;BTN3A2;INHBA;PARP14;PARP9;MMP8;PML;PARP10;OCLN;PLSCR1;ZNF675;RIGI
Positive Regulation Of Immune Response (GO:0050778),6/80,0.00201806401834643,0.0485340402434441,0,0,4.9348665435622,30.6238899087747,GBP5;TASL;PLSCR1;RSAD2;IFI35;FCGR2B
Activin Receptor Signaling Pathway (GO:0032924),3/16,0.00208873335178002,0.0485340402434441,0,0,13.9590532544379,86.1440738273872,SMAD3;INHBA;ACVR1B
Regulation Of Response To Cytokine Stimulus (GO:0060759),3/16,0.00208873335178002,0.0485340402434441,0,0,13.9590532544379,86.1440738273872,IFIH1;PARP9;RIGI
Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),3/16,0.00208873335178002,0.0485340402434441,0,0,13.9590532544379,86.1440738273872,CEACAM1;SERPINB9;MICA
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),6/82,0.00228843838902738,0.0524459921211343,0,0,4.80451127819549,29.2108790324967,IFIH1;OAS1;OAS2;OAS3;MMP8;RIGI
Base Conversion Or Substitution Editing (GO:0016553),3/17,0.00250572599299332,0.0549574765110728,0,0,12.9613186813187,77.6276287401018,APOBEC3D;APOBEC3G;ADAR
Cellular Response To dsRNA (GO:0071359),3/17,0.00250572599299332,0.0549574765110728,0,0,12.9613186813187,77.6276287401018,IFIH1;IFIT1;RIGI
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),11/246,0.00257331514838208,0.0549574765110728,0,0,2.87008524062018,17.1130562281808,TRIM6;SMAD3;AIM2;TRIM5;TRIM14;EIF2AK2;NOD1;TRIM38;TRIM22;IL18R1;RIGI
ISG15-protein Conjugation (GO:0032020),2/5,0.00259512291953063,0.0549574765110728,0,0,40.2229038854806,239.492052619776,ISG15;UBE2L6
Regulation Of Interleukin-1-Mediated Signaling Pathway (GO:2000659),2/5,0.00259512291953063,0.0549574765110728,0,0,40.2229038854806,239.492052619776,IL1RN;ZNF675
Positive Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034157),2/5,0.00259512291953063,0.0549574765110728,0,0,40.2229038854806,239.492052619776,TASL;RSAD2
Positive Regulation Of Cellular Catabolic Process (GO:0031331),8/146,0.00286460804914294,0.0599061158277018,0,0,3.53876811594203,20.7206329764614,MOV10;TRIM6;PNPT1;DTX3L;TRIM5;ZC3HAV1;TRIM38;TRIM22
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),3/18,0.0029706318754521,0.0606081357028214,0,0,12.0966153846154,70.3899702017878,IFITM3;TRIM5;LY6E
Regulation Of RIG-I Signaling Pathway (GO:0039535),3/18,0.0029706318754521,0.0606081357028214,0,0,12.0966153846154,70.3899702017878,DHX58;DDX60;OASL
Regulation Of Type II Interferon Production (GO:0032649),6/87,0.00308340155342018,0.0621509734803851,0,0,4.50678628939499,26.0569849471702,CD274;BTN3A1;ISG15;BTN3A2;INHBA;IL18R1
rRNA Catabolic Process (GO:0016075),3/19,0.00348514464676105,0.0694124642146577,0,0,11.34,64.1758465793809,SLFN12;SLFN13;XRN1
RIG-I Signaling Pathway (GO:0039529),2/6,0.0038505575448098,0.0732878825037719,0,0,30.1656441717791,167.707024685575,OAS3;RIGI
Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034155),2/6,0.0038505575448098,0.0732878825037719,0,0,30.1656441717791,167.707024685575,TASL;RSAD2
Regulation Of MDA-5 Signaling Pathway (GO:0039533),2/6,0.0038505575448098,0.0732878825037719,0,0,30.1656441717791,167.707024685575,DHX58;DDX60
Regulation Of RNA Metabolic Process (GO:0051252),6/91,0.00385495138095154,0.0732878825037719,0,0,4.29382535622945,23.8667854804695,OAS1;OAS2;OAS3;METTL4;HNRNPLL;OASL
T Cell Mediated Immunity (GO:0002456),3/20,0.00405083535727392,0.0761466017159468,0,0,10.6723981900452,58.7924503531271,BTN3A3;BTN3A2;MICA
Negative Regulation Of Growth (GO:0045926),7/124,0.00439327837201684,0.0816661635153797,0,0,3.64472668210986,19.7824084735161,BST2;MT2A;PNPT1;SMAD3;BMPR2;INHBA;PML
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),4/41,0.00446010334601226,0.0819972845920716,0,0,6.55155155155155,35.4608187886902,GBP5;TASL;PLSCR1;IFI35
Modification-Dependent Protein Catabolic Process (GO:0019941),9/192,0.00454102838788209,0.0825776140535515,0,0,3.00462510920397,16.2087559485994,HERC5;RNF144A;NUB1;RNF213;DTX3L;UBE2L6;ISG15;HERC6;TNFSF13B
DNA Damage Response (GO:0006974),14/384,0.00464377808909121,0.0831010580214473,0,0,2.32594250301257,12.4954911168101,RMI2;CBX5;DTX3L;TREX1;FANCA;SAMHD1;PML;TNFSF13B;HELB;AIM2;IRF7;FBXO6;MICA;MAP2K6
Retrotransposon Silencing (GO:0010526),3/21,0.00466915687627976,0.0831010580214473,0,0,10.0789743589744,54.0916053948153,APOBEC3D;MOV10;APOBEC3G
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),4/44,0.00575383649556985,0.101328089021983,0,0,6.05925925925926,31.2529832279587,TRIM6;NLRC5;PARP14;PARP9
Negative Regulation Of Response To Biotic Stimulus (GO:0002832),4/45,0.00623509093151645,0.10753924874667,0,0,5.91117133393556,30.0143396258571,IFI16;TREX1;DHX58;TRAFD1
Positive Regulation Of mRNA Catabolic Process (GO:0061014),4/45,0.00623509093151645,0.10753924874667,0,0,5.91117133393556,30.0143396258571,MOV10;METTL14;PNPT1;ZC3HAV1
Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),3/24,0.00685275157684334,0.113141145945549,0,0,8.6378021978022,43.0430754704317,CEACAM1;FCGR2B;GBP1
DNA Cytosine Deamination (GO:0070383),2/8,0.00703328103905387,0.113141145945549,0,0,20.1083844580777,99.6793120578604,APOBEC3D;APOBEC3G
Regulation Of Dendritic Cell Antigen Processing And Presentation (GO:0002604),2/8,0.00703328103905387,0.113141145945549,0,0,20.1083844580777,99.6793120578604,NOD1;FCGR2B
Cellular Response To Muramyl Dipeptide (GO:0071225),2/8,0.00703328103905387,0.113141145945549,0,0,20.1083844580777,99.6793120578604,NOD1;CHMP5
Negative Regulation Of Leukocyte Degranulation (GO:0043301),2/8,0.00703328103905387,0.113141145945549,0,0,20.1083844580777,99.6793120578604,CEACAM1;FCGR2B
Positive Regulation Of Chromatin Binding (GO:0035563),2/8,0.00703328103905387,0.113141145945549,0,0,20.1083844580777,99.6793120578604,DTX3L;PARP9
Positive Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071639),2/8,0.00703328103905387,0.113141145945549,0,0,20.1083844580777,99.6793120578604,OAS1;OAS3
Regulation Of T Cell Differentiation (GO:0045580),4/47,0.00727618574033675,0.115933892796032,0,0,5.63565891472868,27.7451856809541,SMARCD3;FANCA;RHOH;PRDM1
Negative Regulation Of Transposition (GO:0010529),3/25,0.00769390912897361,0.121433112950687,0,0,8.24475524475525,40.1299139191311,APOBEC3D;MOV10;APOBEC3G
Negative Regulation Of Catalytic Activity (GO:0043086),3/26,0.00859333517678386,0.133117127321846,0,0,7.88588628762542,37.5113343489802,HP;IFIT1;PARP9
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),3/26,0.00859333517678386,0.133117127321846,0,0,7.88588628762542,37.5113343489802,STAT1;INHBA;ACVR1B
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),2/9,0.00894531696221484,0.133620672123084,0,0,17.2348816827344,81.2904760242846,PARP10;PARP9
Type II Interferon-Mediated Signaling Pathway (GO:0060333),2/9,0.00894531696221484,0.133620672123084,0,0,17.2348816827344,81.2904760242846,SP100;STAT1
Positive Regulation Of T Cell Apoptotic Process (GO:0070234),2/9,0.00894531696221484,0.133620672123084,0,0,17.2348816827344,81.2904760242846,CD274;IDO1
Positive Regulation Of Vasculogenesis (GO:2001214),2/9,0.00894531696221484,0.133620672123084,0,0,17.2348816827344,81.2904760242846,CEACAM1;RIN2
mRNA Modification (GO:0016556),3/27,0.00955185949164302,0.141418238314325,0,0,7.55692307692308,35.1473960789876,METTL14;METTL4;CMTR1
Cytokine-Mediated Signaling Pathway (GO:0019221),10/257,0.0102120430052429,0.14986621006817,0,0,2.473073103659,11.3370309774537,CCR1;CEACAM1;AIM2;OAS1;STAT1;OAS2;MX1;ZNF675;IL18R1;OASL
Regulation Of Chromatin Binding (GO:0035561),2/10,0.0110612811916836,0.154299778611054,0,0,15.079754601227,67.9238057473859,DTX3L;PARP9
Aromatic Amino Acid Family Catabolic Process (GO:0009074),2/10,0.0110612811916836,0.154299778611054,0,0,15.079754601227,67.9238057473859,FANCA;IDO1
Positive Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034145),2/10,0.0110612811916836,0.154299778611054,0,0,15.079754601227,67.9238057473859,WDFY1;IFI35
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),4/53,0.0110675274556644,0.154299778611054,0,0,4.94406651549509,22.2667896964553,IFI16;LAMP3;IFI6;NAIP
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),4/53,0.0110675274556644,0.154299778611054,0,0,4.94406651549509,22.2667896964553,EIF2AK2;NOD1;IFI35;MMP8
Positive Regulation Of Chemokine Production (GO:0032722),4/53,0.0110675274556644,0.154299778611054,0,0,4.94406651549509,22.2667896964553,C5;OAS1;OAS3;EIF2AK2
Negative Regulation Of DNA Binding (GO:0043392),3/29,0.0116490725799893,0.161065276250596,0,0,6.97491124260355,31.0559925504686,SP100;IFI16;ZNF675
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),5/83,0.0117936020583873,0.161607014293644,0,0,3.88862427562118,17.2662620929872,TRIM6;EIF2AK2;NOD1;IFI35;MMP8
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),8/186,0.0118814481518937,0.161607014293644,0,0,2.73792134831461,12.1365949836871,CCR1;PARP10;OCLN;TRIM6;SMAD3;PARP14;MMP8;PARP9
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),5/84,0.0123764116095199,0.166981746957474,0,0,3.8392052357252,16.8616469898792,LAMP3;TNFSF10;IFI6;NOD1;NAIP
Protein Polyubiquitination (GO:0000209),9/226,0.0125771358103059,0.168332385685134,0,0,2.52943385868859,11.0684857076622,RNF144A;TRIM6;RNF213;DTX3L;TRIM5;UBE2L6;TRIM38;TRIM22;TNFSF13B
Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),3/30,0.0127889818572046,0.169047682429581,0,0,6.71623931623932,29.2772374775654,CEACAM1;INHBA;ZNF675
Positive Regulation Of Gene Expression (GO:0010628),15/480,0.0133462764358976,0.169047682429581,0,0,1.97949087910955,8.54450771695427,SMAD3;BMPR2;SSB;BTN3A1;EIF2AK2;INHBA;HNRNPLL;MMP8;OCLN;PLSCR1;METTL14;LARP1;IFI16;LAMP3;RIGI
Cellular Response To Peptide (GO:1901653),4/56,0.0133635171798223,0.169047682429581,0,0,4.65811965811966,20.1008431755491,CACNA1A;NOD1;FCGR2B;CHMP5
Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071637),2/11,0.013374012345149,0.169047682429581,0,0,13.4035446489434,57.8288137342338,OAS1;OAS3
Cytidine To Uridine Editing (GO:0016554),2/11,0.013374012345149,0.169047682429581,0,0,13.4035446489434,57.8288137342338,APOBEC3D;APOBEC3G
Post-Transcriptional Gene Silencing (GO:0016441),2/11,0.013374012345149,0.169047682429581,0,0,13.4035446489434,57.8288137342338,HELZ2;MOV10
Regulation Of T Cell Apoptotic Process (GO:0070232),2/11,0.013374012345149,0.169047682429581,0,0,13.4035446489434,57.8288137342338,CD274;IDO1
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),16/525,0.0134389370969123,0.169047682429581,0,0,1.93068359276611,8.32047214260992,BMPR2;IFIT5;SHISA5;EIF2AK2;NOD1;IFI35;SEPTIN4;MMP8;BST2;TRIM6;CASP10;TRIM5;TIFA;TNFSF10;TRIM38;TRIM22
Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),3/31,0.0139904371179113,0.173297229127479,0,0,6.47604395604396,27.648700612697,TNFSF10;INHBA;PML
Regulation Of Cell Morphogenesis (GO:0022604),3/31,0.0139904371179113,0.173297229127479,0,0,6.47604395604396,27.648700612697,NTNG2;MOV10;FMNL2
Signal Transduction In Response To DNA Damage (GO:0042770),4/57,0.0141911060313596,0.173297229127479,0,0,4.5699976706266,19.4459791863522,DTX3L;FBXO6;PARP9;MAP2K6
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),4/57,0.0141911060313596,0.173297229127479,0,0,4.5699976706266,19.4459791863522,GBP5;AIM2;IFI16;NAIP
Regulation Of Bone Mineralization (GO:0030500),4/58,0.0150504799815365,0.182459804413844,0,0,4.4851394604481,18.8211943245289,CCR1;BMPR2;ISG15;TENT5A
Regulation Of Chemokine (C-X-C Motif) Ligand 2 Production (GO:2000341),2/12,0.015876527833582,0.187052331447766,0,0,12.0625766871166,49.9742117698604,OAS1;OAS3
DNA Deamination (GO:0045006),2/12,0.015876527833582,0.187052331447766,0,0,12.0625766871166,49.9742117698604,APOBEC3D;APOBEC3G
Response To Muramyl Dipeptide (GO:0032495),2/12,0.015876527833582,0.187052331447766,0,0,12.0625766871166,49.9742117698604,NOD1;CHMP5
Detection Of Bacterium (GO:0016045),2/12,0.015876527833582,0.187052331447766,0,0,12.0625766871166,49.9742117698604,NOD1;NAIP
Positive Regulation Of Defense Response (GO:0031349),6/124,0.0165489006630757,0.189983528852876,0,0,3.08779871565428,12.6644075920902,GBP5;TASL;PLSCR1;AIM2;IFI35;NAIP
ncRNA Catabolic Process (GO:0034661),3/33,0.016579554819199,0.189983528852876,0,0,6.04369230769231,24.7766302089974,SLFN12;SLFN13;XRN1
Negative Regulation Of Endocytosis (GO:0045806),3/33,0.016579554819199,0.189983528852876,0,0,6.04369230769231,24.7766302089974,RUBCN;PLSCR1;FCGR2B
Regulation Of Activated T Cell Proliferation (GO:0046006),3/33,0.016579554819199,0.189983528852876,0,0,6.04369230769231,24.7766302089974,CD274;BTN2A2;IDO1
DNA Damage Checkpoint Signaling (GO:0000077),3/34,0.0179678196962924,0.200350060415757,0,0,5.84843672456576,23.5058784828437,DTX3L;FBXO6;PARP9
Regulation Of Response To External Stimulus (GO:0032101),6/127,0.0184027858150641,0.200350060415757,0,0,3.01077973409989,12.0288274359085,HERC5;TRIM5;DHX58;SAMHD1;FCGR2B;USP18
Regulation Of Tumor Necrosis Factor Production (GO:0032680),6/127,0.0184027858150641,0.200350060415757,0,0,3.01077973409989,12.0288274359085,IFIH1;OAS1;OAS2;OAS3;MMP8;RIGI
Regulation Of Immune Effector Process (GO:0002697),2/13,0.0185620199428824,0.200350060415757,0,0,10.9654210819855,43.7151613495558,IRF4;FCGR2B
Regulation Of Vasculogenesis (GO:2001212),2/13,0.0185620199428824,0.200350060415757,0,0,10.9654210819855,43.7151613495558,CEACAM1;RIN2
Suppression Of Viral Release By Host (GO:0044790),2/13,0.0185620199428824,0.200350060415757,0,0,10.9654210819855,43.7151613495558,TRIM5;PML
Negative Regulation Of Translational Initiation (GO:0045947),2/13,0.0185620199428824,0.200350060415757,0,0,10.9654210819855,43.7151613495558,LARP1;EIF2AK2
Negative Regulation Of Viral Transcription (GO:0032897),2/13,0.0185620199428824,0.200350060415757,0,0,10.9654210819855,43.7151613495558,IFITM3;TRIM14
Regulation Of Cell Projection Organization (GO:0031344),2/13,0.0185620199428824,0.200350060415757,0,0,10.9654210819855,43.7151613495558,NTNG2;MOV10
Response To Exogenous dsRNA (GO:0043330),3/35,0.0194188413706168,0.208254625724628,0,0,5.66538461538462,22.3301784976384,IFIH1;IFIT1;RIGI
T Cell Receptor Signaling Pathway (GO:0050852),5/95,0.0201115016977072,0.213345859630304,0,0,3.36807705538356,13.1572697580618,BTN3A1;BTN2A2;BTN3A3;BTN3A2;BTN2A3P
Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),4/64,0.0208934333749485,0.213345859630304,0,0,4.03539094650206,15.6101849668488,AIM2;IFI16;TNFSF10;NOD1
Positive Regulation Of Interleukin-1 Production (GO:0032732),4/64,0.0208934333749485,0.213345859630304,0,0,4.03539094650206,15.6101849668488,GBP5;AIM2;IFI16;NAIP
Regulation Of Erythrocyte Differentiation (GO:0045646),3/36,0.0209327520834191,0.213345859630304,0,0,5.49342657342657,21.2400056758668,STAT1;INHBA;ACVR1B
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),3/36,0.0209327520834191,0.213345859630304,0,0,5.49342657342657,21.2400056758668,STAT1;INHBA;ACVR1B
Regulation Of Neuron Projection Arborization (GO:0150011),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,NTNG2;MOV10
Regulation Of Transposition (GO:0010528),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,APOBEC3D;APOBEC3G
Histone H2A Monoubiquitination (GO:0035518),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,PCGF5;BRCA2
Histone mRNA Catabolic Process (GO:0071044),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,SSB;XRN1
Negative Regulation Of Single Stranded Viral RNA Replication Via Double Stranded DNA Intermediate (GO:0045869),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,APOBEC3D;APOBEC3G
Positive Regulation Of Response To Cytokine Stimulus (GO:0060760),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,IFIH1;RIGI
Positive Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060340),2/14,0.0214238520130849,0.213345859630304,0,0,10.0511247443763,38.6289891700189,TRIM6;NLRC5
Regulation Of Defense Response (GO:0031347),5/97,0.0217930177160503,0.215737980112143,0,0,3.2945214699152,12.6053848772421,HERC5;DHX58;SAMHD1;FCGR2B;USP18
Negative Regulation Of Endopeptidase Activity (GO:0010951),4/66,0.0231098337317496,0.2274279519601,0,0,3.90481879729192,14.7113932971098,SERPINB10;IFI16;SERPING1;SERPINB9
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),6/134,0.0232698395146464,0.227663400631599,0,0,2.84510869565217,10.6993077898849,BTN2A2;BTN3A1;CD38;BTN3A3;BTN3A2;BTN2A3P
Response To Peptide (GO:1901652),3/38,0.024149459545222,0.23353783710495,0,0,5.17898901098901,19.2839307703607,STAT1;STAT2;CACNA1A
Positive Regulation Of Bone Mineralization (GO:0030501),3/38,0.024149459545222,0.23353783710495,0,0,5.17898901098901,19.2839307703607,BMPR2;ISG15;TENT5A
Negative Regulation Of Phagocytosis (GO:0050765),2/15,0.0244555546962699,0.235138752912986,0,0,9.27748938178386,34.4278158912481,PLSCR1;FCGR2B
Protein Localization To Organelle (GO:0033365),6/137,0.025597213704085,0.244709363011053,0,0,2.77952681238443,10.1877211680191,GBP5;SSB;TTC21A;ISG15;TOR1B;GBP1
Positive Regulation Of Wound Healing (GO:0090303),3/40,0.0276177965777859,0.255579147252647,0,0,4.8985446985447,17.5823215554047,OCLN;PRKCE;ENPP4
B Cell Activation Involved In Immune Response (GO:0002312),2/16,0.0276508222670228,0.255579147252647,0,0,8.61437335670464,30.9092314307044,FCGR2B;GAPT
Regulation Of Natural Killer Cell Activation (GO:0032814),2/16,0.0276508222670228,0.255579147252647,0,0,8.61437335670464,30.9092314307044,PRDM1;MICA
Innate Immune Response-Activating Signaling Pathway (GO:0002758),2/16,0.0276508222670228,0.255579147252647,0,0,8.61437335670464,30.9092314307044,NOD1;NAIP
Negative Regulation Of RNA Biosynthetic Process (GO:1902679),2/16,0.0276508222670228,0.255579147252647,0,0,8.61437335670464,30.9092314307044,APOBEC3D;APOBEC3G
Negative Regulation Of Chemokine Production (GO:0032682),2/16,0.0276508222670228,0.255579147252647,0,0,8.61437335670464,30.9092314307044,OAS1;OAS3
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),5/105,0.0294217204591695,0.266287691024642,0,0,3.0297213622291,10.6828644384975,EIF2AK2;TNIK;MMP8;FCGR2B;NAIP
Response To Amino Acid Starvation (GO:1990928),3/41,0.0294460387564607,0.266287691024642,0,0,4.76939271255061,16.813043565912,LARP1;EIF2AK2;KPTN
Positive Regulation Of Ossification (GO:0045778),3/41,0.0294460387564607,0.266287691024642,0,0,4.76939271255061,16.813043565912,BMPR2;ISG15;TENT5A
Protein Localization To Lysosome (GO:0061462),3/41,0.0294460387564607,0.266287691024642,0,0,4.76939271255061,16.813043565912,SCARB2;GLMP;KPTN
Regulation Of Cellular Localization (GO:0060341),4/72,0.0305910653127543,0.270150367850336,0,0,3.55918663761801,12.4110521403183,TRIM6;TRIM5;TRIM38;TRIM22
NAD Biosynthetic Process (GO:0009435),2/17,0.0310035090419991,0.270150367850336,0,0,8.03967280163599,27.927048709243,PARP10;PARP9
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),2/17,0.0310035090419991,0.270150367850336,0,0,8.03967280163599,27.927048709243,METTL14;EIF2AK2
Carbohydrate Derivative Catabolic Process (GO:1901136),2/17,0.0310035090419991,0.270150367850336,0,0,8.03967280163599,27.927048709243,FBXO6;SAMHD1
Regulation Of Single Stranded Viral RNA Replication Via Double Stranded DNA Intermediate (GO:0045091),2/17,0.0310035090419991,0.270150367850336,0,0,8.03967280163599,27.927048709243,APOBEC3D;APOBEC3G
Regulation Of Viral Transcription (GO:0046782),2/17,0.0310035090419991,0.270150367850336,0,0,8.03967280163599,27.927048709243,IFITM3;TRIM14
Toll-Like Receptor 4 Signaling Pathway (GO:0034142),2/17,0.0310035090419991,0.270150367850336,0,0,8.03967280163599,27.927048709243,OAS1;PRKCE
DNA Integrity Checkpoint Signaling (GO:0031570),3/42,0.0313367405970581,0.271639207351701,0,0,4.64686390532544,16.0919226439616,DTX3L;FBXO6;PARP9
Positive Regulation Of Autophagy (GO:0010508),5/107,0.0315609957874705,0.272172917280609,0,0,2.97001153402537,10.2638645566322,TRIM6;LARP1;TRIM5;TRIM38;TRIM22
Positive Regulation Of Biomineral Tissue Development (GO:0070169),3/43,0.0332896498175573,0.285608123819351,0,0,4.53046153846154,15.4149350107444,BMPR2;ISG15;TENT5A
Maintenance Of Protein Location In Nucleus (GO:0051457),2/18,0.0345076258272868,0.290106824166084,0,0,7.53680981595092,25.3732350606955,SP100;PML
ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),2/18,0.0345076258272868,0.290106824166084,0,0,7.53680981595092,25.3732350606955,HELZ2;MOV10
Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),2/18,0.0345076258272868,0.290106824166084,0,0,7.53680981595092,25.3732350606955,CEACAM1;GBP1
Regulation Of Adaptive Immune Response (GO:0002819),2/18,0.0345076258272868,0.290106824166084,0,0,7.53680981595092,25.3732350606955,IRF7;FCGR2B
Regulation Of JNK Cascade (GO:0046328),5/110,0.0349483556983735,0.292342995416894,0,0,2.88471177944862,9.67498827399616,TNIK;MMP8;FCGR2B;ZNF675;NAIP
Regulation Of B Cell Proliferation (GO:0030888),3/44,0.0353044686458356,0.293852617136731,0,0,4.4197373358349,14.7784778555626,CD38;FCGR2B;TNFSF13B
Positive Regulation Of DNA-templated Transcription (GO:0045893),29/1243,0.0356375939058082,0.295156903982263,0,0,1.47466293465864,4.91704853460216,ZNF496;SP100;BMPR2;SMARCD3;NLRC5;BRCA2;HELZ2;IFI16;CREB3L2;CD38;SMAD3;DTX3L;STAT1;PCGF5;STAT2;LMO2;GLMP;INHBA;PARP9;PLSCR1;ELF1;IRF4;TFEC;IRF7;NCOA7;AGRN;ATF3;IRF9;RIGI
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),3/45,0.0373808559767245,0.308069813049557,0,0,4.31428571428571,14.1793166646244,TIFA;AZI2;ZNF675
Positive Regulation Of JNK Cascade (GO:0046330),4/77,0.0377963018308358,0.308392386276422,0,0,3.31456113647894,10.8569908972735,TNIK;MMP8;FCGR2B;NAIP
Positive Regulation Of Response To Stimulus (GO:0048584),4/77,0.0377963018308358,0.308392386276422,0,0,3.31456113647894,10.8569908972735,IFIH1;RSAD2;FCGR2B;RIGI
tRNA Metabolic Process (GO:0006399),2/19,0.0381573364968436,0.308392386276422,0,0,7.09310718152292,23.1663521534981,SLFN13;SSB
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),2/19,0.0381573364968436,0.308392386276422,0,0,7.09310718152292,23.1663521534981,IFI16;PML
Protein Modification By Small Protein Conjugation (GO:0032446),11/364,0.0385708837430347,0.310236002413928,0,0,1.89908043717214,6.18199601532806,HERC5;IFIH1;RNF144A;NUB1;RNF213;TRIM14;TRIM69;UBE2L6;ISG15;PML;HERC6
Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),3/46,0.0395184294360659,0.314830154507325,0,0,4.21373881932021,13.6145401834956,CEACAM1;RHBDF2;IFI6
Regulation Of mRNA Catabolic Process (GO:0061013),3/46,0.0395184294360659,0.314830154507325,0,0,4.21373881932021,13.6145401834956,MOV10;PNPT1;ZC3HAV1
Inflammatory Response (GO:0006954),8/236,0.0414188770261726,0.32840654627861,0,0,2.13201754385965,6.78838337714092,CCR1;HP;OLR1;CYBB;NOD1;SIGLEC1;FCGR2B;NAIP
Fc-gamma Receptor Signaling Pathway Involved In Phagocytosis (GO:0038096),2/20,0.0419469545895752,0.329470680884316,0,0,6.69870483980913,21.2439338752791,PRKCE;FCGR2B
Negative Regulation Of B Cell Activation (GO:0050869),2/20,0.0419469545895752,0.329470680884316,0,0,6.69870483980913,21.2439338752791,INHBA;FCGR2B
Positive Regulation Of Response To External Stimulus (GO:0032103),6/155,0.0428175745094538,0.334737393244468,0,0,2.44149401809163,7.6926755668868,GBP5;TASL;PLSCR1;AIM2;IFI35;NAIP
Regulation Of DNA Binding (GO:0051101),3/48,0.0439754109620345,0.34219005832318,0,0,4.02605128205128,12.5778860244237,SP100;IFI16;MMP8
Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),4/81,0.0442027894088575,0.342366975375086,0,0,3.14173480840148,9.79896839372925,PARP10;AIM2;NLRC5;ZNF675
Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),2/21,0.0458709399870625,0.348827648174343,0,0,6.34581853406522,19.5573271283313,TAP2;MICA
Negative Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:2000042),2/21,0.0458709399870625,0.348827648174343,0,0,6.34581853406522,19.5573271283313,RMI2;HELB
Negative Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010804),2/21,0.0458709399870625,0.348827648174343,0,0,6.34581853406522,19.5573271283313,ZNF675;NAIP
Positive Regulation Of T Cell Cytokine Production (GO:0002726),2/21,0.0458709399870625,0.348827648174343,0,0,6.34581853406522,19.5573271283313,RSAD2;IL18R1
Negative Regulation Of T Cell Activation (GO:0050868),3/49,0.0462938657896782,0.348872240838431,0,0,3.93832775919732,12.101480140216,CD274;CEACAM1;FCGR2B
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),3/49,0.0462938657896782,0.348872240838431,0,0,3.93832775919732,12.101480140216,LAMP3;IFI6;NAIP
Regulation Of Epithelial Cell Migration (GO:0010632),3/50,0.0486716039595096,0.363516042072587,0,0,3.85433715220949,11.6503488088084,CEACAM1;BMPR2;PRKCE
Blood Circulation (GO:0008015),3/50,0.0486716039595096,0.363516042072587,0,0,3.85433715220949,11.6503488088084,STAT1;OLR1;SERPING1
Regulation Of Interleukin-1 Beta Production (GO:0032651),4/84,0.0493825040538006,0.36632753292586,0,0,3.02345679012346,9.09503901576625,GBP5;AIM2;IFI16;NAIP
Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),2/22,0.0499238957005954,0.36632753292586,0,0,6.02822085889571,18.0681182396291,PRKCE;FCGR2B
Postreplication Repair (GO:0006301),2/22,0.0499238957005954,0.36632753292586,0,0,6.02822085889571,18.0681182396291,PARP10;TNFSF13B
Regulation Of Catabolic Process (GO:0009894),2/22,0.0499238957005954,0.36632753292586,0,0,6.02822085889571,18.0681182396291,SCARB2;NUB1
RNA Modification (GO:0009451),3/51,0.0511080657393503,0.373379013021542,0,0,3.77384615384615,11.2227125710533,SSB;APOBEC3G;ADAR
Organonitrogen Compound Biosynthetic Process (GO:1901566),5/123,0.052156411451877,0.379381201560827,0,0,2.56519913942383,7.576336596938,GCH1;GCNT1;CHPT1;INHBA;PCSK5
Exocytosis (GO:0006887),4/86,0.0530134246066846,0.381899766449187,0,0,2.94941282746161,8.6630451548498,RPH3A;CCR1;EXOC3L1;STX17
Negative Regulation Of Binding (GO:0051100),4/86,0.0530134246066846,0.381899766449187,0,0,2.94941282746161,8.6630451548498,SP100;IFI16;IFIT1;IFIT2
Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),2/23,0.0541005646434294,0.381899766449187,0,0,5.74087058136138,16.7456065743637,BTN3A3;BTN3A2
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),2/23,0.0541005646434294,0.381899766449187,0,0,5.74087058136138,16.7456065743637,WDFY1;IFI35
Translesion Synthesis (GO:0019985),2/23,0.0541005646434294,0.381899766449187,0,0,5.74087058136138,16.7456065743637,PARP10;TNFSF13B
Histone mRNA Metabolic Process (GO:0008334),2/23,0.0541005646434294,0.381899766449187,0,0,5.74087058136138,16.7456065743637,SSB;XRN1
Negative Regulation Of Lymphocyte Activation (GO:0051250),2/23,0.0541005646434294,0.381899766449187,0,0,5.74087058136138,16.7456065743637,FCGR2B;MICA
Negative Regulation Of Cell Growth (GO:0030308),5/125,0.0551733892237036,0.387836471307799,0,0,2.52218782249742,7.30747051584655,BST2;SMAD3;BMPR2;INHBA;PML
mRNA Stabilization (GO:0048255),3/53,0.056154772329234,0.391445558778369,0,0,3.62252307692308,10.431575426565,LARP1;IGF2BP3;TENT5A
Protein Homotetramerization (GO:0051289),3/53,0.056154772329234,0.391445558778369,0,0,3.62252307692308,10.431575426565,GBP5;SAMHD1;KCNJ2
Protein-Containing Complex Organization (GO:0043933),5/126,0.0567189947442742,0.392572600474307,0,0,2.50121536217793,7.17760295946248,NUP205;OCLN;FANCA;PML;CD2AP
Regulation Of Endothelial Cell Migration (GO:0010594),4/88,0.0567857557171442,0.392572600474307,0,0,2.87889476778366,8.25802259608459,CEACAM1;SP100;BMPR2;RIN2
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),5/127,0.058289332558092,0.398760072796657,0,0,2.48058671268335,7.0506613545322,CEACAM1;SP100;FMNL2;STAT2;TNIK
Fc-gamma Receptor Signaling Pathway (GO:0038094),2/24,0.0583958265601799,0.398760072796657,0,0,5.47964305633017,15.5649855814541,PRKCE;FCGR2B
Multivesicular Body Sorting Pathway (GO:0071985),2/24,0.0583958265601799,0.398760072796657,0,0,5.47964305633017,15.5649855814541,RUBCN;CHMP5
Protein K63-linked Ubiquitination (GO:0070534),3/54,0.058763753704254,0.399073652263295,0,0,3.55131221719457,10.0652357949216,RNF213;TRIM5;TRIM22
Double-Strand Break Repair (GO:0006302),6/168,0.0589188237352264,0.399073652263295,0,0,2.24407637451116,6.35431465928124,ZFYVE26;RMI2;DTX3L;BRCA2;PARP9;SAMHD1
Protein Homooligomerization (GO:0051260),5/129,0.061504129120829,0.414904871044947,0,0,2.4403275741536,6.80522184762357,GBP5;PNPT1;TIFA;SAMHD1;KCNJ2
rRNA Metabolic Process (GO:0016072),4/91,0.0627072918831947,0.415889124909148,0,0,2.77919682134242,7.69636733693801,SLFN12;SLFN13;XRN1;IGF2BP3
Negative Regulation Of Protein Transport (GO:0051224),2/25,0.062804694947421,0.415889124909148,0,0,5.2411309682582,14.5060115571132,RSAD2;RHBDF2
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),2/25,0.062804694947421,0.415889124909148,0,0,5.2411309682582,14.5060115571132,LAMP3;PML
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),3/57,0.0669250978644498,0.415889124909148,0,0,3.35350427350427,9.06848330200163,LARP1;TDRD7;PARP9
Acute Inflammatory Response (GO:0002526),2/26,0.0673223140898021,0.415889124909148,0,0,5.02249488752556,13.5520148136174,PLSCR1;HP
Nuclear Membrane Organization (GO:0071763),2/26,0.0673223140898021,0.415889124909148,0,0,5.02249488752556,13.5520148136174,TOR1B;CHMP5
Renal System Development (GO:0072001),3/58,0.0697546252857649,0.415889124909148,0,0,3.29236363636364,8.76681221703495,STAT1;C1GALT1;PCSK5
Positive Regulation Of Type II Interferon Production (GO:0032729),3/58,0.0697546252857649,0.415889124909148,0,0,3.29236363636364,8.76681221703495,ISG15;BTN3A2;IL18R1
Recombinational Repair (GO:0000725),4/95,0.0710871771413537,0.415889124909148,0,0,2.65649165649166,7.02336097141019,ZFYVE26;RMI2;BRCA2;SAMHD1
DNA Synthesis Involved In DNA Repair (GO:0000731),2/27,0.0719439560918514,0.415889124909148,0,0,4.82134969325153,12.6891552545555,PARP10;TNFSF13B
Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),2/27,0.0719439560918514,0.415889124909148,0,0,4.82134969325153,12.6891552545555,IFI6;INHBA
Regulation Of Transcription Regulatory Region DNA Binding (GO:2000677),2/27,0.0719439560918514,0.415889124909148,0,0,4.82134969325153,12.6891552545555,TRIM6;ZNF675
Positive Regulation Of Nitric Oxide Biosynthetic Process (GO:0045429),2/27,0.0719439560918514,0.415889124909148,0,0,4.82134969325153,12.6891552545555,SMAD3;MMP8
Positive Regulation Of Response To Wounding (GO:1903036),2/27,0.0719439560918514,0.415889124909148,0,0,4.82134969325153,12.6891552545555,OCLN;PRKCE
Anterior/Posterior Pattern Specification (GO:0009952),3/59,0.0726374469904663,0.415889124909148,0,0,3.23340659340659,8.47888027677666,BMPR2;PCSK5;HES4
Regulation Of Type I Interferon Production (GO:0032479),3/59,0.0726374469904663,0.415889124909148,0,0,3.23340659340659,8.47888027677666,DHX58;IRF7;XAF1
Glucose Metabolic Process (GO:0006006),3/59,0.0726374469904663,0.415889124909148,0,0,3.23340659340659,8.47888027677666,OAS1;GALM;PCK2
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),5/137,0.0753459862160186,0.415889124909148,0,0,2.29149075898302,5.92502659140842,CEACAM1;LARP1;BMPR2;EIF2AK2;IGF2BP3
Regulation Of Protein Localization (GO:0032880),4/97,0.0754813920341956,0.415889124909148,0,0,2.5990973051905,6.71572725695164,TRIM6;TRIM5;TRIM38;TRIM22
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),3/60,0.075572787493985,0.415889124909148,0,0,3.17651821862348,8.20386341166652,SP100;TNFSF10;PML
Negative Regulation Of Peptidase Activity (GO:0010466),3/60,0.075572787493985,0.415889124909148,0,0,3.17651821862348,8.20386341166652,SERPINB10;SERPING1;SERPINB9
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),14/557,0.0762448700930204,0.415889124909148,0,0,1.57069125288853,4.04265322510526,ZNF496;SP100;SMAD3;SMARCD3;DTX3L;STAT1;INHBA;BRCA2;PARP9;ELF1;IRF4;CREB3L2;IRF7;CD38
Regulation Of Plasma Membrane Bounded Cell Projection Organization (GO:0120035),2/28,0.0766650180684572,0.415889124909148,0,0,4.63567720622935,11.905855024155,NTNG2;FCGR2B
Negative Regulation Of Type II Interferon Production (GO:0032689),2/28,0.0766650180684572,0.415889124909148,0,0,4.63567720622935,11.905855024155,CD274;INHBA
Positive Regulation Of Nitric Oxide Metabolic Process (GO:1904407),2/28,0.0766650180684572,0.415889124909148,0,0,4.63567720622935,11.905855024155,SMAD3;MMP8
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),4/98,0.0777288144589459,0.415889124909148,0,0,2.57131599684791,6.56850191953118,LARP1;BMPR2;EIF2AK2;IGF2BP3
CD4-positive, Alpha-Beta T Cell Activation (GO:0035710),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,RSAD2
Regulation Of Endothelial Cell-Matrix Adhesion Via Fibronectin (GO:1904904),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,RIN2
PML Body Organization (GO:0030578),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,PML
Regulation Of Hematopoietic Stem Cell Proliferation (GO:1902033),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,EIF2AK2
Regulation Of Lysosome Organization (GO:1905671),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,SCARB2
Regulation Of Macrophage Apoptotic Process (GO:2000109),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,IRF7
Aminophospholipid Transport (GO:0015917),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,SCARB2
Aromatic Compound Biosynthetic Process (GO:0019438),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,GCH1
Regulation Of Neutrophil Activation (GO:1902563),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,FCGR2B
Axonemal Central Apparatus Assembly (GO:1904158),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,RSPH9
Regulation Of Resting Membrane Potential (GO:0060075),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,KCNJ2
Regulation Of Superoxide Metabolic Process (GO:0090322),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,GCH1
Chondrocyte Development (GO:0002063),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,BMPR2
Resolution Of Recombination Intermediates (GO:0071139),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,RMI2
Detection Of Virus (GO:0009597),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,RIGI
Short-Chain Fatty Acid Catabolic Process (GO:0019626),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,PCK2
snRNA Modification (GO:0040031),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,METTL4
Establishment Of Protein Localization To Telomere (GO:0070200),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,BRCA2
tRNA Catabolic Process (GO:0016078),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,SLFN13
tRNA Transport (GO:0051031),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,SSB
Hepatocyte Differentiation (GO:0070365),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,PCK2
Lipoprotein Metabolic Process (GO:0042157),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,OLR1
Maintenance Of DNA Repeat Elements (GO:0043570),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,RMI2
Mesenchymal Cell Differentiation Involved In Kidney Development (GO:0072161),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,STAT1
Mitochondrial RNA 3'-End Processing (GO:0000965),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,PNPT1
Negative Regulation Of B Cell Receptor Signaling Pathway (GO:0050859),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,FCGR2B
Negative Regulation Of Myeloid Cell Apoptotic Process (GO:0033033),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,IRF7
Negative Regulation Of Protein Polyubiquitination (GO:1902915),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,PARP10
Nucleotide-Binding Domain, Leucine Rich Repeat Containing Receptor Signaling Pathway (GO:0035872),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,MAP2K6
Positive Regulation Of T-helper 1 Cell Cytokine Production (GO:2000556),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,IL18R1
Positive Regulation Of Antigen Processing And Presentation (GO:0002579),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,NOD1
Positive Regulation Of Dendritic Cell Antigen Processing And Presentation (GO:0002606),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,NOD1
Positive Regulation Of Interleukin-18 Production (GO:0032741),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,GBP5
Positive Regulation Of Microglial Cell Activation (GO:1903980),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,MMP8
Protection From Natural Killer Cell Mediated Cytotoxicity (GO:0042270),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,SERPINB9
Pteridine-Containing Compound Metabolic Process (GO:0042558),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,GCH1
Purine Deoxyribonucleotide Catabolic Process (GO:0009155),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,SAMHD1
Purine Ribonucleoside Catabolic Process (GO:0046130),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,ENPP4
Radial Glial Cell Differentiation (GO:0060019),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,METTL14
Regulation Of T-helper 1 Cell Cytokine Production (GO:2000554),1/5,0.0793615385474878,0.415889124909148,0,0,15.0366972477064,38.0991027756684,IL18R1
Regulation Of Cell Growth (GO:0001558),7/227,0.0809870681226473,0.415889124909148,0,0,1.92812234494477,4.84626955268794,BST2;CEACAM1;SMAD3;BMPR2;CHPT1;INHBA;PML
RNA-mediated Gene Silencing (GO:0031047),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,HELZ2;MOV10
Alpha-Amino Acid Catabolic Process (GO:1901606),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,FANCA;IDO1
Regulation Of Neuron Migration (GO:2001222),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,SRGAP2C;NTNG2
Chondrocyte Differentiation (GO:0002062),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,BMPR2;CREB3L2
Integrated Stress Response Signaling (GO:0140467),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,BATF2;EIF2AK2
Positive Regulation Of B Cell Proliferation (GO:0030890),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,CD38;TNFSF13B
Positive Regulation Of Viral Genome Replication (GO:0045070),2/29,0.0814810193015707,0.415889124909148,0,0,4.46375823676437,11.192361240432,LARP1;IFIT1
RNA Methylation (GO:0001510),3/62,0.0815978389185484,0.415889124909148,0,0,3.06852672750978,7.68958222781475,METTL14;METTL4;CMTR1
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),3/62,0.0815978389185484,0.415889124909148,0,0,3.06852672750978,7.68958222781475,TNFSF10;SEPTIN4;PML
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),10/367,0.0815983069847207,0.415889124909148,0,0,1.70137237284851,4.26354859373813,HERC5;RNF144A;NUB1;RNF213;DTX3L;UBE2L6;PML;HERC6;TNFSF13B;CHMP5
Apoptotic Process (GO:0006915),7/228,0.0824461201733171,0.415889124909148,0,0,1.91929913590166,4.78982266893177,PLSCR1;CASP10;PRKCE;MX1;IFI6;SEPTIN4;IFIT2
Immunoglobulin Mediated Immune Response (GO:0016064),2/30,0.0863875984783802,0.415889124909148,0,0,4.30411919368975,10.5404054826526,FCGR2B;GAPT
Positive Regulation Of Interleukin-10 Production (GO:0032733),2/30,0.0863875984783802,0.415889124909148,0,0,4.30411919368975,10.5404054826526,IRF4;ISG15
Regulation Of Secretion By Cell (GO:1903530),3/64,0.0878232563042396,0.415889124909148,0,0,2.96761664564943,7.2185165975618,RHBDF2;OTOF;SEPTIN4
Cellular Response To Virus (GO:0098586),3/64,0.0878232563042396,0.415889124909148,0,0,2.96761664564943,7.2185165975618,IFIH1;OAS1;IFI6
Regulation Of Macrophage Activation (GO:0043030),2/31,0.0913805110606201,0.415889124909148,0,0,4.15548973979268,9.94293608513025,MMP8;FCGR2B
Endodermal Cell Differentiation (GO:0035987),2/31,0.0913805110606201,0.415889124909148,0,0,4.15548973979268,9.94293608513025,INHBA;MMP8
Negative Regulation Of DNA Biosynthetic Process (GO:2000279),2/31,0.0913805110606201,0.415889124909148,0,0,4.15548973979268,9.94293608513025,BMPR2;XRN1
Receptor Signaling Pathway Via STAT (GO:0097696),2/31,0.0913805110606201,0.415889124909148,0,0,4.15548973979268,9.94293608513025,STAT1;STAT2
Positive Regulation Of Inflammatory Response (GO:0050729),4/104,0.091902112159118,0.415889124909148,0,0,2.4162962962963,5.76777480875359,AIM2;IFI35;MMP8;NAIP
Protein-Containing Complex Assembly (GO:0065003),9/328,0.0921954555510008,0.415889124909148,0,0,1.71162822692387,4.0802554298214,NT5C3A;OCLN;SMAD3;AIM2;FANCA;RSPH9;GBP1;PML;CD2AP
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),21/938,0.093009578309056,0.415889124909148,0,0,1.39903523385633,3.32278254745698,SMAD3;BMPR2;STAT1;PCGF5;STAT2;LMO2;NLRC5;GLMP;INHBA;HELZ2;PLSCR1;ELF1;IFI16;IRF4;TFEC;IRF7;NCOA7;AGRN;ATF3;IRF9;RIGI
Lysosomal Transport (GO:0007041),4/105,0.0943765847060543,0.415889124909148,0,0,2.39225033614473,5.64681668270703,SCARB2;DTX3L;ANKFY1;CHMP5
DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SAMHD1
G Protein-Coupled Receptor Internalization (GO:0002031),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,GTF2H2
Regulation Of Extracellular Matrix Assembly (GO:1901201),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SMAD3
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,EIF2AK2
SMAD Protein Complex Assembly (GO:0007183),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SMAD3
Adenosine To Inosine Editing (GO:0006382),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,ADAR
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I (GO:0019885),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,TAP2
Autophagosome Membrane Docking (GO:0016240),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,STX17
Regulation Of Skeletal Muscle Contraction (GO:0014819),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,KCNJ2
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,STAT1
Regulation Of Transforming Growth Factor Beta2 Production (GO:0032909),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SMAD3
Regulation Of Translational Termination (GO:0006449),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SHFL
Response To Lead Ion (GO:0010288),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,PLSCR1
Development Of Primary Female Sexual Characteristics (GO:0046545),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,LHFPL2
Spontaneous Synaptic Transmission (GO:0098814),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,RPH3A
tRNA 3'-End Processing (GO:0042780),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SSB
Free Ubiquitin Chain Polymerization (GO:0010994),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,TRIM6
Galactose Metabolic Process (GO:0006012),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,GALM
Toll-Like Receptor 3 Signaling Pathway (GO:0034138),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,OAS1
Vacuole Organization (GO:0007033),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,ZFYVE26
Histone H2A-K119 Monoubiquitination (GO:0036353),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,PCGF5
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,STAT1
Macrophage Derived Foam Cell Differentiation (GO:0010742),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,STAT1
Negative Regulation Of RIG-I Signaling Pathway (GO:0039536),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,DHX58
Negative Regulation Of Acute Inflammatory Response (GO:0002674),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,FCGR2B
Negative Regulation Of Dendritic Spine Development (GO:0061000),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SRGAP2C
Negative Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901533),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,METTL14
Negative Regulation Of Lymphocyte Differentiation (GO:0045620),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,INHBA
Negative Regulation Of Response To Type II Interferon (GO:0060331),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,PARP14
Negative Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060336),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,PARP14
Nucleotide Catabolic Process (GO:0009166),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,SAMHD1
Peptide Transport (GO:0015833),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,TAP2
Pharyngeal Arch Artery Morphogenesis (GO:0061626),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,BMPR2
Positive Regulation Of Helicase Activity (GO:0051096),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,GTF2H2
Positive Regulation Of Humoral Immune Response (GO:0002922),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,FCGR2B
Positive Regulation Of Lymphocyte Apoptotic Process (GO:0070230),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,IDO1
Positive Regulation Of Receptor Catabolic Process (GO:2000646),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,DTX3L
Positive Regulation Of Toll-Like Receptor 3 Signaling Pathway (GO:0034141),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,WDFY1
Purine Ribonucleoside Metabolic Process (GO:0046128),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,ENPP4
Regulation Of MHC Class I Biosynthetic Process (GO:0045343),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,NLRC5
Regulation Of T-helper Cell Differentiation (GO:0045622),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,IRF4
Regulation Of Blood-Brain Barrier Permeability (GO:1905603),1/6,0.0944637581981329,0.415889124909148,0,0,12.02874617737,28.3822960775142,OCLN
Regulation Of DNA-templated Transcription (GO:0006355),39/1922,0.0963062569243383,0.421332280007008,0,0,1.27487609957606,2.98349308152302,ZNF496;SP100;SMARCD3;BNC2;SP140;PRDM1;BRCA2;ACVR1B;IFI16;CREB3L2;METTL4;CD38;TRIM22;HES4;CDK17;ZNF441;BATF2;CBX5;SMAD3;DTX3L;SP110;STAT1;PCGF5;STAT2;RHOH;GTF2H2;INHBA;PARP9;PML;ETV7;ELF1;IRF4;TFEC;IRF7;NCOA7;SP140L;ZNF675;ATF3;IRF9
Regulation Of Transmembrane Transport (GO:0034762),2/32,0.0964556265646647,0.421332280007008,0,0,4.01676891615542,9.39390581706069,OCLN;KCNJ2
Negative Regulation Of Fat Cell Differentiation (GO:0045599),2/32,0.0964556265646647,0.421332280007008,0,0,4.01676891615542,9.39390581706069,SMAD3;TRIB2
Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),3/67,0.0975222742778404,0.421407053812749,0,0,2.82807692307692,6.58284246135208,SMAD3;CASP10;NOD1
Extrinsic Apoptotic Signaling Pathway (GO:0097191),3/67,0.0975222742778404,0.421407053812749,0,0,2.82807692307692,6.58284246135208,SMAD3;CASP10;INHBA
Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),5/149,0.0989924377277343,0.421407053812749,0,0,2.09924320605435,4.8549445722406,PARP10;SP100;AIM2;NLRC5;ZNF675
Negative Regulation Of Translation (GO:0017148),4/107,0.0994191059787058,0.421407053812749,0,0,2.34555915138439,5.4145144775395,METTL14;LARP1;EIF2AK2;IGF2BP3
Negative Regulation Of Double-Strand Break Repair (GO:2000780),2/33,0.101608926048493,0.421407053812749,0,0,3.8869978230754,8.88810209385083,HELB;RMI2
Positive Regulation Of DNA Binding (GO:0043388),2/33,0.101608926048493,0.421407053812749,0,0,3.8869978230754,8.88810209385083,TRIM6;MMP8
Positive Regulation Of RNA Metabolic Process (GO:0051254),2/33,0.101608926048493,0.421407053812749,0,0,3.8869978230754,8.88810209385083,PNPT1;HNRNPLL
Positive Regulation Of Reproductive Process (GO:2000243),2/33,0.101608926048493,0.421407053812749,0,0,3.8869978230754,8.88810209385083,INHBA;LHFPL2
Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),2/33,0.101608926048493,0.421407053812749,0,0,3.8869978230754,8.88810209385083,GBP5;EIF2AK2
Response To Tumor Necrosis Factor (GO:0034612),4/108,0.101986526651409,0.421407053812749,0,0,2.32288698955366,5.30295254379952,NUB1;GCH1;GBP1;GBP3
Glycerophospholipid Biosynthetic Process (GO:0046474),4/108,0.101986526651409,0.421407053812749,0,0,2.32288698955366,5.30295254379952,PI4K2B;PLSCR1;CHPT1;SELENOI
Regulation Of Autophagy (GO:0010506),7/241,0.102778698099557,0.421407053812749,0,0,1.81145991426365,4.12139223109316,RUBCN;TRIM6;IFI16;TRIM5;LAMP3;TRIM38;TRIM22
Regulation Of Endopeptidase Activity (GO:0052548),3/69,0.104218729432281,0.421407053812749,0,0,2.7420979020979,6.20060568222141,SERPINB10;SERPING1;SERPINB9
Response To Molecule Of Bacterial Origin (GO:0002237),3/69,0.104218729432281,0.421407053812749,0,0,2.7420979020979,6.20060568222141,TRIM6;GCH1;FCGR2B
Positive Regulation Of Protein Metabolic Process (GO:0051247),6/196,0.104337224580657,0.421407053812749,0,0,1.91062438705459,4.31825391976665,METTL14;LARP1;SSB;INHBA;RIGI;TNFSF13B
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),4/109,0.104584289449917,0.421407053812749,0,0,2.30064667842446,5.1943124966505,SMAD3;CASP10;TNFSF10;NOD1
Apoptotic Mitochondrial Changes (GO:0008637),2/34,0.106836499527293,0.421407053812749,0,0,3.76533742331288,8.4210101732298,IFI6;IFIT2
Cellular Response To Amyloid-Beta (GO:1904646),2/34,0.106836499527293,0.421407053812749,0,0,3.76533742331288,8.4210101732298,CACNA1A;FCGR2B
Purine Nucleotide Metabolic Process (GO:0006163),2/34,0.106836499527293,0.421407053812749,0,0,3.76533742331288,8.4210101732298,NMRK1;CD38
Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),2/34,0.106836499527293,0.421407053812749,0,0,3.76533742331288,8.4210101732298,CEACAM1;GBP1
DNA Repair (GO:0006281),8/291,0.107404554416549,0.421407053812749,0,0,1.71280918727915,3.82153882855501,RMI2;DTX3L;TREX1;FANCA;FBXO6;GTF2H2;BRCA2;PARP9
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),3/70,0.107633425470154,0.421407053812749,0,0,2.70103329506315,6.02066813095564,CEACAM1;STAT1;BRCA2
Regulation Of Chemokine (C-C Motif) Ligand 5 Production (GO:0071649),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,OAS3
T-helper 17 Cell Lineage Commitment (GO:0072540),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,IRF4
Regulation Of Lipase Activity (GO:0060191),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PCSK5
Regulation Of Lymphocyte Apoptotic Process (GO:0070228),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,CD274
Regulation Of Myeloid Leukocyte Differentiation (GO:0002761),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,IRF7
Regulation Of Natural Killer Cell Mediated Cytotoxicity Directed Against Tumor Cell Target (GO:0002858),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,CEACAM1
Cellular Modified Amino Acid Biosynthetic Process (GO:0042398),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PLSCR1
Somatic Hypermutation Of Immunoglobulin Genes (GO:0016446),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,SAMHD1
Foam Cell Differentiation (GO:0090077),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,STAT1
Translocation Of Molecules Into Host (GO:0044417),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,THOC7
Tryptophan Catabolic Process (GO:0006569),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,IDO1
Tryptophan Metabolic Process (GO:0006568),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,IDO1
Venous Blood Vessel Development (GO:0060841),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,BMPR2
Viral mRNA Export From Host Cell Nucleus (GO:0046784),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,THOC7
Lymphatic Endothelial Cell Differentiation (GO:0060836),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,BMPR2
Mitral Valve Development (GO:0003174),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,BMPR2
Myeloid Leukocyte Mediated Immunity (GO:0002444),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,SERPINB9
Negative Regulation Of T Cell Mediated Cytotoxicity (GO:0001915),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,FCGR2B
Negative Regulation Of Lipid Kinase Activity (GO:0090219),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,RUBCN
Negative Regulation Of Macrophage Migration (GO:1905522),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,C5
Negative Regulation Of Osteoblast Proliferation (GO:0033689),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,EIF2AK2
Negative Regulation Of Protein K63-linked Ubiquitination (GO:1900045),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PARP10
Plasma Membrane Phospholipid Scrambling (GO:0017121),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PLSCR1
Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,RSAD2
Positive Regulation Of Fibroblast Migration (GO:0010763),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PRKCE
Positive Regulation Of Isomerase Activity (GO:0010912),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PLSCR1
Positive Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904754),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,DOCK4
Protein Localization To Cytoplasmic Stress Granule (GO:1903608),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,SSB
Regulation Of Alpha-Beta T Cell Differentiation (GO:0046637),1/7,0.10931898467109,0.421407053812749,0,0,10.0234454638124,22.1867482437178,PRDM1
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),4/111,0.109869505013581,0.422555590546485,0,0,2.25741317641629,4.98541107276719,ZFYVE26;RMI2;BRCA2;SAMHD1
Myeloid Leukocyte Differentiation (GO:0002573),3/71,0.111091232435662,0.425298928752545,0,0,2.66117647058824,5.84767849437036,BATF2;IFI16;CASP10
Protein Autoubiquitination (GO:0051865),3/71,0.111091232435662,0.425298928752545,0,0,2.66117647058824,5.84767849437036,RNF213;DTX3L;BRCA2
Endoderm Formation (GO:0001706),2/35,0.112134543575161,0.427337338043837,0,0,3.65105038111173,7.98870213308914,INHBA;MMP8
Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),2/35,0.112134543575161,0.427337338043837,0,0,3.65105038111173,7.98870213308914,IFI16;PML
Negative Regulation Of Defense Response (GO:0031348),4/112,0.112556272620327,0.427969645667744,0,0,2.23639689071788,4.88496615942847,IFI16;TREX1;DHX58;TRAFD1
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),3/72,0.114591241804773,0.430159694001638,0,0,2.62247491638796,5.68128744138075,SMAD3;DTX3L;PARP9
Regulation Of Translation (GO:0006417),6/202,0.115926159654689,0.430159694001638,0,0,1.85156547090886,3.98975669334096,METTL14;LARP1;SSB;EIF2AK2;IGF2BP3;SHFL
DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330),2/36,0.117499358818263,0.430159694001638,0,0,3.54348610609888,7.5877461811527,SP100;PML
Negative Regulation Of T Cell Proliferation (GO:0042130),2/36,0.117499358818263,0.430159694001638,0,0,3.54348610609888,7.5877461811527,CD274;BTN2A2
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),2/36,0.117499358818263,0.430159694001638,0,0,3.54348610609888,7.5877461811527,STAT1;STAT2
Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),2/36,0.117499358818263,0.430159694001638,0,0,3.54348610609888,7.5877461811527,CEACAM1;MICA
Protein Tetramerization (GO:0051262),3/73,0.118132540050951,0.430159694001638,0,0,2.58487912087912,5.52116755413857,GBP5;SAMHD1;KCNJ2
Response To Lipopolysaccharide (GO:0032496),5/159,0.121212112443526,0.430159694001638,0,0,1.96192352539102,4.14007706327798,CD274;TRIM6;GCH1;CHMP5;GBP3
Regulation Of mRNA Stability (GO:0043488),3/74,0.121714209463223,0.430159694001638,0,0,2.54834236186349,5.36701167785109,METTL14;LARP1;TENT5A
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),3/74,0.121714209463223,0.430159694001638,0,0,2.54834236186349,5.36701167785109,CD274;CD38;TNFSF13B
RNA Stabilization (GO:0043489),2/37,0.122927347629165,0.430159694001638,0,0,3.44206836108677,7.21513210068255,LARP1;TENT5A
Regulation Of Ossification (GO:0030278),2/37,0.122927347629165,0.430159694001638,0,0,3.44206836108677,7.21513210068255,BMPR2;TENT5A
Positive Regulation Of Immune Effector Process (GO:0002699),2/37,0.122927347629165,0.430159694001638,0,0,3.44206836108677,7.21513210068255,DHX58;DDX60
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Transcription Of P21 Class Mediator (GO:0006978),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,SP100
Regulation Of Dendritic Spine Maintenance (GO:1902950),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,FCGR2B
Regulation Of Endothelial Cell Differentiation (GO:0045601),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,CEACAM1
Regulation Of Fertilization (GO:0080154),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,LHFPL2
Regulation Of Generation Of Precursor Metabolites And Energy (GO:0043467),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,PNPT1
Regulation Of Helicase Activity (GO:0051095),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,IFIT1
T Cell Mediated Cytotoxicity (GO:0001913),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,MICA
T-helper 17 Cell Differentiation (GO:0072539),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,IRF4
Regulation Of Interleukin-18 Production (GO:0032661),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,GBP5
Regulation Of miRNA Metabolic Process (GO:2000628),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,SMAD3
Regulation Of Mitochondrial Gene Expression (GO:0062125),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,METTL4
Bone Resorption (GO:0045453),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,ZNF675
Regulation Of Toll-Like Receptor 3 Signaling Pathway (GO:0034139),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,WDFY1
Cilium Movement Involved In Cell Motility (GO:0060294),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,RSPH9
Retrograde Transport, Vesicle Recycling Within Golgi (GO:0000301),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,COG6
Formation Of Translation Preinitiation Complex (GO:0001731),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,EIF2S3B
Kynurenine Metabolic Process (GO:0070189),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,IDO1
Modification-Dependent Macromolecule Catabolic Process (GO:0043632),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,ISG15
ncRNA Export From Nucleus (GO:0097064),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,SSB
Negative Regulation Of Cholesterol Storage (GO:0010887),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,TTC39B
Negative Regulation Of Platelet Aggregation (GO:0090331),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,CEACAM1
Negative Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002701),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,FCGR2B
Negative Regulation Of Protein-Containing Complex Disassembly (GO:0043242),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,RUBCN
Negative Regulation Of Systemic Arterial Blood Pressure (GO:0003085),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,BMPR2
p38MAPK Cascade (GO:0038066),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,MAP2K6
Positive Regulation Of Dendritic Cell Cytokine Production (GO:0002732),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,RIGI
Positive Regulation Of Extracellular Matrix Assembly (GO:1901203),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,SMAD3
Proteasome Assembly (GO:0043248),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,NT5C3A
Pyrimidine-Containing Compound Metabolic Process (GO:0072527),1/8,0.123931244775128,0.430159694001638,0,0,8.5910878112713,17.9384348623992,NT5C3A
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),4/117,0.126417444331745,0.437880712975174,0,0,2.1368950071015,4.41945316725824,CD274;FCGR2B;CHMP5;GBP3
RNA 3'-End Processing (GO:0031123),2/38,0.128415011703119,0.442054145224935,0,0,3.34628493524199,6.86820961053348,PNPT1;SSB
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),2/38,0.128415011703119,0.442054145224935,0,0,3.34628493524199,6.86820961053348,AIM2;STAT1
Negative Regulation Of Type I Interferon Production (GO:0032480),2/38,0.128415011703119,0.442054145224935,0,0,3.34628493524199,6.86820961053348,DHX58;XAF1
Positive Regulation Of Interleukin-6 Production (GO:0032755),3/76,0.128994974119443,0.443138791995541,0,0,2.47827186512118,5.07545576367925,IFIH1;MMP8;RIGI
Cellular Response To Tumor Necrosis Factor (GO:0071356),4/119,0.132154413742187,0.447550151882197,0,0,2.09951690821256,4.24896922836035,AIM2;STAT1;GBP1;GBP3
Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),2/39,0.133958949913904,0.447550151882197,0,0,3.25567899187531,6.54463711080983,SMAD3;MMP8
Negative Regulation Of Lymphocyte Proliferation (GO:0050672),2/39,0.133958949913904,0.447550151882197,0,0,3.25567899187531,6.54463711080983,CD274;FCGR2B
Negative Regulation Of Protein Secretion (GO:0050709),2/39,0.133958949913904,0.447550151882197,0,0,3.25567899187531,6.54463711080983,RSAD2;RHBDF2
Positive Regulation Of Lymphocyte Differentiation (GO:0045621),2/39,0.133958949913904,0.447550151882197,0,0,3.25567899187531,6.54463711080983,SMARCD3;RHOH
Regulation Of Cellular Response To Oxidative Stress (GO:1900407),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,GCH1
B Cell Homeostasis (GO:0001782),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,GAPT
DNA Damage Response, Signal Transduction Resulting In Transcription (GO:0042772),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,SP100
ESCRT III Complex Disassembly (GO:1904903),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,CHMP5
ESCRT Complex Disassembly (GO:1904896),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,CHMP5
Regulation Of Granulocyte Differentiation (GO:0030852),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,CEACAM1
Regulation Of Mast Cell Activation (GO:0033003),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,PLSCR1
Cell Differentiation Involved In Metanephros Development (GO:0072202),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,STAT1
Ether Lipid Biosynthetic Process (GO:0008611),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,CHPT1
Excitatory Synapse Assembly (GO:1904861),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,SRGAP2C
Vesicle Fusion With Vacuole (GO:0051469),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,CHMP5
Mitochondrial RNA Processing (GO:0000963),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,PNPT1
Mitochondrion Morphogenesis (GO:0070584),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,PNPT1
Mitral Valve Morphogenesis (GO:0003183),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,BMPR2
Multivesicular Body-Lysosome Fusion (GO:0061763),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,CHMP5
Myeloid Dendritic Cell Differentiation (GO:0043011),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,BATF2
Negative Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034115),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,IL1RN
Negative Regulation Of Humoral Immune Response Mediated By Circulating Immunoglobulin (GO:0002924),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,FCGR2B
Negative Regulation Of Sodium Ion Transmembrane Transport (GO:1902306),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,PRKCE
Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,PARP14
Nuclear mRNA Surveillance (GO:0071028),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,XRN1
Nucleoside Metabolic Process (GO:0009116),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,NT5C3A
Phosphatidylethanolamine Biosynthetic Process (GO:0006646),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,SELENOI
Positive Regulation Of Mesenchymal Cell Proliferation (GO:0002053),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,STAT1
Regulation Of Cell-Cell Adhesion Involved In Gastrulation (GO:0070587),1/9,0.138304500013805,0.447550151882197,0,0,7.51681957186544,14.8705053878693,IL1RN
Negative Regulation Of Secretion By Cell (GO:1903531),2/40,0.139555856013127,0.450727697123478,0,0,3.16984178237004,6.24233885312026,RSAD2;RHBDF2
Vesicle Fusion (GO:0006906),3/79,0.140195799504852,0.451109219815754,0,0,2.38008097165992,4.67618141830388,SAMD9;STX17;CHMP5
Vesicle-Mediated Transport (GO:0016192),10/411,0.140213266171065,0.451109219815754,0,0,1.51123762919745,2.96896337015437,CCR1;RPH3A;EXOC3L1;RUBCN;STX17;DTX3L;HEATR5B;AP4E1;ANKFY1;CHMP5
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),4/122,0.140956502701601,0.451392122978765,0,0,2.04582548650345,4.00839391104437,METTL14;LARP1;SSB;NLRC5
Regulation Of Chemokine Production (GO:0032642),2/41,0.145202516433828,0.451392122978765,0,0,3.08840648104452,5.95946896856162,C5;EIF2AK2
O-glycan Processing (GO:0016266),2/41,0.145202516433828,0.451392122978765,0,0,3.08840648104452,5.95946896856162,GCNT1;C1GALT1
Negative Regulation Of DNA Recombination (GO:0045910),2/41,0.145202516433828,0.451392122978765,0,0,3.08840648104452,5.95946896856162,HELB;RMI2
Negative Regulation Of mRNA Catabolic Process (GO:1902373),2/41,0.145202516433828,0.451392122978765,0,0,3.08840648104452,5.95946896856162,LARP1;TENT5A
Positive Regulation Of Viral Process (GO:0048524),2/41,0.145202516433828,0.451392122978765,0,0,3.08840648104452,5.95946896856162,LARP1;IFIT1
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),9/364,0.145989053342338,0.451392122978765,0,0,1.53519360678176,2.9540558258355,OCLN;PLSCR1;SMAD3;BMPR2;DTX3L;LAMP3;INHBA;MMP8;RIGI
Cellular Response To Lipopolysaccharide (GO:0071222),4/124,0.146951010336976,0.451392122978765,0,0,2.01152263374486,3.85740846938388,CD274;PRKCE;CHMP5;GBP3
DNA Recombination (GO:0006310),2/42,0.150895808189882,0.451392122978765,0,0,3.01104294478528,5.69438111528789,RMI2;TREX1
Regulation Of Osteoclast Differentiation (GO:0045670),2/42,0.150895808189882,0.451392122978765,0,0,3.01104294478528,5.69438111528789,CCR1;ZNF675
Cellular Response To Amino Acid Starvation (GO:0034198),2/42,0.150895808189882,0.451392122978765,0,0,3.01104294478528,5.69438111528789,EIF2AK2;KPTN
Cellular Response To Glucose Starvation (GO:0042149),2/42,0.150895808189882,0.451392122978765,0,0,3.01104294478528,5.69438111528789,IFI16;KPTN
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),2/42,0.150895808189882,0.451392122978765,0,0,3.01104294478528,5.69438111528789,NUB1;PML
Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),2/42,0.150895808189882,0.451392122978765,0,0,3.01104294478528,5.69438111528789,STAT1;RHOH
Regulation Of Phosphorylation (GO:0042325),3/82,0.151709972234467,0.451392122978765,0,0,2.28934761441091,4.31721660863285,STAT2;NLRC5;INHBA
CRD-mediated mRNA Stabilization (GO:0070934),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,IGF2BP3
Regulation Of Dendritic Cell Differentiation (GO:2001198),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,FCGR2B
Regulation Of Gene Expression By Genomic Imprinting (GO:0006349),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,PCGF5
T-helper Cell Lineage Commitment (GO:0002295),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,IRF4
TORC1 Signaling (GO:0038202),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,LARP1
Regulation Of Mitochondrial Depolarization (GO:0051900),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,IFI6
Atrial Septum Morphogenesis (GO:0060413),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,BMPR2
Cardiac Muscle Cell Membrane Repolarization (GO:0099622),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,KCNJ2
Cellular Response To Cholesterol (GO:0071397),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,GRAMD1B
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,RSAD2
Response To Corticosteroid (GO:0031960),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,IL1RN
Signal Release (GO:0023061),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,PCSK5
Endosomal Vesicle Fusion (GO:0034058),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,SAMD9
Epithelial Cell Apoptotic Process (GO:1904019),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,BMPR2
Surfactant Homeostasis (GO:0043129),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,OAS1
Vacuole Fusion (GO:0097576),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,CHMP5
Lens Fiber Cell Differentiation (GO:0070306),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,TDRD7
Metanephric Mesenchyme Development (GO:0072075),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,STAT1
Monocyte Differentiation (GO:0030224),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,IFI16
Negative Regulation Of B Cell Proliferation (GO:0030889),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,FCGR2B
Negative Regulation Of Activated T Cell Proliferation (GO:0046007),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,CD274
Negative Regulation Of Homotypic Cell-Cell Adhesion (GO:0034111),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,CEACAM1
Negative Regulation Of Natural Killer Cell Mediated Immunity (GO:0002716),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,MICA
Negative Regulation Of Oxidoreductase Activity (GO:0051354),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,HP
Negative Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000650),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,PRKCE
Nuclear RNA Surveillance (GO:0071027),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,XRN1
Nuclear Pore Complex Assembly (GO:0051292),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,NUP205
Positive Regulation Of Interleukin-13 Production (GO:0032736),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,IRF4
Receptor-Mediated Endocytosis Of Virus By Host Cell (GO:0019065),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,SIGLEC1
Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),1/10,0.152442647628812,0.451392122978765,0,0,6.68127760788311,12.5672615944763,RSAD2
Cellular Response To Starvation (GO:0009267),4/126,0.153042884559938,0.452368808955434,0,0,1.97834446468326,3.71342596791343,BMPR2;IFI16;EIF2AK2;KPTN
Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),3/83,0.155613336148681,0.45326180716734,0,0,2.26061538461538,4.20560582623538,RNF144A;NUB1;TRIB2
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),3/83,0.155613336148681,0.45326180716734,0,0,2.26061538461538,4.20560582623538,RNF144A;NUB1;TRIB2
Regulation Of Filopodium Assembly (GO:0051489),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,SRGAP2C;AGRN
SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,FBXO39;FBXO6
Response To Amyloid-Beta (GO:1904645),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,CACNA1A;FCGR2B
Lysosome Organization (GO:0007040),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,TASL;ZFYVE26
mRNA Catabolic Process (GO:0006402),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,PNPT1;XRN1
mRNA Destabilization (GO:0061157),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,MOV10;METTL14
Neurotransmitter Secretion (GO:0007269),2/43,0.156632696762504,0.45326180716734,0,0,2.93745323956307,5.44560275712876,RPH3A;OTOF
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),5/174,0.158434374452991,0.45326180716734,0,0,1.78641434773847,3.29131625591035,METTL14;LARP1;SMAD3;SSB;MMP8
Autophagosome Maturation (GO:0097352),2/44,0.16241023407636,0.45326180716734,0,0,2.86736780601811,5.21181327365247,STX17;CHMP5
Cellular Response To Ketone (GO:1901655),2/44,0.16241023407636,0.45326180716734,0,0,2.86736780601811,5.21181327365247,LARP1;PCK2
Establishment Of Protein Localization To Mitochondrion (GO:0072655),2/44,0.16241023407636,0.45326180716734,0,0,2.86736780601811,5.21181327365247,TIMM10;DNAJC15
Nucleobase-Containing Compound Catabolic Process (GO:0034655),2/44,0.16241023407636,0.45326180716734,0,0,2.86736780601811,5.21181327365247,PNPT1;TREX1
Nucleus Organization (GO:0006997),2/44,0.16241023407636,0.45326180716734,0,0,2.86736780601811,5.21181327365247,NUP205;CHMP5
Positive Regulation Of Osteoblast Differentiation (GO:0045669),2/44,0.16241023407636,0.45326180716734,0,0,2.86736780601811,5.21181327365247,BMPR2;TENT5A
Positive Regulation Of Amide Metabolic Process (GO:0034250),3/85,0.163512481563913,0.45326180716734,0,0,2.20525328330206,3.9934180856463,METTL14;LARP1;SSB
Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),4/130,0.165505451613664,0.45326180716734,0,0,1.91514795218499,3.44487457077177,SMAD3;BMPR2;INHBA;ACVR1B
Regulation Of Transcription By RNA Polymerase II (GO:0006357),39/2028,0.166302694146071,0.45326180716734,0,0,1.19974218060927,2.15227231689088,ZNF496;SP100;BMPR2;SMARCD3;SP140;NLRC5;PRDM1;HELZ2;IFI16;CREB3L2;ZNF589;ZNF684;HES4;ZNF441;BATF2;CBX5;SMAD3;SP110;STAT1;PCGF5;STAT2;LMO2;GLMP;GTF2H2;INHBA;PARP9;ETV7;PLSCR1;ELF1;IRF4;TFEC;IRF7;NCOA7;AGRN;SP140L;ZNF675;ATF3;IRF9;RIGI
Regulation Of Mesenchymal Cell Proliferation (GO:0010464),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,STAT1
cGMP Metabolic Process (GO:0046068),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,PDE9A
Regulation Of Protein K63-linked Ubiquitination (GO:1900044),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,PARP10
Catecholamine Biosynthetic Process (GO:0042423),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,GCH1
Cell Part Morphogenesis (GO:0032990),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,PNPT1
Cellular Response To Thyroid Hormone Stimulus (GO:0097067),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,LMO2
Desensitization Of G Protein-Coupled Receptor Signaling Pathway (GO:0002029),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,GTF2H2
Dosage Compensation By Inactivation Of X Chromosome (GO:0009048),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,PCGF5
Sulfate Transport (GO:0008272),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,SLC26A8
Tyrosine Metabolic Process (GO:0006570),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,FANCA
Heterocycle Biosynthetic Process (GO:0018130),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,GCH1
Histone H2A Ubiquitination (GO:0033522),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,BRCA2
Intracellular Copper Ion Homeostasis (GO:0006878),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,MT2A
Lysosomal Membrane Organization (GO:0097212),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,CHMP5
Macrophage Activation Involved In Immune Response (GO:0002281),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,IFI35
Mast Cell Mediated Immunity (GO:0002448),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,SERPINB9
Negative Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000515),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,CD274
Negative Regulation Of Leukocyte Apoptotic Process (GO:2000107),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,IRF7
Negative Regulation Of Leukocyte Chemotaxis (GO:0002689),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,C5
Negative Regulation Of Vascular Permeability (GO:0043116),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,CEACAM1
Nucleotide-Binding Oligomerization Domain Containing Signaling Pathway (GO:0070423),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,MAP2K6
Organic Cyclic Compound Catabolic Process (GO:1901361),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,STS
Positive Regulation Of Coagulation (GO:0050820),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,ENPP4
Positive Regulation Of Hemostasis (GO:1900048),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,ENPP4
Positive Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090267),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,NDC80
Positive Regulation Of Spindle Checkpoint (GO:0090232),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,NDC80
Positive Regulation Of Vascular Permeability (GO:0043117),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,OCLN
Regulation Of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043370),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,IRF4
Regulation Of Cell Cycle Checkpoint (GO:1901976),1/11,0.16634952157845,0.45326180716734,0,0,6.01284403669725,10.7850228032903,BRCA2
Hexose Metabolic Process (GO:0019318),2/45,0.168225556461143,0.457628221072346,0,0,2.8005421600799,4.99182525882771,OAS1;GALM
Replication Fork Processing (GO:0031297),2/46,0.174075882754452,0.463076839543399,0,0,2.73675404350251,4.78456848093592,BRCA2;SAMHD1
Development Of Primary Male Sexual Characteristics (GO:0046546),2/46,0.174075882754452,0.463076839543399,0,0,2.73675404350251,4.78456848093592,INHBA;LHFPL2
Negative Regulation Of Cold-Induced Thermogenesis (GO:0120163),2/46,0.174075882754452,0.463076839543399,0,0,2.73675404350251,4.78456848093592,IL18R1;MAP2K6
Protein Sumoylation (GO:0016925),2/46,0.174075882754452,0.463076839543399,0,0,2.73675404350251,4.78456848093592,IFIH1;PML
Negative Regulation Of Cellular Process (GO:0048523),12/537,0.174162428772004,0.463076839543399,0,0,1.3849547920434,2.42057816640495,BST2;APOBEC3D;SMAD3;BMPR2;APOBEC3G;EIF2AK2;IFI35;INHBA;ACVR1B;IFIT3;PML;CHMP5
Negative Regulation Of Protein Kinase Activity (GO:0006469),3/88,0.175578481113478,0.463076839543399,0,0,2.12709502262443,3.70044159040842,CEACAM1;ADAR;TRIB2
Regulation Of Interleukin-2 Production (GO:0032663),2/47,0.179958512268429,0.463076839543399,0,0,2.67580095432856,4.58907607985413,IRF4;GBP1
Regulation Of Wound Healing (GO:0061041),2/47,0.179958512268429,0.463076839543399,0,0,2.67580095432856,4.58907607985413,OCLN;PRKCE
Protein Monoubiquitination (GO:0006513),2/47,0.179958512268429,0.463076839543399,0,0,2.67580095432856,4.58907607985413,FANCA;TNFSF13B
Regulation Of Chromosome Separation (GO:1905818),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,PLSCR1
Regulation Of Hematopoietic Stem Cell Differentiation (GO:1902036),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,EIF2AK2
Attachment Of Mitotic Spindle Microtubules To Kinetochore (GO:0051315),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,NDC80
Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,DOCK4
Relaxation Of Cardiac Muscle (GO:0055119),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,KCNJ2
Response To Thyroid Hormone (GO:0097066),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,LMO2
Endochondral Bone Morphogenesis (GO:0060350),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,BMPR2
Steroid Catabolic Process (GO:0006706),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,STS
tRNA 5'-Leader Removal (GO:0001682),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,SSB
Gamma-Delta T Cell Activation (GO:0046629),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,MICA
Histone Monoubiquitination (GO:0010390),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,BRCA2
Lipid Droplet Formation (GO:0140042),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,RNF213
Mesoderm Morphogenesis (GO:0048332),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,BMPR2
Negative Regulation Of JUN Kinase Activity (GO:0043508),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,ZNF675
Negative Regulation Of Complement Activation (GO:0045916),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,SERPING1
Negative Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900025),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,GBP1
Nuclear Body Organization (GO:0030575),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,PML
Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,TRIM38
Positive Regulation Of T-helper 1 Type Immune Response (GO:0002827),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,IL18R1
Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,RIGI
Positive Regulation Of Neuroinflammatory Response (GO:0150078),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,MMP8
Positive Regulation Of Neuron Migration (GO:2001224),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,SRGAP2C
Positive Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903428),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,MMP8
Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,TRIM38
Primary miRNA Processing (GO:0031053),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,SMAD3
Protein Insertion Into Mitochondrial Inner Membrane (GO:0045039),1/12,0.18002889355399,0.463076839543399,0,0,5.46594384209063,9.37211458695922,TIMM10
Negative Regulation Of Multicellular Organismal Process (GO:0051241),6/231,0.180193079822327,0.463076839543399,0,0,1.61051759834369,2.75998642497813,BMPR2;BTN2A2;BRCA2;FCGR2B;IL18R1;MAP2K6
Macromolecule Biosynthetic Process (GO:0009059),5/183,0.182750572458228,0.468928999574563,0,0,1.69530733641771,2.88140037530726,GCNT1;SRBD1;IGF2BP3;INHBA;GTPBP2
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),3/90,0.183756717748492,0.470788650525616,0,0,2.07798408488064,3.52040132370837,RNF144A;NUB1;TRIB2
Cellular Response To Radiation (GO:0071478),2/48,0.185870823039076,0.471178347744939,0,0,2.61749799946652,4.40447264272892,IFI16;BRCA2
Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),2/48,0.185870823039076,0.471178347744939,0,0,2.61749799946652,4.40447264272892,ZNF675;NAIP
Positive Regulation Of Binding (GO:0051099),3/91,0.187883403731641,0.471178347744939,0,0,2.05426573426573,3.43459611289014,DTX3L;MMP8;PARP9
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),2/49,0.191810269926464,0.471178347744939,0,0,2.56167602140713,4.22996387481104,IFI16;PML
Positive Regulation Of miRNA Metabolic Process (GO:2000630),2/49,0.191810269926464,0.471178347744939,0,0,2.56167602140713,4.22996387481104,PNPT1;SMAD3
Positive Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0010862),2/49,0.191810269926464,0.471178347744939,0,0,2.56167602140713,4.22996387481104,BMPR2;INHBA
Regulation Of Humoral Immune Response (GO:0002920),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,FCGR2B
Acute-Phase Response (GO:0006953),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,PLSCR1
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,MICA
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,MICA
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,MICA
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,MICA
Atrial Septum Development (GO:0003283),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,BMPR2
Atrioventricular Valve Development (GO:0003171),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,BMPR2
Regulation Of Oxidoreductase Activity (GO:0051341),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,HP
Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905897),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,FCGR2B
Relaxation Of Muscle (GO:0090075),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,KCNJ2
Signal Peptide Processing (GO:0006465),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,PCSK5
Endolysosomal Toll-Like Receptor Signaling Pathway (GO:0140894),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,OAS1
Endothelial Cell Differentiation (GO:0045446),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,BMPR2
Substrate-Dependent Cell Migration (GO:0006929),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,CD2AP
Immune Response-Regulating Cell Surface Receptor Signaling Pathway (GO:0002768),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,BTLA
Inhibitory Synapse Assembly (GO:1904862),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,SRGAP2C
Intracellular Potassium Ion Homeostasis (GO:0030007),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,KCNJ2
Intraciliary Retrograde Transport (GO:0035721),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,TTC21A
Mature B Cell Differentiation Involved In Immune Response (GO:0002313),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,FCGR2B
Membrane Depolarization During Action Potential (GO:0086010),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,KCNJ2
Microvillus Organization (GO:0032528),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,TNIK
Myeloid Dendritic Cell Activation (GO:0001773),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,BATF2
Negative Regulation Of Bone Mineralization (GO:0030502),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,CCR1
Positive Regulation Of Chromosome Separation (GO:1905820),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,PLSCR1
Positive Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032725),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,RIGI
Positive Regulation Of Type 2 Immune Response (GO:0002830),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,RSAD2
Protein Localization To Phagophore Assembly Site (GO:0034497),1/13,0.193484473939494,0.471178347744939,0,0,5.01019367991845,8.22953374943037,STX17
DNA Metabolic Process (GO:0006259),7/288,0.195812590409847,0.476154743830921,0,0,1.50482810611856,2.45376856938276,RMI2;SP100;HELB;TREX1;FANCA;FBXO6;SAMHD1
Negative Regulation Of Amide Metabolic Process (GO:0034249),3/93,0.196207457532939,0.476422462195366,0,0,2.00841025641026,3.2708622437261,LARP1;EIF2AK2;IGF2BP3
Mitotic Metaphase Plate Congression (GO:0007080),2/50,0.19777438274677,0.479531220775865,0,0,2.5081799591002,4.06482762152409,NDC80;CHMP5
Vesicle Organization (GO:0016050),3/94,0.20040306146184,0.479670477285357,0,0,1.98623837700761,3.192728494475,PI4K2B;STX17;CHMP5
SMAD Protein Signal Transduction (GO:0060395),2/51,0.203760764660371,0.479670477285357,0,0,2.4568674095405,3.90840603895423,SMAD3;INHBA
Metaphase Plate Congression (GO:0051310),2/51,0.203760764660371,0.479670477285357,0,0,2.4568674095405,3.90840603895423,NDC80;CHMP5
Receptor Internalization (GO:0031623),2/51,0.203760764660371,0.479670477285357,0,0,2.4568674095405,3.90840603895423,CEACAM1;GTF2H2
Positive Regulation Of Epithelial Cell Migration (GO:0010634),3/95,0.204619884568147,0.479670477285357,0,0,1.96454849498328,3.11695508340515,BMPR2;PRKCE;RIN2
Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),3/95,0.204619884568147,0.479670477285357,0,0,1.96454849498328,3.11695508340515,BMPR2;INHBA;ACVR1B
Regulation Of Cholesterol Storage (GO:0010885),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,TTC39B
Regulation Of Exit From Mitosis (GO:0007096),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,MAD2L1BP
Regulation Of Leukocyte Activation (GO:0002694),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,PLSCR1
Regulation Of Macrophage Differentiation (GO:0045649),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,INHBA
Regulation Of Microglial Cell Activation (GO:1903978),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,MMP8
Regulation Of Non-Canonical Wnt Signaling Pathway (GO:2000050),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,RNF213
Bone Morphogenesis (GO:0060349),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,BMPR2
Ceramide Transport (GO:0035627),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,ABCA13
Copper Ion Homeostasis (GO:0055070),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,MT2A
Establishment Of Chromosome Localization (GO:0051303),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,NDC80
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,BRCA2
Striated Muscle Cell Development (GO:0055002),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,TMOD2
Striated Muscle Tissue Development (GO:0014706),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,BMPR2
tRNA 5'-End Processing (GO:0099116),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,SSB
Membrane Repolarization During Cardiac Muscle Cell Action Potential (GO:0086013),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,KCNJ2
Microvillus Assembly (GO:0030033),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,TNIK
Negative Regulation Of T Cell Mediated Immunity (GO:0002710),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,CEACAM1
Negative Regulation Of Blood Pressure (GO:0045776),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,BMPR2
Negative Regulation Of Fatty Acid Biosynthetic Process (GO:0045717),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,CEACAM1
Negative Regulation Of Nucleocytoplasmic Transport (GO:0046823),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,SP100
Negative Regulation Of Transcription Regulatory Region DNA Binding (GO:2000678),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,ZNF675
Nuclear Pore Organization (GO:0006999),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,NUP205
Protein Homotrimerization (GO:0070207),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,PNPT1
Protein Trimerization (GO:0070206),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,PNPT1
Regulation Of Carbohydrate Catabolic Process (GO:0043470),1/14,0.206719912804986,0.479670477285357,0,0,4.62455892731122,7.29011066809337,SCARB2
Regulation Of Protein Localization To Nucleus (GO:1900180),2/52,0.209767090263164,0.484724229295958,0,0,2.40760736196319,3.76009875287855,DTX3L;PARP9
Cellular Response To Ionizing Radiation (GO:0071479),2/52,0.209767090263164,0.484724229295958,0,0,2.40760736196319,3.76009875287855,IFI16;BRCA2
Positive Regulation Of B Cell Activation (GO:0050871),2/52,0.209767090263164,0.484724229295958,0,0,2.40760736196319,3.76009875287855,CD38;TNFSF13B
Positive Regulation Of Programmed Cell Death (GO:0043068),6/245,0.215429867813792,0.486917899277573,0,0,1.5150861508875,2.32583884254184,GBP5;TNFSF10;SEPTIN4;GBP1;IFIT2;GBP3
Cellular Response To Alcohol (GO:0097306),2/53,0.215791104080057,0.486917899277573,0,0,2.36027908095754,3.61935685712602,GRAMD1B;LARP1
Glycoprotein Metabolic Process (GO:0009100),2/53,0.215791104080057,0.486917899277573,0,0,2.36027908095754,3.61935685712602,GCNT1;FBXO6
Negative Regulation Of Metabolic Process (GO:0009892),2/53,0.215791104080057,0.486917899277573,0,0,2.36027908095754,3.61935685712602,IL18R1;MAP2K6
MAPK Cascade (GO:0000165),3/98,0.21738904584036,0.486917899277573,0,0,1.90221862348178,2.90291248349754,TNIK;RASGRP3;MAP2K6
Negative Regulation Of Response To External Stimulus (GO:0032102),4/146,0.218571719427475,0.486917899277573,0,0,1.69796557120501,2.58199620498848,IFI16;TREX1;DHX58;TRAFD1
3'-UTR-mediated mRNA Destabilization (GO:0061158),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,MOV10
B Cell Mediated Immunity (GO:0019724),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,FCGR2B
Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032645),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,RIGI
Regulation Of Interleukin-13 Production (GO:0032656),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,IRF4
Regulation Of Lipoprotein Lipase Activity (GO:0051004),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,PCSK5
Alpha-Beta T Cell Activation (GO:0046631),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,RSAD2
Regulation Of Monocyte Differentiation (GO:0045655),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,IRF7
Cardiac Myofibril Assembly (GO:0055003),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,NEBL
Cellular Response To Estrogen Stimulus (GO:0071391),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,SERPINB9
Regulation Of Systemic Arterial Blood Pressure (GO:0003073),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,BMPR2
Cellular Response To Sterol (GO:0036315),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,GRAMD1B
Cellular Response To Zinc Ion (GO:0071294),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,MT2A
Dendritic Cell Chemotaxis (GO:0002407),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,CCR1
Endosome To Lysosome Transport Via Multivesicular Body Sorting Pathway (GO:0032510),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,CHMP5
Epiboly Involved In Wound Healing (GO:0090505),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,CEACAM1
Intracellular Sterol Transport (GO:0032366),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,GRAMD1B
Keratan Sulfate Biosynthetic Process (GO:0018146),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,B4GALT4
Membrane Repolarization During Action Potential (GO:0086011),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,KCNJ2
Midbody Abscission (GO:0061952),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,CHMP5
Negative Regulation Of Macrophage Activation (GO:0043031),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,FCGR2B
Negative Regulation Of Platelet Activation (GO:0010544),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,CEACAM1
Nitric Oxide Biosynthetic Process (GO:0006809),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,GCH1
Protein Localization To Chromosome, Telomeric Region (GO:0070198),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,BRCA2
Regulation Of Activin Receptor Signaling Pathway (GO:0032925),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,ACVR1B
Regulation Of Carbohydrate Metabolic Process (GO:0006109),1/15,0.219738800929209,0.486917899277573,0,0,4.29401485364788,6.50678815165536,SCARB2
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),2/54,0.22183061875217,0.490254458616091,0,0,2.3147711184521,3.4856776421626,BMPR2;STAT1
Negative Regulation Of Protein Ubiquitination (GO:0031397),2/54,0.22183061875217,0.490254458616091,0,0,2.3147711184521,3.4856776421626,DTX3L;ISG15
Response To Peptide Hormone (GO:0043434),2/55,0.227883513569832,0.494342101652266,0,0,2.27098043755064,3.3585999465491,STAT1;STAT2
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),2/55,0.227883513569832,0.494342101652266,0,0,2.27098043755064,3.3585999465491,PARP9;PARP14
DNA Repair-Dependent Chromatin Remodeling (GO:0140861),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,DTX3L
Regulation Of Interleukin-1 Production (GO:0032652),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,CEACAM1
Activation Of Cysteine-Type Endopeptidase Activity (GO:0097202),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,IFI16
Regulation Of Nucleocytoplasmic Transport (GO:0046822),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,MX2
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,EIF2AK2
Cell Surface Toll-Like Receptor Signaling Pathway (GO:0140895),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,OAS1
Regulation Of Secretion (GO:0051046),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,OAS2
Regulation Of Stem Cell Proliferation (GO:0072091),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,EIF2AK2
Regulation Of Transforming Growth Factor Beta Production (GO:0071634),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,SMAD3
Glycoprotein Catabolic Process (GO:0006516),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,FBXO6
Vasculature Development (GO:0001944),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,BMPR2
Late Endosome To Lysosome Transport (GO:1902774),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,CHMP5
Lymphocyte Mediated Immunity (GO:0002449),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,BTN3A3
Membrane Depolarization During Cardiac Muscle Cell Action Potential (GO:0086012),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,KCNJ2
Negative Regulation Of ATP-dependent Activity (GO:0032780),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,IFIT1
Negative Regulation Of Biosynthetic Process (GO:0009890),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,CEACAM1
Negative Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002862),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,RHBDF2
Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,PARP14
Negative Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039532),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,DHX58
Nitric Oxide Metabolic Process (GO:0046209),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,GCH1
Nuclear Chromosome Segregation (GO:0098813),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,NDC80
Pharyngeal System Development (GO:0060037),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,BMPR2
Positive Regulation Of Muscle Hypertrophy (GO:0014742),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,PDE9A
Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,RIGI
Positive Regulation Of Smooth Muscle Cell Migration (GO:0014911),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,DOCK4
Protein Localization To Mitochondrion (GO:0070585),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,ISG15
Regulation Of B Cell Receptor Signaling Pathway (GO:0050855),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,FCGR2B
Regulation Of Autophagosome Maturation (GO:1901096),1/16,0.232544670651723,0.494342101652266,0,0,4.00754332313965,5.84569500364308,RUBCN
Nucleotide-Excision Repair (GO:0006289),2/56,0.233947732723541,0.496693600058991,0,0,2.22881163371961,3.2377000539444,GTF2H2;BRCA2
Regulation Of Protein Secretion (GO:0050708),3/102,0.234659962327033,0.497574292741604,0,0,1.82498834498835,2.6455355559791,RSAD2;RHBDF2;CD2AP
Myeloid Cell Differentiation (GO:0030099),2/57,0.240021283932037,0.498930520510166,0,0,2.18817624093698,3.12258805692516,IFI16;INHBA
Macroautophagy (GO:0016236),3/104,0.243385703739138,0.498930520510166,0,0,1.78866717440975,2.52757959983014,ZFYVE26;STX17;CHMP5
Regulation Of MAPK Cascade (GO:0043408),5/204,0.244115054085757,0.498930520510166,0,0,1.514772002427,2.13600367906473,CEACAM1;TRIM5;EIF2AK2;TNIK;MMP8
Regulation Of Cellular Respiration (GO:0043457),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PNPT1
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PML
Regulation Of Glucose Transmembrane Transport (GO:0010827),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,OCLN
Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002861),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,RHBDF2
Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090266),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,NDC80
cGMP-mediated Signaling (GO:0019934),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PDE9A
Carboxylic Acid Biosynthetic Process (GO:0046394),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,NAIP
Cellular Response To Glucocorticoid Stimulus (GO:0071385),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PCK2
Regulation Of Vacuole Organization (GO:0044088),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,SCARB2
Diol Biosynthetic Process (GO:0034312),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,GCH1
Triglyceride Biosynthetic Process (GO:0019432),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PCK2
Keratan Sulfate Metabolic Process (GO:0042339),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,B4GALT4
Leukocyte Tethering Or Rolling (GO:0050901),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,GCNT1
Membrane Lipid Metabolic Process (GO:0006643),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,B4GALT4
Mesenchyme Development (GO:0060485),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,BMPR2
Motile Cilium Assembly (GO:0044458),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,RSPH9
Myeloid Cell Activation Involved In Immune Response (GO:0002275),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,IFI35
Negative Regulation Of Fibroblast Proliferation (GO:0048147),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PARP10
Negative Regulation Of Leukocyte Activation (GO:0002695),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,FCGR2B
Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,DTX3L
Nicotinamide Nucleotide Metabolic Process (GO:0046496),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,NMRK1
Nuclear Envelope Organization (GO:0006998),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,TOR1B
Peptidyl-Threonine Dephosphorylation (GO:0035970),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PPM1K
Positive Regulation Of SMAD Protein Signal Transduction (GO:0060391),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,BMPR2
Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,PDE9A
Positive Regulation Of Cartilage Development (GO:0061036),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,BMPR2
Positive Regulation Of Macrophage Activation (GO:0043032),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,MMP8
Positive Regulation Of Nitric-Oxide Synthase Activity (GO:0051000),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,GCH1
Regulation Of DNA-templated DNA Replication (GO:0090329),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,METTL4
Regulation Of Cartilage Development (GO:0061035),1/17,0.24514099692729,0.498930520510166,0,0,3.75688073394495,5.28188028457851,BMPR2
Regulation Of Phagocytosis (GO:0050764),2/58,0.246102236755127,0.500278301447543,0,0,2.1489921121823,3.012904633546,PLSCR1;FCGR2B
Intrinsic Apoptotic Signaling Pathway (GO:0097193),3/105,0.247768325152403,0.503053893179575,0,0,1.7710407239819,2.47106430342755,IFI16;IFI6;PML
Protein Targeting To Mitochondrion (GO:0006626),2/59,0.252188721207513,0.504507839025979,0,0,2.11118286513831,2.90831817822233,TIMM10;DNAJC15
Regulation Of Cell Death (GO:0010941),2/59,0.252188721207513,0.504507839025979,0,0,2.11118286513831,2.90831817822233,HP;CHMP5
Positive Regulation Of T Cell Activation (GO:0050870),3/107,0.256569138273022,0.504507839025979,0,0,1.73680473372781,2.36267466085805,CD274;SMARCD3;RHOH
Regulation Of Defense Response To Virus (GO:0050688),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,HERC5
Regulation Of Epithelial Cell Differentiation (GO:0030856),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,CEACAM1
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,TAP2
Cardiac Atrium Morphogenesis (GO:0003209),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,BMPR2
Cardiac Muscle Cell Contraction (GO:0086003),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,KCNJ2
Response To Cholesterol (GO:0070723),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,GRAMD1B
Dendritic Cell Migration (GO:0036336),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,CCR1
Response To Organophosphorus (GO:0046683),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,STAT1
Endothelial Cell Proliferation (GO:0001935),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,BMPR2
Vesicle-Mediated Transport In Synapse (GO:0099003),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,OTOF
Icosanoid Biosynthetic Process (GO:0046456),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,NAIP
Intracellular Lipid Transport (GO:0032365),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,GRAMD1B
Maintenance Of Protein Localization In Organelle (GO:0072595),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,PML
Membrane Repolarization (GO:0086009),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,KCNJ2
Mitotic Cytokinetic Process (GO:1902410),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,CHMP5
Negative Regulation Of Lipid Storage (GO:0010888),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,TTC39B
Neuromuscular Process (GO:0050905),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,GCH1
Nucleosome Disassembly (GO:0006337),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,SMARCD3
Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,GBP5
Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,GBP5
Positive Regulation Of Extracellular Matrix Organization (GO:1903055),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,SMAD3
Positive Regulation Of Interleukin-4 Production (GO:0032753),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,IRF4
Positive Regulation Of Monocyte Chemotaxis (GO:0090026),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,CCR1
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,SMARCD3
Positive Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905898),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,FCGR2B
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,EIF2AK2
Regulation Of DNA Damage Checkpoint (GO:2000001),1/18,0.257531198163889,0.504507839025979,0,0,3.5357078611261,4.79659222794098,BRCA2
Response To Light Stimulus (GO:0009416),2/60,0.258278926304854,0.50479047162152,0,0,2.07467738523376,2.80852224578222,GTF2H2;TNFSF13B
protein-DNA Complex Organization (GO:0071824),2/60,0.258278926304854,0.50479047162152,0,0,2.07467738523376,2.80852224578222,PARP10;CBX5
Positive Regulation Of Translation (GO:0045727),3/108,0.260985784430084,0.509485667854761,0,0,1.72017582417582,2.31069384569686,METTL14;LARP1;SSB
BMP Signaling Pathway (GO:0030509),2/61,0.264371098631774,0.510130218670899,0,0,2.03940937922429,2.71323326916945,BMPR2;INHBA
Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),2/61,0.264371098631774,0.510130218670899,0,0,2.03940937922429,2.71323326916945,BMPR2;INHBA
Positive Regulation Of Interleukin-8 Production (GO:0032757),2/61,0.264371098631774,0.510130218670899,0,0,2.03940937922429,2.71323326916945,NOD1;RIGI
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),3/109,0.265412241871538,0.510130218670899,0,0,1.70386066763425,2.26012181823296,RNF144A;NUB1;TRIB2
DNA Catabolic Process (GO:0006308),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,TREX1
RNA Destabilization (GO:0050779),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,METTL14
Regulation Of Lymphocyte Differentiation (GO:0045619),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,PRDM1
Regulation Of Neuroinflammatory Response (GO:0150077),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,MMP8
Atrioventricular Valve Morphogenesis (GO:0003181),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,BMPR2
Regulation Of Protein-Containing Complex Disassembly (GO:0043244),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,SHFL
Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle (GO:0000083),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,CDK17
Release Of Cytochrome C From Mitochondria (GO:0001836),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,IFI6
Cortical Actin Cytoskeleton Organization (GO:0030866),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,FMNL2
Dopamine Metabolic Process (GO:0042417),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,GCH1
Embryonic Digestive Tract Development (GO:0048566),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,PCSK5
Superoxide Anion Generation (GO:0042554),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,CYBB
Glycosphingolipid Biosynthetic Process (GO:0006688),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,B4GALT4
Vesicle Docking (GO:0048278),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,STX17
Immunoglobulin Production Involved In Immunoglobulin-Mediated Immune Response (GO:0002381),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,GAPT
Leukocyte Adhesion To Vascular Endothelial Cell (GO:0061756),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,GCNT1
Negative Regulation Of Fatty Acid Metabolic Process (GO:0045922),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,CEACAM1
Negative Regulation Of Telomere Maintenance Via Telomerase (GO:0032211),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,XRN1
Phosphatidylcholine Biosynthetic Process (GO:0006656),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,CHPT1
Pore Complex Assembly (GO:0046931),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,NUP205
Protein Insertion Into Membrane (GO:0051205),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,RTP4
Regulation Of B Cell Differentiation (GO:0045577),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,INHBA
Regulation Of Behavior (GO:0050795),1/19,0.269718637218605,0.510130218670899,0,0,3.33910975195379,4.37548910571323,AIM2
Cell Junction Organization (GO:0034330),2/62,0.270463540921152,0.510130218670899,0,0,2.00531697341513,2.62218851761407,OCLN;SMAD3
Negative Regulation Of Kinase Activity (GO:0033673),2/62,0.270463540921152,0.510130218670899,0,0,2.00531697341513,2.62218851761407,CEACAM1;TRIB2
Protein-Containing Complex Disassembly (GO:0032984),2/62,0.270463540921152,0.510130218670899,0,0,2.00531697341513,2.62218851761407,STX17;CHMP5
T Cell Activation (GO:0042110),3/111,0.274291601377059,0.51620501524225,0,0,1.67213675213675,2.16301506939222,IRF4;RHOH;MICA
Protein Polymerization (GO:0051258),2/63,0.276554610679423,0.51620501524225,0,0,1.972342351403,2.5351442662508,TRIM6;PSTPIP2
Regulation Of Cellular Catabolic Process (GO:0031329),2/63,0.276554610679423,0.51620501524225,0,0,1.972342351403,2.5351442662508,IFI16;LAMP3
DNA Methylation (GO:0006306),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,METTL4
Regulation Of Fibroblast Migration (GO:0010762),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,PRKCE
Regulation Of Macrophage Chemotaxis (GO:0010758),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,C5
Regulation Of Mitotic Spindle Assembly (GO:1901673),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,CHMP5
Regulation Of Protein Localization To Cell Periphery (GO:1904375),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,GBP1
Cellular Response To Copper Ion (GO:0071280),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,MT2A
Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,IRF7
Cilium-Dependent Cell Motility (GO:0060285),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,RSPH9
Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,PML
Stress-Activated Protein Kinase Signaling Cascade (GO:0031098),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,MAP2K6
Late Endosome To Vacuole Transport (GO:0045324),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,CHMP5
Limb Morphogenesis (GO:0035108),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,PCSK5
Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,PRKCE
Mesoderm Formation (GO:0001707),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,BMPR2
Mitochondrial RNA Metabolic Process (GO:0000959),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,PNPT1
Monocarboxylic Acid Catabolic Process (GO:0072329),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,FANCA
Negative Regulation Of Phosphate Metabolic Process (GO:0045936),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,INHBA
Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,GBP1
Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,GBP1
Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,CD2AP
Phosphatidylserine Metabolic Process (GO:0006658),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,PLSCR1
protein-DNA Complex Disassembly (GO:0032986),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,SMARCD3
Pulmonary Valve Development (GO:0003177),1/20,0.2817066221854,0.51620501524225,0,0,3.16320618058909,4.00743141998222,BMPR2
Positive Regulation Of T Cell Differentiation (GO:0045582),2/64,0.282642718918452,0.517353685722725,0,0,1.94043142687512,2.4518741519053,SMARCD3;RHOH
Negative Regulation Of Cell Population Proliferation (GO:0008285),8/379,0.284163143531079,0.519568239483602,0,0,1.3006064690027,1.63643184710761,PARP10;SMAD3;BMPR2;EIF2AK2;IFI35;INHBA;IFIT3;PML
Regulation Of Interleukin-6 Production (GO:0032675),3/114,0.287665791138213,0.525398328137806,0,0,1.62669438669439,2.02678950133343,IFIH1;MMP8;RIGI
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),2/65,0.288726328911921,0.526138179210922,0,0,1.90953354757036,2.37216769409666,PARP9;PARP14
Regulation Of Dendritic Spine Development (GO:0060998),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,SRGAP2C
Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031664),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,TRIM5
Regulation Of Neurotransmitter Transport (GO:0051588),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,OTOF
Regulation Of Steroid Metabolic Process (GO:0019218),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,TTC39B
Regulation Of Transferase Activity (GO:0051338),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,NLRC5
Sulfur Compound Transport (GO:0072348),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,SLC26A8
Lipid Catabolic Process (GO:0016042),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,STS
Macrophage Differentiation (GO:0030225),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,CASP10
Negative Regulation Of Biomineral Tissue Development (GO:0070168),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,CCR1
Negative Regulation Of Interleukin-2 Production (GO:0032703),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,GBP1
Negative Regulation Of Osteoclast Differentiation (GO:0045671),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,ZNF675
Plasma Membrane Repair (GO:0001778),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,CHMP5
Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,TNFSF13B
Positive Regulation Of Blood Coagulation (GO:0030194),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,ENPP4
Positive Regulation Of Transcription Regulatory Region DNA Binding (GO:2000679),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,TRIM6
Positive Regulation Of Translational Initiation (GO:0045948),1/21,0.293498407418785,0.526138179210922,0,0,3.00489296636086,3.68364740230318,LARP1
Membrane Organization (GO:0061024),4/167,0.29373165533951,0.526138179210922,0,0,1.4776187230175,1.8102139493248,RTP4;OTOF;TOR1B;CHMP5
Cellular Response To BMP Stimulus (GO:0071773),2/66,0.294803954680189,0.527494134951824,0,0,1.87960122699387,2.29582896428079,BMPR2;INHBA
Negative Regulation Of Cellular Catabolic Process (GO:0031330),2/67,0.300874160015357,0.537780416352235,0,0,1.85058990089665,2.22267538141804,RUBCN;HP
Positive Regulation Of Multicellular Organismal Process (GO:0051240),8/387,0.303238836852082,0.539262462184269,0,0,1.2726253298153,1.51854050451349,SMAD3;BMPR2;BTN3A1;IFI16;IRF4;EIF2AK2;INHBA;ACVR1B
NAD Metabolic Process (GO:0019674),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,NMRK1
Regulation Of Protein Export From Nucleus (GO:0046825),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,SP100
Regulation Of Regulatory T Cell Differentiation (GO:0045589),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,FANCA
Dendritic Cell Differentiation (GO:0097028),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,BATF2
Natural Killer Cell Mediated Immunity (GO:0002228),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,MICA
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001240),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,IFI6
Negative Regulation Of Macroautophagy (GO:0016242),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,RUBCN
Negative Regulation Of Signal Transduction In Absence Of Ligand (GO:1901099),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,IFI6
Positive Regulation Of Viral Life Cycle (GO:1903902),1/22,0.305097194371998,0.539262462184269,0,0,2.86165720110674,3.39714447024204,TRIM38
Regulation Of Protein Binding (GO:0043393),3/118,0.305571317483973,0.539262462184269,0,0,1.56979264214047,1.86110233182807,DTX3L;IFIT1;IFIT2
Positive Regulation Of Cell Cycle Process (GO:0090068),3/118,0.305571317483973,0.539262462184269,0,0,1.56979264214047,1.86110233182807,PLSCR1;PRKCE;NDC80
Cell-Cell Junction Organization (GO:0045216),2/68,0.306935557057837,0.541099248638315,0,0,1.82245770589329,2.15253662618882,OCLN;SMAD3
Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903844),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,SMAD3
Regulation Of Centrosome Cycle (GO:0046605),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,CHMP5
Regulation Of Cholesterol Metabolic Process (GO:0090181),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,TTC39B
Regulation Of Cholesterol Transport (GO:0032374),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,TTC39B
Regulation Of Interleukin-4 Production (GO:0032673),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,IRF4
Artery Development (GO:0060840),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,BMPR2
Bile Acid And Bile Salt Transport (GO:0015721),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,CEACAM1
Response To BMP (GO:0071772),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,BMPR2
Endocardial Cushion Development (GO:0003197),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,BMPR2
Entrainment Of Circadian Clock By Photoperiod (GO:0043153),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,PML
Nuclear Membrane Reassembly (GO:0031468),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,CHMP5
Positive Regulation Of Lamellipodium Assembly (GO:0010592),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,OCLN
Potassium Ion Homeostasis (GO:0055075),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,KCNJ2
Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),1/23,0.316506132320809,0.549859563211541,0,0,2.73144286905755,3.14228646254248,PDE9A
Positive Regulation Of Protein Polymerization (GO:0032273),2/70,0.31902660999135,0.552711167555439,0,0,1.76867556838686,2.02067781247302,OCLN;PRKCE
Protein K48-linked Ubiquitination (GO:0070936),2/70,0.31902660999135,0.552711167555439,0,0,1.76867556838686,2.02067781247302,TRIM6;DTX3L
Positive Regulation Of Cell Differentiation (GO:0045597),6/283,0.320368820954097,0.552711167555439,0,0,1.30468417158105,1.4850990058028,CEACAM1;SMAD3;BMPR2;SMARCD3;TENT5A;RIN2
Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),2/71,0.325053721805575,0.552711167555439,0,0,1.74295367653597,1.95867001142022,HELB;RMI2
Kidney Development (GO:0001822),2/71,0.325053721805575,0.552711167555439,0,0,1.74295367653597,1.95867001142022,C1GALT1;PCSK5
Negative Regulation Of Protein Binding (GO:0032091),2/71,0.325053721805575,0.552711167555439,0,0,1.74295367653597,1.95867001142022,IFIT1;IFIT2
Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000116),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,IFI16
Regulation Of Cytokine Production Involved In Immune Response (GO:0002718),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,TRIM6
Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902235),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,FCGR2B
Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034114),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,IL1RN
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,SMARCD3
Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,NUB1
Response To Copper Ion (GO:0046688),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,MT2A
Response To Purine-Containing Compound (GO:0014074),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,STAT1
Dicarboxylic Acid Transport (GO:0006835),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,SLC26A8
Endosome Transport Via Multivesicular Body Sorting Pathway (GO:0032509),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,CHMP5
Gliogenesis (GO:0042063),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,METTL14
mRNA Polyadenylation (GO:0006378),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,PNPT1
Mononuclear Cell Differentiation (GO:1903131),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,IFI16
Natural Killer Cell Mediated Cytotoxicity (GO:0042267),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,MICA
Negative Regulation Of Ion Transmembrane Transporter Activity (GO:0032413),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,PRKCE
Negative Regulation Of Ossification (GO:0030279),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,CCR1
Outflow Tract Septum Morphogenesis (GO:0003148),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,BMPR2
Peroxisome Organization (GO:0007031),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,TMEM135
Photoperiodism (GO:0009648),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,PML
Positive Regulation Of BMP Signaling Pathway (GO:0030513),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,BMPR2
Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,TNFSF13B
Positive Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010800),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,TRIM6
Positive Regulation Of Vascular Endothelial Growth Factor Production (GO:0010575),1/24,0.327728319315598,0.552711167555439,0,0,2.61255152240394,2.9144849080637,C5
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),5/231,0.329293332127065,0.552933523489734,0,0,1.33195430011781,1.47954327907265,AIM2;STAT1;RHOH;IFI35;CD2AP
Cholesterol Homeostasis (GO:0042632),2/72,0.331066934830822,0.552933523489734,0,0,1.71796669588081,1.89910000597051,GRAMD1B;TTC39B
Response To Ionizing Radiation (GO:0010212),2/72,0.331066934830822,0.552933523489734,0,0,1.71796669588081,1.89910000597051,IFI16;BRCA2
Plasma Membrane Organization (GO:0007009),2/72,0.331066934830822,0.552933523489734,0,0,1.71796669588081,1.89910000597051,PLSCR1;CHMP5
DNA Replication (GO:0006260),2/73,0.337065086038474,0.552933523489734,0,0,1.69368357383565,1.8418457148905,HELB;TREX1
Sterol Homeostasis (GO:0055092),2/73,0.337065086038474,0.552933523489734,0,0,1.69368357383565,1.8418457148905,GRAMD1B;TTC39B
RNA Polyadenylation (GO:0043631),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,PNPT1
Regulation Of Lysosomal Lumen pH (GO:0035751),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,TASL
Regulation Of Monocyte Chemotaxis (GO:0090025),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,CCR1
Regulation Of Platelet Aggregation (GO:0090330),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,CEACAM1
Regulation Of Postsynapse Organization (GO:0099175),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,FCGR2B
Cellular Response To Hexose Stimulus (GO:0071331),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,PCK2
Response To dsRNA (GO:0043331),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,RIGI
Response To Zinc Ion (GO:0010043),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,MT2A
Ribonucleoside Bisphosphate Metabolic Process (GO:0033875),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,ACOT9
Sterol Transport (GO:0015918),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,GRAMD1B
Wound Healing, Spreading Of Cells (GO:0044319),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,CEACAM1
Late Endosome To Vacuole Transport Via Multivesicular Body Sorting Pathway (GO:0032511),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,CHMP5
Mismatch Repair (GO:0006298),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,TREX1
Negative Regulation Of TORC1 Signaling (GO:1904262),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,KPTN
Negative Regulation Of Intracellular Protein Transport (GO:0090317),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,SP100
Negative Regulation Of Lipid Biosynthetic Process (GO:0051055),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,CEACAM1
Negative Regulation Of Protein Localization To Membrane (GO:1905476),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,GBP1
Negative Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904357),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,XRN1
Peptide Hormone Secretion (GO:0030072),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,EXOC3L1
Phosphatidylethanolamine Metabolic Process (GO:0046337),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,SELENOI
Positive Regulation Of Glucose Import (GO:0046326),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,OCLN
Positive Regulation Of Interleukin-2 Production (GO:0032743),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,IRF4
Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,TNFSF10
Proteoglycan Metabolic Process (GO:0006029),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,BMPR2
Purine Nucleoside Bisphosphate Metabolic Process (GO:0034032),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,ACOT9
Purine Ribonucleotide Catabolic Process (GO:0009154),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,PDE9A
Regulation Of B Cell Activation (GO:0050864),1/25,0.338766803094428,0.552933523489734,0,0,2.50356778797146,2.70997019017172,FCGR2B
Regulation Of Fat Cell Differentiation (GO:0045598),2/75,0.349011757871232,0.559198781343329,0,0,1.64711320279015,1.73383316471127,SMAD3;TRIB2
Negative Regulation Of Phosphorylation (GO:0042326),2/75,0.349011757871232,0.559198781343329,0,0,1.64711320279015,1.73383316471127,OCLN;INHBA
Regulation Of Fatty Acid Biosynthetic Process (GO:0042304),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,CEACAM1
Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,FCGR2B
Regulation Of Nucleotide-Excision Repair (GO:2000819),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,SMARCD3
Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903426),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,MMP8
Regulation Of Vascular Endothelial Growth Factor Production (GO:0010574),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,C5
Cellular Response To Xenobiotic Stimulus (GO:0071466),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,AIM2
Regulation Of Vasoconstriction (GO:0019229),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,BMPR2
Response To Glucocorticoid (GO:0051384),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,IL1RN
Spindle Assembly Checkpoint Signaling (GO:0071173),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,NDC80
miRNA-mediated Gene Silencing (GO:0035195),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,MOV10
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,PML
Mitotic Spindle Assembly Checkpoint Signaling (GO:0007094),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,NDC80
Mitotic Spindle Checkpoint Signaling (GO:0071174),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,NDC80
Negative Regulation Of Lipid Metabolic Process (GO:0045833),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,CEACAM1
Organelle Membrane Fusion (GO:0090174),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,STX17
Plasma Membrane Invagination (GO:0099024),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,FCGR2B
Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,OCLN
Positive Regulation Of Monooxygenase Activity (GO:0032770),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,GCH1
Protein Targeting To Lysosome (GO:0006622),1/26,0.349624581760384,0.559198781343329,0,0,2.40330275229358,2.52561962385132,SCARB2
Protein Targeting (GO:0006605),3/129,0.354918063829301,0.567123133511385,0,0,1.43194139194139,1.48330272724669,RTP4;AP4E1;TIMM10
Regulation Of Inflammatory Response (GO:0050727),5/240,0.358454163575453,0.567612760558662,0,0,1.28035043804756,1.31358127204878,AIM2;IFI35;MMP8;USP18;NAIP
Golgi Organization (GO:0007030),3/130,0.359392376648942,0.567612760558662,0,0,1.4205935796487,1.45375096708682,PI4K2B;COG6;STX17
Regulation Of Chromatin Organization (GO:1902275),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,METTL4
Regulation Of Immunoglobulin Production (GO:0002637),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,FCGR2B
Regulation Of Mitochondrial Fission (GO:0090140),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,STAT2
Respiratory Tube Development (GO:0030323),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,PCSK5
Clathrin-Dependent Endocytosis (GO:0072583),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,SIGLEC1
Cortical Cytoskeleton Organization (GO:0030865),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,FMNL2
Ventricular Septum Morphogenesis (GO:0060412),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,BMPR2
Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,IFI35
Positive Regulation Of Immune System Process (GO:0002684),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,RSAD2
Regulation Of SMAD Protein Signal Transduction (GO:0060390),1/27,0.360304604636581,0.567612760558662,0,0,2.31075041166784,2.35882668615275,BMPR2
Actomyosin Structure Organization (GO:0031032),2/77,0.360885247026313,0.567612760558662,0,0,1.60302658486708,1.63379707523861,FRMD3;TMOD2
Chloride Transport (GO:0006821),2/77,0.360885247026313,0.567612760558662,0,0,1.60302658486708,1.63379707523861,SLC26A8;APOL1
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),2/77,0.360885247026313,0.567612760558662,0,0,1.60302658486708,1.63379707523861,STAT1;PML
Regulation Of T Cell Proliferation (GO:0042129),2/77,0.360885247026313,0.567612760558662,0,0,1.60302658486708,1.63379707523861,CD274;IDO1
Regulation Of Intracellular Signal Transduction (GO:1902531),6/297,0.360992215920153,0.567612760558662,0,0,1.24101940193379,1.26447328294504,TRIM6;CEACAM1;ARHGEF3;TNIK;GBP1;MAP2K6
Epithelial Cell Differentiation (GO:0030855),3/132,0.368327223462472,0.572820637316472,0,0,1.39842576028623,1.39672463369209,DHRS9;TDRD7;PCK2
Regulation Of Chromosome Segregation (GO:0051983),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,RMI2
Golgi To Plasma Membrane Protein Transport (GO:0043001),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,VAMP5
RNA Phosphodiester Bond Hydrolysis (GO:0090501),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,XRN1
Regulation Of Lipid Biosynthetic Process (GO:0046890),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,CEACAM1
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,FCGR2B
Regulation Of Monoatomic Ion Transport (GO:0043269),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,KCNJ2
Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,GCH1
Regulation Of Protein Localization To Membrane (GO:1905475),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,GBP1
Regulation Of Protein Transport (GO:0051223),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,RHBDF2
Hematopoietic Progenitor Cell Differentiation (GO:0002244),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,INHBA
Limb Development (GO:0060173),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,PCSK5
Membrane Fusion (GO:0061025),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,OTOF
Negative Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0045841),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,NDC80
Positive Regulation Of Protein Import Into Nucleus (GO:0042307),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,SMAD3
Protein Insertion Into Mitochondrial Membrane (GO:0051204),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,TIMM10
Protein Localization To Golgi Apparatus (GO:0034067),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,GBP5
Pyroptosis (GO:0070269),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,NAIP
Regulation Of Calcium Ion-Dependent Exocytosis (GO:0017158),1/28,0.370809772990878,0.572820637316472,0,0,2.22505379997735,2.20740042146058,RPH3A
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),14/763,0.372059060099612,0.574115800778858,0,0,1.12643609738675,1.11371038112806,SP100;CBX5;SMAD3;STAT1;PRDM1;PARP9;ETV7;IFI16;TFEC;IRF7;ZNF589;ZNF675;ATF3;ZNF684
Response To Insulin (GO:0032868),2/79,0.372677680601219,0.574115800778858,0,0,1.56123018086208,1.54099876096903,CEACAM1;PCK2
Positive Regulation Of Endocytosis (GO:0045807),2/79,0.372677680601219,0.574115800778858,0,0,1.56123018086208,1.54099876096903,ANKFY1;FCGR2B
Regulation Of Cytokinesis (GO:0032465),2/80,0.378541202477408,0.574979387146073,0,0,1.54113575585968,1.49710605404389,ZFYVE26;PRKCE
Regulation Of Protein Localization To Plasma Membrane (GO:1903076),2/80,0.378541202477408,0.574979387146073,0,0,1.54113575585968,1.49710605404389,PRKCE;GBP1
Glycoprotein Biosynthetic Process (GO:0009101),2/80,0.378541202477408,0.574979387146073,0,0,1.54113575585968,1.49710605404389,BMPR2;GCNT1
Wound Healing (GO:0042060),2/80,0.378541202477408,0.574979387146073,0,0,1.54113575585968,1.49710605404389,SMAD3;CHMP5
Organelle Organization (GO:0006996),8/418,0.379275570487557,0.574979387146073,0,0,1.17451219512195,1.13868045801214,PI4K2B;TMEM135;FMNL2;COG6;STX17;TNIK;TOR1B;CHMP5
RNA Biosynthetic Process (GO:0032774),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,HELB
TOR Signaling (GO:0031929),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,LARP1
Regulation Of Monoatomic Ion Transmembrane Transport (GO:0034765),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,KCNJ2
Carbohydrate Derivative Biosynthetic Process (GO:1901137),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,GCNT1
Cardiac Muscle Cell Action Potential (GO:0086001),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,KCNJ2
Regulation Of Spindle Assembly (GO:0090169),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,CHMP5
Regulation Of Voltage-Gated Calcium Channel Activity (GO:1901385),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,CACNA1A
Establishment Of Mitotic Spindle Orientation (GO:0000132),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,NDC80
Lipid Droplet Organization (GO:0034389),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,RNF213
Maintenance Of Blood-Brain Barrier (GO:0035633),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,OCLN
Multivesicular Body Assembly (GO:0036258),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,CHMP5
Negative Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120033),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,SRGAP2C
Organic Cyclic Compound Biosynthetic Process (GO:1901362),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,GCH1
Positive Regulation Of Calcium Ion Transport (GO:0051928),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,CCR1
Positive Regulation Of Endopeptidase Activity (GO:0010950),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,AIM2
Positive Regulation Of Microtubule Polymerization (GO:0031116),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,OCLN
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,SMARCD3
Regulation Of Blood Coagulation (GO:0030193),1/29,0.381142941031079,0.574979387146073,0,0,2.14547837483617,2.06948724912475,ENPP4
Regulation Of Interleukin-8 Production (GO:0032677),2/81,0.384381772221645,0.578821516585789,0,0,1.5215500504776,1.45478294586495,NOD1;RIGI
Cellular Response To Interleukin-1 (GO:0071347),2/81,0.384381772221645,0.578821516585789,0,0,1.5215500504776,1.45478294586495,GBP1;GBP3
Artery Morphogenesis (GO:0048844),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,BMPR2
Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,KCNJ2
Regulation Of Vasculature Development (GO:1901342),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,SP100
Cytoplasmic Translational Initiation (GO:0002183),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,EIF2S3B
Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:0008625),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,CASP10
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,TNFSF13B
Multivesicular Body Organization (GO:0036257),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,CHMP5
Negative Regulation Of Interleukin-1 Production (GO:0032692),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,CEACAM1
Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,PARP14
Nucleic Acid Metabolic Process (GO:0090304),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,TREX1
Phagocytosis, Engulfment (GO:0006911),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,FCGR2B
Regulation Of Calcium-Mediated Signaling (GO:0050848),1/30,0.391306916332132,0.582953224419997,0,0,2.07139091004956,1.94350960407465,GBP1
Endomembrane System Organization (GO:0010256),4/196,0.401292089692007,0.589448958011078,0,0,1.25257201646091,1.14368056205839,PI4K2B;COG6;STX17;TOR1B
Regulation Of Centrosome Duplication (GO:0010824),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,CHMP5
B Cell Proliferation (GO:0042100),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,GAPT
Regulation Of Dendrite Morphogenesis (GO:0048814),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,TNIK
Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,SP100
Actin Filament Polymerization (GO:0030041),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,PSTPIP2
acyl-CoA Metabolic Process (GO:0006637),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,ACOT9
Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,FCGR2B
Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,SMAD3
Leukocyte Cell-Cell Adhesion (GO:0007159),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,OLR1
Phospholipid Translocation (GO:0045332),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,PLSCR1
Positive Regulation Of Rho Protein Signal Transduction (GO:0035025),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,ARHGEF3
Positive Regulation Of Cholesterol Transport (GO:0032376),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,ABCA13
Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,OCLN
Positive Regulation Of Lamellipodium Organization (GO:1902745),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,OCLN
Positive Regulation Of Mononuclear Cell Migration (GO:0071677),1/31,0.401304460953149,0.589448958011078,0,0,2.00224260958206,1.82811735181503,CCR1
Purine Ribonucleotide Metabolic Process (GO:0009150),2/84,0.401757692615722,0.589597034865002,0,0,1.46565913511896,1.33654354508607,ACOT9;PDE9A
Regulation Of Osteoblast Differentiation (GO:0045667),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,BMPR2;TENT5A
Response To Interleukin-1 (GO:0070555),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,GBP1;GBP3
Defense Response To Gram-positive Bacterium (GO:0050830),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,GBP6;GBP4
Integrin-Mediated Signaling Pathway (GO:0007229),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,CEACAM1;ISG15
mRNA Metabolic Process (GO:0016071),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,PNPT1;SSB
Macromolecule Catabolic Process (GO:0009057),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,PNPT1;TREX1
Positive Regulation Of Endothelial Cell Migration (GO:0010595),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,BMPR2;RIN2
Positive Regulation Of Protein Localization (GO:1903829),2/85,0.407498539443166,0.592449924456609,0,0,1.44792667602927,1.29982973911523,DTX3L;PARP9
Regulation Of Cholesterol Efflux (GO:0010874),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,TTC39B
Amide Transport (GO:0042886),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,ABCA13
Regulation Of Metaphase/Anaphase Transition Of Cell Cycle (GO:1902099),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,SMARCD3
Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0042269),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,MICA
Cellular Nitrogen Compound Biosynthetic Process (GO:0044271),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,GCH1
Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,DTX3L
Gluconeogenesis (GO:0006094),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,PCK2
Vesicle Budding From Membrane (GO:0006900),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,CHMP5
miRNA Processing (GO:0035196),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,SMAD3
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,INHBA
Protein Transmembrane Import Into Intracellular Organelle (GO:0044743),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,DNAJC15
Proteoglycan Biosynthetic Process (GO:0030166),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,BMPR2
Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901019),1/32,0.411138291867378,0.592449924456609,0,0,1.93755548978988,1.72214900700281,CACNA1A
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),2/86,0.413212635723264,0.594415081311282,0,0,1.43061641834648,1.26436872191554,SMARCD3;MAD2L1BP
Negative Regulation Of Angiogenesis (GO:0016525),2/86,0.413212635723264,0.594415081311282,0,0,1.43061641834648,1.26436872191554,STAT1;PML
Regulation Of Lamellipodium Assembly (GO:0010591),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,OCLN
Regulation Of Sprouting Angiogenesis (GO:1903670),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,CEACAM1
Signal Transduction By P53 Class Mediator (GO:0072331),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,IFI16
Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,CHMP5
intra-Golgi Vesicle-Mediated Transport (GO:0006891),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,COG6
Negative Regulation Of Epithelial Cell Migration (GO:0010633),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,SP100
Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,MICA
Positive Regulation Of Chromosome Organization (GO:2001252),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,PML
Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,TRIM6
Positive Regulation Of Nitrogen Compound Metabolic Process (GO:0051173),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,INHBA
Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,PRKCE
Regulation Of G0 To G1 Transition (GO:0070316),1/33,0.420811081919183,0.599163353234718,0,0,1.87691131498471,1.62460053413666,SMARCD3
Cellular Component Assembly (GO:0022607),5/260,0.423329491252086,0.602236597674099,0,0,1.17871668791356,1.01323012674686,OCLN;FANCA;RSPH9;PML;CD2AP
Regulation Of Double-Strand Break Repair (GO:2000779),2/88,0.424557936403398,0.602958767065267,0,0,1.39720359537737,1.19699382258033,SMARCD3;PML
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),2/88,0.424557936403398,0.602958767065267,0,0,1.39720359537737,1.19699382258033,OCLN;AGRN
Regulation Of Cold-Induced Thermogenesis (GO:0120161),3/146,0.430042410735394,0.603971891940369,0,0,1.26061323292093,1.06379551113299,IRF4;IL18R1;MAP2K6
Cellular Response To Peptide Hormone Stimulus (GO:0071375),2/89,0.430187892218493,0.603971891940369,0,0,1.38107326704746,1.16498116217259,CEACAM1;PCK2
Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,RUBCN
Cellular Response To Glucose Stimulus (GO:0071333),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,PCK2
Response To Estrogen (GO:0043627),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,SERPINB9
Embryonic Skeletal System Development (GO:0048706),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,PCSK5
Sister Chromatid Segregation (GO:0000819),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,NDC80
Establishment Of Mitotic Spindle Localization (GO:0040001),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,NDC80
Superoxide Metabolic Process (GO:0006801),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,CYBB
Inner Mitochondrial Membrane Organization (GO:0007007),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,TIMM10
Negative Regulation Of JNK Cascade (GO:0046329),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,ZNF675
Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,PRKCE
Protein Targeting To Vacuole (GO:0006623),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,SCARB2
Regulation Of DNA Biosynthetic Process (GO:2000278),1/34,0.430325460366359,0.603971891940369,0,0,1.81994254471319,1.53460007199411,BMPR2
Regulation Of Angiogenesis (GO:0045765),4/205,0.434365049267281,0.608635621370406,0,0,1.19593391069345,0.997253375532065,CEACAM1;SP100;STAT1;PML
Negative Regulation Of Protein Metabolic Process (GO:0051248),3/147,0.434375930613428,0.608635621370406,0,0,1.25179487179487,1.04380279503611,LARP1;EIF2AK2;IGF2BP3
Regulation Of Cellular Senescence (GO:2000772),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,PNPT1
Action Potential (GO:0001508),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,KCNJ2
Regulation Of Regulated Secretory Pathway (GO:1903305),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,RPH3A
Establishment Of Spindle Orientation (GO:0051294),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,NDC80
Hexose Biosynthetic Process (GO:0019319),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,PCK2
Liver Development (GO:0001889),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,PCK2
Macrophage Activation (GO:0042116),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,IFI35
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,INHBA
Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),1/35,0.439684013772904,0.611464135529567,0,0,1.76632487857528,1.45138731677114,TNFSF13B
Skeletal System Development (GO:0001501),3/149,0.443006158473855,0.615061662345859,0,0,1.23452054794521,1.0051115787491,CREB3L2;COL9A2;PCSK5
Negative Regulation Of Protein Phosphorylation (GO:0001933),3/149,0.443006158473855,0.615061662345859,0,0,1.23452054794521,1.0051115787491,OCLN;CEACAM1;TRIB2
Steroid Metabolic Process (GO:0008202),2/92,0.446900065991236,0.619630178450528,0,0,1.3348329925017,1.07510155640477,STS;DHRS9
Regulation Of Glucose Import (GO:0046324),1/36,0.448889286480598,0.619630178450528,0,0,1.71577107907383,1.37429660252686,OCLN
Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),1/36,0.448889286480598,0.619630178450528,0,0,1.71577107907383,1.37429660252686,TRIM6
Regulation Of Trans-Synaptic Signaling (GO:0099177),1/36,0.448889286480598,0.619630178450528,0,0,1.71577107907383,1.37429660252686,CACNA1A
Interstrand Cross-Link Repair (GO:0036297),1/36,0.448889286480598,0.619630178450528,0,0,1.71577107907383,1.37429660252686,FANCA
Lytic Vacuole Organization (GO:0080171),1/36,0.448889286480598,0.619630178450528,0,0,1.71577107907383,1.37429660252686,ZFYVE26
Positive Regulation Of RNA Splicing (GO:0033120),1/36,0.448889286480598,0.619630178450528,0,0,1.71577107907383,1.37429660252686,HNRNPLL
Regulation Of Endothelial Cell Proliferation (GO:0001936),2/93,0.452409791568172,0.623974922748188,0,0,1.32009708083328,1.04705729790663,BMPR2;STAT1
Cellular Response To Hormone Stimulus (GO:0032870),2/94,0.457888196666325,0.625420364471421,0,0,1.30568151507069,1.01990731098781,LMO2;SERPINB9
Muscle Contraction (GO:0006936),2/94,0.457888196666325,0.625420364471421,0,0,1.30568151507069,1.01990731098781,TMOD2;SNTB1
Peptidyl-Lysine Modification (GO:0018205),2/94,0.457888196666325,0.625420364471421,0,0,1.30568151507069,1.01990731098781,IFIH1;PML
Calcium Ion Import Across Plasma Membrane (GO:0098703),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,CACNA1A
Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000649),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,PRKCE
Synaptic Vesicle Cycle (GO:0099504),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,OTOF
Ventricular Septum Development (GO:0003281),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,BMPR2
Negative Regulation Of Endothelial Cell Migration (GO:0010596),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,SP100
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,STAT1
Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,BMPR2
Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,ZNF675
Negative Regulation Of Transferase Activity (GO:0051348),1/37,0.457943781516731,0.625420364471421,0,0,1.66802582398913,1.30274293086787,DTX3L
Regulation Of Cellular Component Organization (GO:0051128),3/153,0.460109282142494,0.627865276528868,0,0,1.20135384615385,0.932600476327269,CEACAM1;METTL4;CHPT1
Positive Regulation Of Cell Migration (GO:0030335),5/272,0.461748140610231,0.628350752064432,0,0,1.12504493222481,0.869362368319581,CCR1;SRGAP2C;BMPR2;PRKCE;ACVR1B
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),8/452,0.463723567439974,0.628350752064432,0,0,1.08265765765766,0.831986318562991,SMAD3;BNC2;RHOH;BRCA2;ACVR1B;ZNF675;TRIM22;PML
Regulation Of Intracellular Transport (GO:0032386),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,MX2
Amino Acid Catabolic Process (GO:0009063),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,IDO1
Regulation Of Neurotransmitter Secretion (GO:0046928),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,OTOF
Regulation Of Protein Import Into Nucleus (GO:0042306),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,SMAD3
Regulation Of Telomere Maintenance (GO:0032204),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,PML
Response To cAMP (GO:0051591),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,STAT1
Connective Tissue Development (GO:0061448),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,CREB3L2
Response To Transforming Growth Factor Beta (GO:0071559),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,SMAD3
Signal Release From Synapse (GO:0099643),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,OTOF
Establishment Of Protein Localization To Plasma Membrane (GO:0061951),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,VAMP5
Maturation Of SSU-rRNA (GO:0030490),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,IGF2BP3
Membrane Assembly (GO:0071709),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,CHMP5
Membrane Fission (GO:0090148),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,CHMP5
Positive Regulation Of Myoblast Differentiation (GO:0045663),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,SMARCD3
Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),1/38,0.46684996103771,0.628350752064432,0,0,1.6228613935036,1.2362103748607,TRIM6
Cellular Response To Growth Factor Stimulus (GO:0071363),3/155,0.46857672759978,0.629893561238922,0,0,1.18542510121457,0.898617920396996,SMAD3;BMPR2;ACVR1B
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),2/96,0.468749243121613,0.629893561238922,0,0,1.27777052604099,0.968150520816145,OCLN;PRKCE
Regulation Of Mitotic Spindle Organization (GO:0060236),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,CHMP5
Digestive Tract Development (GO:0048565),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,PCSK5
Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,GBP1
Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,LAMP3
Negative Regulation Of Transport (GO:0051051),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,RUBCN
Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,PML
Nuclear Transport (GO:0051169),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,NUP205
Odontogenesis (GO:0042476),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,INHBA
Positive Regulation Of ATP-dependent Activity (GO:0032781),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,PLSCR1
Positive Regulation Of Cytokinesis (GO:0032467),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,PRKCE
Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),1/39,0.475610247281171,0.633515878743153,0,0,1.58007403830678,1.17424240011037,SEPTIN4
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),2/98,0.479479830356189,0.638162097204379,0,0,1.25102249488753,0.919568400208119,GBP5;ISG15
Peptide Biosynthetic Process (GO:0043043),3/158,0.481165609484326,0.638889439454418,0,0,1.16230272952854,0.850275315610906,SRBD1;IGF2BP3;PCSK5
Regulation Of Microtubule Polymerization (GO:0031113),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,OCLN
Aortic Valve Development (GO:0003176),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,BMPR2
Regulation Of Small Molecule Metabolic Process (GO:0062012),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,TTC39B
Cyclic-Nucleotide-Mediated Signaling (GO:0019935),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,PDE9A
Endothelial Cell Migration (GO:0043542),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,STAT1
Negative Regulation Of Cell-Cell Adhesion (GO:0022408),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,IL1RN
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,INHBA
Positive Regulation Of Monoatomic Ion Transport (GO:0043270),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,CCR1
Positive Regulation Of Myeloid Leukocyte Differentiation (GO:0002763),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,CCR1
Protein Localization To Cilium (GO:0061512),1/40,0.484227022850091,0.638889439454418,0,0,1.53948090645338,1.11643374983322,TTC21A
Cellular Response To Insulin Stimulus (GO:0032869),2/99,0.484795243938232,0.639135100952452,0,0,1.23806210865853,0.896392442884857,CEACAM1;PCK2
Response To UV (GO:0009411),2/100,0.490076935611151,0.644481237596891,0,0,1.22536622010767,0.873922474296664,GTF2H2;TNFSF13B
ncRNA Processing (GO:0034470),2/100,0.490076935611151,0.644481237596891,0,0,1.22536622010767,0.873922474296664,SSB;IGF2BP3
Protein Complex Oligomerization (GO:0051259),2/100,0.490076935611151,0.644481237596891,0,0,1.22536622010767,0.873922474296664,PNPT1;TIFA
Regulation Of Dendrite Development (GO:0050773),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,TNIK
Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,KCNJ2
Axoneme Assembly (GO:0035082),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,RSPH9
Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,TNFSF10
Detection Of Chemical Stimulus Involved In Sensory Perception Of Bitter Taste (GO:0001580),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,RTP4
Synaptic Vesicle Exocytosis (GO:0016079),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,OTOF
Positive Regulation Of Actin Filament Polymerization (GO:0030838),1/41,0.492702631731275,0.644481237596891,0,0,1.50091743119266,1.06242360517985,PRKCE
Hemopoiesis (GO:0030097),2/101,0.495324579537995,0.647404704349269,0,0,1.21292681415381,0.852132048139603,IFI16;INHBA
Mitochondrion Organization (GO:0007005),3/162,0.497728973906366,0.649532428506514,0,0,1.13283018867925,0.790375145955151,PNPT1;TIMM10;IFIT2
Protein Autophosphorylation (GO:0046777),3/162,0.497728973906366,0.649532428506514,0,0,1.13283018867925,0.790375145955151,EIF2AK2;TNIK;ACVR1B
Protein Catabolic Process (GO:0030163),2/102,0.500537869382186,0.649797583098949,0,0,1.20073619631902,0.83099592485909,CEACAM1;FBXO6
Regulation Of RNA Splicing (GO:0043484),2/102,0.500537869382186,0.649797583098949,0,0,1.20073619631902,0.83099592485909,METTL4;HNRNPLL
Ceramide Biosynthetic Process (GO:0046513),1/42,0.501039379675818,0.649797583098949,0,0,1.46423510106661,1.01188979885036,B4GALT4
Sensory Perception Of Bitter Taste (GO:0050913),1/42,0.501039379675818,0.649797583098949,0,0,1.46423510106661,1.01188979885036,RTP4
Stress-Activated MAPK Cascade (GO:0051403),1/42,0.501039379675818,0.649797583098949,0,0,1.46423510106661,1.01188979885036,MAP2K6
Substantia Nigra Development (GO:0021762),1/42,0.501039379675818,0.649797583098949,0,0,1.46423510106661,1.01188979885036,CNP
Translational Elongation (GO:0006414),1/42,0.501039379675818,0.649797583098949,0,0,1.46423510106661,1.01188979885036,GTPBP2
Potassium Ion Import Across Plasma Membrane (GO:1990573),1/42,0.501039379675818,0.649797583098949,0,0,1.46423510106661,1.01188979885036,KCNJ2
Inorganic Cation Import Across Plasma Membrane (GO:0098659),2/103,0.505716518029634,0.655352108976793,0,0,1.1887869768572,0.810490005491749,CACNA1A;KCNJ2
Regulation Of Chromosome Organization (GO:0033044),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,RMI2
Regulation Of Primary Metabolic Process (GO:0080090),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,RNF213
Intracellular Glucose Homeostasis (GO:0001678),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,PCK2
Positive Regulation Of T Cell Mediated Immunity (GO:0002711),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,MICA
Positive Regulation Of Cell Division (GO:0051781),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,PRKCE
Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,RIN2
Positive Regulation Of miRNA Transcription (GO:1902895),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,SMAD3
Regulation Of JUN Kinase Activity (GO:0043506),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,ZNF675
Regulation Of Cell-Cell Adhesion (GO:0022407),1/43,0.509239534769774,0.655352108976793,0,0,1.4292995485656,0.96454389695772,CEACAM1
Regulation Of Neuron Apoptotic Process (GO:0043523),2/105,0.51596883550767,0.661660408607798,0,0,1.16558460897016,0.771277723011373,FCGR2B;NAIP
Protein Localization (GO:0008104),6/351,0.516585605248063,0.661660408607798,0,0,1.04385633270321,0.68948199639258,RTP4;OCLN;STX17;HEATR5B;AP4E1;DNAJC15
Response To Unfolded Protein (GO:0006986),1/44,0.517305328427376,0.661660408607798,0,0,1.39598890548325,0.920127001547226,TOR1B
Extracellular Matrix Disassembly (GO:0022617),1/44,0.517305328427376,0.661660408607798,0,0,1.39598890548325,0.920127001547226,MMP8
Negative Regulation Of Immune System Process (GO:0002683),1/44,0.517305328427376,0.661660408607798,0,0,1.39598890548325,0.920127001547226,FCGR2B
Phosphatidylinositol Phosphate Biosynthetic Process (GO:0046854),1/44,0.517305328427376,0.661660408607798,0,0,1.39598890548325,0.920127001547226,PI4K2B
Positive Regulation Of Biosynthetic Process (GO:0009891),1/44,0.517305328427376,0.661660408607798,0,0,1.39598890548325,0.920127001547226,MMP8
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),1/44,0.517305328427376,0.661660408607798,0,0,1.39598890548325,0.920127001547226,SMAD3
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),2/106,0.521042020794165,0.665930711068478,0,0,1.15431807456347,0.752528333294197,SMARCD3;INHBA
Regulation Of Cellular Metabolic Process (GO:0031323),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,PNPT1
Regulation Of Protein Modification Process (GO:0031399),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,STAT2
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,EIF2AK2
Detection Of Chemical Stimulus Involved In Sensory Perception Of Taste (GO:0050912),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,RTP4
Zymogen Activation (GO:0031638),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,IFI16
Mitotic Nuclear Division (GO:0140014),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,NDC80
Organic Hydroxy Compound Transport (GO:0015850),1/45,0.525238955424021,0.667723991203942,0,0,1.36419238254101,0.878406158147198,CEACAM1
Lipid Transport (GO:0006869),2/108,0.531081364194825,0.670511449646829,0,0,1.13242273411274,0.716642449756573,CEACAM1;ABCA13
B Cell Receptor Signaling Pathway (GO:0050853),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,CD38
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,GBP5
Regulation Of Fibroblast Proliferation (GO:0048145),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,PARP10
T Cell Differentiation (GO:0030217),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,RHOH
Cardiac Conduction (GO:0061337),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,KCNJ2
Cellular Component Disassembly (GO:0022411),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,MMP8
Response To Glucose (GO:0009749),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,PCK2
Response To Hydrogen Peroxide (GO:0042542),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,HP
Epithelial Cell Migration (GO:0010631),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,STAT1
Intracellular Protein Transmembrane Transport (GO:0065002),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,DNAJC15
Male Gonad Development (GO:0008584),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,INHBA
Mitotic G2/M Transition Checkpoint (GO:0044818),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,TNFSF13B
Myofibril Assembly (GO:0030239),1/46,0.533042575033044,0.670511449646829,0,0,1.33380903839619,0.839171264927693,TMOD2
Gene Expression (GO:0010467),5/296,0.536008261924192,0.673278426549967,0,0,1.03098103050227,0.642925651329239,CASP10;SRBD1;ADAR;IGF2BP3;THOC7
Extracellular Structure Organization (GO:0043062),2/109,0.536047139369131,0.673278426549967,0,0,1.12178200791239,0.699468297269349,COL9A2;MMP8
Golgi To Plasma Membrane Transport (GO:0006893),1/47,0.540718311131998,0.675917931789521,0,0,1.3047467092142,0.802232409354233,VAMP5
Bicellular Tight Junction Assembly (GO:0070830),1/47,0.540718311131998,0.675917931789521,0,0,1.3047467092142,0.802232409354233,OCLN
Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),1/47,0.540718311131998,0.675917931789521,0,0,1.3047467092142,0.802232409354233,MAP2K6
Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),1/47,0.540718311131998,0.675917931789521,0,0,1.3047467092142,0.802232409354233,SMAD3
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.540718311131998,0.675917931789521,0,0,1.3047467092142,0.802232409354233,STAT1
Response To Lipid (GO:0033993),2/110,0.54097675473172,0.675917931789521,0,0,1.11133833219723,0.682782897948627,TRIM6;GCH1
External Encapsulating Structure Organization (GO:0045229),2/110,0.54097675473172,0.675917931789521,0,0,1.11133833219723,0.682782897948627,COL9A2;MMP8
RNA Metabolic Process (GO:0016070),2/111,0.545870057466598,0.680507158078702,0,0,1.10108628355941,0.666569361876972,PNPT1;ADAR
Cytoskeleton Organization (GO:0007010),2/111,0.545870057466598,0.680507158078702,0,0,1.10108628355941,0.666569361876972,FMNL2;TNIK
Mitotic Sister Chromatid Segregation (GO:0000070),2/111,0.545870057466598,0.680507158078702,0,0,1.10108628355941,0.666569361876972,NDC80;CHMP5
Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),1/48,0.548268253276219,0.680959753326737,0,0,1.27692107489101,0.767417561072903,SEPTIN4
Cellular Defense Response (GO:0006968),1/48,0.548268253276219,0.680959753326737,0,0,1.27692107489101,0.767417561072903,LGALS3BP
Chloride Transmembrane Transport (GO:1902476),1/48,0.548268253276219,0.680959753326737,0,0,1.27692107489101,0.767417561072903,APOL1
Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),1/48,0.548268253276219,0.680959753326737,0,0,1.27692107489101,0.767417561072903,GBP1
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),1/48,0.548268253276219,0.680959753326737,0,0,1.27692107489101,0.767417561072903,MMP8
Calcium Ion Transport (GO:0006816),2/112,0.550726909610349,0.682493422057863,0,0,1.09102063580591,0.650811505104823,CCR1;CACNA1A
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),2/112,0.550726909610349,0.682493422057863,0,0,1.09102063580591,0.650811505104823,HERC5;TRIB2
Small GTPase Mediated Signal Transduction (GO:0007264),2/112,0.550726909610349,0.682493422057863,0,0,1.09102063580591,0.650811505104823,RIN2;RASGRP3
Regulation Of Protein Ubiquitination (GO:0031396),2/113,0.55554718737423,0.685602379256303,0,0,1.081136351075,0.635493815086513,ISG15;SEPTIN4
Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),1/49,0.555694456826986,0.685602379256303,0,0,1.25025484199796,0.734570571349729,SMARCD3
Erythrocyte Differentiation (GO:0030218),1/49,0.555694456826986,0.685602379256303,0,0,1.25025484199796,0.734570571349729,INHBA
Negative Regulation Of DNA Metabolic Process (GO:0051053),1/49,0.555694456826986,0.685602379256303,0,0,1.25025484199796,0.734570571349729,BMPR2
Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),1/49,0.555694456826986,0.685602379256303,0,0,1.25025484199796,0.734570571349729,CD274
Neurogenesis (GO:0022008),1/49,0.555694456826986,0.685602379256303,0,0,1.25025484199796,0.734570571349729,METTL14
Phosphorylation (GO:0016310),7/429,0.558502562719114,0.688521368803261,0,0,0.994743913422214,0.579434422123281,CDK17;BMPR2;PRKCE;EIF2AK2;TNIK;ACVR1B;TRIB2
Response To Endoplasmic Reticulum Stress (GO:0034976),2/114,0.560330780803561,0.688521368803261,0,0,1.07142857142857,0.62060141746002,CREB3L2;ATF3
G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,CCR1
Regulation Of Mitochondrion Organization (GO:0010821),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,STAT2
Cell Chemotaxis (GO:0060326),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,DOCK4
tRNA Processing (GO:0008033),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,SSB
Nucleocytoplasmic Transport (GO:0006913),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,NUP205
Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,TNIK
Positive Regulation Of Cell Death (GO:0010942),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,HP
Positive Regulation Of Developmental Growth (GO:0048639),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,AGRN
Pyruvate Metabolic Process (GO:0006090),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,PCK2
Regulation Of TORC1 Signaling (GO:1903432),1/50,0.562998943528309,0.688521368803261,0,0,1.22467702677401,0.703549430141157,KPTN
Amide Biosynthetic Process (GO:0043604),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,PCSK5
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,EIF2AK2
Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,GBP1
Regulation Of Telomere Maintenance Via Telomerase (GO:0032210),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,XRN1
Microtubule Bundle Formation (GO:0001578),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,RSPH9
Negative Regulation Of MAP Kinase Activity (GO:0043407),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,ZNF675
Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,ARHGEF3
Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,MICA
Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,PRKCE
Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,PRKCE
Regulated Exocytosis (GO:0045055),1/51,0.570183702549725,0.69174571019992,0,0,1.20012232415902,0.674224743188577,OTOF
Protein Maturation (GO:0051604),2/117,0.574460553948972,0.696280032353008,0,0,1.04331821819152,0.578336166875972,CASP10;PCSK5
Rho Protein Signal Transduction (GO:0007266),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,ARHGEF3
Cardiac Muscle Tissue Development (GO:0048738),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,BMPR2
Cartilage Development (GO:0051216),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,CREB3L2
Sprouting Angiogenesis (GO:0002040),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,RNF213
Icosanoid Metabolic Process (GO:0006690),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,NAIP
Negative Regulation Of Response To Stimulus (GO:0048585),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,FCGR2B
Positive Regulation Of Telomere Maintenance (GO:0032206),1/52,0.577250690301029,0.696280032353008,0,0,1.17653055105834,0.646478401118517,PML
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),2/118,0.57909657217553,0.69800328908477,0,0,1.03427120795431,0.565007905925976,ARHGEF3;CD2AP
Regulation Of Protein Kinase Activity (GO:0045859),2/119,0.583695549215166,0.69911993133001,0,0,1.02537884746474,0.552039108012214,CEACAM1;TRIB2
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,HERC5
Actin Cytoskeleton Reorganization (GO:0031532),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,TNIK
Actin Polymerization Or Depolymerization (GO:0008154),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,PSTPIP2
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,LAMP3
Endosome Organization (GO:0007032),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,PI4K2B
Spermatid Development (GO:0007286),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,TTC21A
Tight Junction Assembly (GO:0120192),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,OCLN
Gonad Development (GO:0008406),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,INHBA
Mitochondrial Transport (GO:0006839),1/53,0.58420183144014,0.69911993133001,0,0,1.15384615384615,0.620202408553139,TIMM10
Regulation Of Exocytosis (GO:0017157),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,SEPTIN4
Regulation Of Lipid Metabolic Process (GO:0019216),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,RNF213
Apical Junction Assembly (GO:0043297),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,OCLN
Regulation Of Myoblast Differentiation (GO:0045661),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,SMARCD3
Endoplasmic Reticulum Organization (GO:0007029),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,TOR1B
Monoatomic Anion Transmembrane Transport (GO:0098656),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,APOL1
Negative Regulation Of TOR Signaling (GO:0032007),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,KPTN
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,LAMP3
Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,ISG15
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),1/54,0.591039019382703,0.702278607547772,0,0,1.1320177716231,0.595297854558998,CCR1
Protein Localization To Nucleus (GO:0034504),2/122,0.597269932523028,0.708257341970617,0,0,0.99959100204499,0.515175327629073,TOR1B;PML
Receptor-Mediated Endocytosis (GO:0006898),2/122,0.597269932523028,0.708257341970617,0,0,0.99959100204499,0.515175327629073,SCARB2;FCGR2B
Neuron Migration (GO:0001764),1/55,0.597764116474902,0.708257341970617,0,0,1.11099784800091,0.571674004890073,SEPTIN4
Phosphatidylcholine Metabolic Process (GO:0046470),1/55,0.597764116474902,0.708257341970617,0,0,1.11099784800091,0.571674004890073,CHPT1
Modulation Of Chemical Synaptic Transmission (GO:0050804),2/123,0.601720498424085,0.711575387397122,0,0,0.991279217157633,0.503532401522212,CACNA1A;OTOF
Regulation Of Cell Motility (GO:2000145),2/123,0.601720498424085,0.711575387397122,0,0,0.991279217157633,0.503532401522212,CEACAM1;RIGI
Endocytosis (GO:0006897),3/189,0.6018405099623,0.711575387397122,0,0,0.967047146401985,0.491030569102132,SCARB2;HEATR5B;FCGR2B
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),1/56,0.604378954925109,0.712562361937779,0,0,1.0907422852377,0.549247497780122,TNFSF13B
Peptide Metabolic Process (GO:0006518),1/56,0.604378954925109,0.712562361937779,0,0,1.0907422852377,0.549247497780122,PCSK5
Positive Regulation Of Cellular Metabolic Process (GO:0031325),1/56,0.604378954925109,0.712562361937779,0,0,1.0907422852377,0.549247497780122,PRKCE
Regulation Of Cation Channel Activity (GO:2001257),1/56,0.604378954925109,0.712562361937779,0,0,1.0907422852377,0.549247497780122,CACNA1A
Intracellular Monoatomic Cation Homeostasis (GO:0030003),3/190,0.605414637728502,0.713123841857223,0,0,0.961826408885232,0.482684604064215,CCR1;MT2A;KCNJ2
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),2/124,0.606133952851746,0.713123841857223,0,0,0.983103691038922,0.49219506374991,BMPR2;ACVR1B
Protein Dephosphorylation (GO:0006470),2/124,0.606133952851746,0.713123841857223,0,0,0.983103691038922,0.49219506374991,DAPP1;PPM1K
RNA Catabolic Process (GO:0006401),1/57,0.610885337009432,0.716195633368451,0,0,1.07121013543032,0.527941632431668,PNPT1
Chemokine-Mediated Signaling Pathway (GO:0070098),1/57,0.610885337009432,0.716195633368451,0,0,1.07121013543032,0.527941632431668,CCR1
Endosome To Lysosome Transport (GO:0008333),1/57,0.610885337009432,0.716195633368451,0,0,1.07121013543032,0.527941632431668,DTX3L
Monoatomic Anion Transport (GO:0006820),1/57,0.610885337009432,0.716195633368451,0,0,1.07121013543032,0.527941632431668,SLC26A8
Regulation Of Calcium Ion Transport (GO:0051924),1/57,0.610885337009432,0.716195633368451,0,0,1.07121013543032,0.527941632431668,CCR1
Transcription By RNA Polymerase II (GO:0006366),3/192,0.612499106269454,0.717584737247057,0,0,0.951550671550672,0.466457557213154,ETV7;GTF2H2;IRF9
Regulation Of Signal Transduction (GO:0009966),3/193,0.61600930502252,0.718662397008867,0,0,0.946493927125506,0.458569881004852,PLSCR1;SP100;TRIM5
Negative Regulation Of DNA-templated Transcription (GO:0045892),16/1025,0.616952922060847,0.718662397008867,0,0,0.948540062514294,0.458109336235921,SP100;CBX5;SMAD3;STAT1;PRDM1;PARP9;PML;ETV7;IFI16;TFEC;IRF7;CD38;ZNF589;ZNF675;ATF3;ZNF684
Selective Autophagy (GO:0061912),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,RNF213
Glycosaminoglycan Biosynthetic Process (GO:0006024),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,B4GALT4
Inorganic Anion Transport (GO:0015698),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,SLC26A8
mRNA Transport (GO:0051028),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,THOC7
Muscle Organ Development (GO:0007517),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,VAMP5
Peptidyl-Threonine Phosphorylation (GO:0018107),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,ACVR1B
Positive Regulation Of Mitochondrion Organization (GO:0010822),1/58,0.617285035565895,0.718662397008867,0,0,1.05236332421267,0.507685736456063,TNFSF10
Cytosolic Transport (GO:0016482),2/127,0.619151859290344,0.720334534487305,0,0,0.959361963190184,0.459922640249588,HEATR5B;ANKFY1
Regulation Of Programmed Cell Death (GO:0043067),3/195,0.622965312417667,0.720475826187582,0,0,0.936538461538462,0.443230350582552,STAT1;SEPTIN4;NAIP
DNA-templated Transcription Initiation (GO:0006352),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,GTF2H2
Regulation Of miRNA Transcription (GO:1902893),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,SMAD3
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,OAS2
Cellular Response To Chemokine (GO:1990869),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,CCR1
Chordate Embryonic Development (GO:0043009),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,PCSK5
Cilium Movement (GO:0003341),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,RSPH9
Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,NDC80
Phospholipid Transport (GO:0015914),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,SCARB2
Positive Regulation Of Protein Binding (GO:0032092),1/59,0.623579794572396,0.720475826187582,0,0,1.03416640303701,0.488414602652351,DTX3L
Regulation Of DNA Repair (GO:0006282),2/129,0.627645453888656,0.72467277043183,0,0,0.94415728708758,0.439769426160068,SMARCD3;PML
Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),1/60,0.629771329640683,0.726125040998527,0,0,1.01658632664697,0.470067986777693,CEACAM1
Positive Regulation Of Phagocytosis (GO:0050766),1/60,0.629771329640683,0.726125040998527,0,0,1.01658632664697,0.470067986777693,FCGR2B
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),2/130,0.631836904855469,0.727503882879009,0,0,0.936733128834356,0.430076642379979,PARP14;PARP9
Regulation Of Cell Cycle Process (GO:0010564),2/130,0.631836904855469,0.727503882879009,0,0,0.936733128834356,0.430076642379979,ZFYVE26;SMARCD3
Autophagosome Organization (GO:1905037),1/61,0.635861328439538,0.731131273181682,0,0,0.999592252803262,0.452590158814443,ZFYVE26
Negative Regulation Of Autophagy (GO:0010507),1/61,0.635861328439538,0.731131273181682,0,0,0.999592252803262,0.452590158814443,RUBCN
DNA-templated Transcription (GO:0006351),3/199,0.636618273326104,0.731498881369898,0,0,0.91723704866562,0.414210547638527,ETV7;GTF2H2;IRF9
mRNA Export From Nucleus (GO:0006406),1/62,0.641851451004321,0.737005818483341,0,0,0.983155361708528,0.435929501349654,THOC7
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),1/63,0.647743330367774,0.741227490906489,0,0,0.967248692907172,0.420038148822788,CDK17
Telomere Organization (GO:0032200),1/63,0.647743330367774,0.741227490906489,0,0,0.967248692907172,0.420038148822788,SP100
Inorganic Anion Transmembrane Transport (GO:0098661),1/63,0.647743330367774,0.741227490906489,0,0,0.967248692907172,0.420038148822788,APOL1
Phosphatidylinositol Metabolic Process (GO:0046488),1/63,0.647743330367774,0.741227490906489,0,0,0.967248692907172,0.420038148822788,PI4K2B
Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),1/63,0.647743330367774,0.741227490906489,0,0,0.967248692907172,0.420038148822788,TNFSF13B
Cellular Response To Metal Ion (GO:0071248),2/135,0.652243657535951,0.745310178929729,0,0,0.901286959730615,0.385153336702748,MT2A;CACNA1A
Non-Membrane-Bounded Organelle Assembly (GO:0140694),2/135,0.652243657535951,0.745310178929729,0,0,0.901286959730615,0.385153336702748,RNF213;TMOD2
Response To Metal Ion (GO:0010038),1/64,0.653538572916863,0.745310178929729,0,0,0.951846997718557,0.404871663766522,PLSCR1
Negative Regulation Of Cell Death (GO:0060548),1/64,0.653538572916863,0.745310178929729,0,0,0.951846997718557,0.404871663766522,CHMP5
Positive Regulation Of Macroautophagy (GO:0016239),1/64,0.653538572916863,0.745310178929729,0,0,0.951846997718557,0.404871663766522,LARP1
RNA Export From Nucleus (GO:0006405),1/65,0.659238758990242,0.749766447172451,0,0,0.936926605504587,0.390388745033856,THOC7
Autophagosome Assembly (GO:0000045),1/65,0.659238758990242,0.749766447172451,0,0,0.936926605504587,0.390388745033856,STX17
Regulation Of Translational Initiation (GO:0006446),1/65,0.659238758990242,0.749766447172451,0,0,0.936926605504587,0.390388745033856,LARP1
Positive Regulation Of T Cell Proliferation (GO:0042102),1/65,0.659238758990242,0.749766447172451,0,0,0.936926605504587,0.390388745033856,CD274
Negative Regulation Of Cell Differentiation (GO:0045596),3/207,0.662879695901865,0.753395197855856,0,0,0.880904977375566,0.362194440367301,METTL14;SMAD3;TRIB2
Regulation Of Endocytosis (GO:0030100),1/66,0.664845443012192,0.754092492311456,0,0,0.922465302281816,0.376550965385665,RUBCN
Response To Reactive Oxygen Species (GO:0000302),1/66,0.664845443012192,0.754092492311456,0,0,0.922465302281816,0.376550965385665,HP
Peptidyl-Threonine Modification (GO:0018210),1/66,0.664845443012192,0.754092492311456,0,0,0.922465302281816,0.376550965385665,ACVR1B
Intracellular Calcium Ion Homeostasis (GO:0006874),2/139,0.667914183549497,0.757059911299667,0,0,0.874792888809279,0.353062544597205,CCR1;PML
tRNA Modification (GO:0006400),1/67,0.670360154137342,0.75880415282258,0,0,0.908442220368826,0.363322533808633,SSB
Protein Secretion (GO:0009306),1/67,0.670360154137342,0.75880415282258,0,0,0.908442220368826,0.363322533808633,PCSK5
Telomere Maintenance (GO:0000723),1/68,0.675784396526695,0.763910334722405,0,0,0.894837737915925,0.350670081046044,SP100
Neuropeptide Signaling Pathway (GO:0007218),1/68,0.675784396526695,0.763910334722405,0,0,0.894837737915925,0.350670081046044,CYSLTR1
DNA-templated DNA Replication (GO:0006261),1/69,0.681119649844736,0.76786602034383,0,0,0.881633387299874,0.338562465037152,HELB
Cellular Response To Calcium Ion (GO:0071277),1/69,0.681119649844736,0.76786602034383,0,0,0.881633387299874,0.338562465037152,CACNA1A
Establishment Of Protein Localization To Membrane (GO:0090150),1/69,0.681119649844736,0.76786602034383,0,0,0.881633387299874,0.338562465037152,RTP4
Phagocytosis (GO:0006909),1/69,0.681119649844736,0.76786602034383,0,0,0.881633387299874,0.338562465037152,FCGR2B
Sulfur Compound Biosynthetic Process (GO:0044272),1/70,0.686367369633568,0.770518325663827,0,0,0.868811771484288,0.326970594588075,B4GALT4
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),1/70,0.686367369633568,0.770518325663827,0,0,0.868811771484288,0.326970594588075,IFI6
Positive Regulation Of Protein Transport (GO:0051222),1/70,0.686367369633568,0.770518325663827,0,0,0.868811771484288,0.326970594588075,CD2AP
Regulation Of Actin Filament Polymerization (GO:0030833),1/70,0.686367369633568,0.770518325663827,0,0,0.868811771484288,0.326970594588075,PRKCE
Regulation Of Actin Filament-Based Process (GO:0032970),1/70,0.686367369633568,0.770518325663827,0,0,0.868811771484288,0.326970594588075,BST2
Ras Protein Signal Transduction (GO:0007265),2/144,0.686696248394959,0.770518325663827,0,0,0.843774302255249,0.317143731774328,ARHGEF3;RASGRP3
Actin Filament Organization (GO:0007015),2/144,0.686696248394959,0.770518325663827,0,0,0.843774302255249,0.317143731774328,NEBL;CD2AP
Regulation Of Hydrolase Activity (GO:0051336),1/71,0.691528987767049,0.774901538201121,0,0,0.856356487549148,0.315867269094212,SCARB2
Synapse Assembly (GO:0007416),1/71,0.691528987767049,0.774901538201121,0,0,0.856356487549148,0.315867269094212,SRGAP2C
Neuron Projection Morphogenesis (GO:0048812),2/146,0.693961914144879,0.777107284045771,0,0,0.831970006816633,0.303950423691937,NTNG2;TNIK
Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),1/72,0.696605912633115,0.778504804165132,0,0,0.844252056682603,0.305227033077218,SMAD3
Negative Regulation Of Catabolic Process (GO:0009895),1/72,0.696605912633115,0.778504804165132,0,0,0.844252056682603,0.305227033077218,PML
Protein Targeting To Membrane (GO:0006612),1/72,0.696605912633115,0.778504804165132,0,0,0.844252056682603,0.305227033077218,RTP4
Ubiquitin-Dependent ERAD Pathway (GO:0030433),1/73,0.701599529720355,0.781996011473787,0,0,0.832483860006796,0.295026043200765,FBXO6
Monocarboxylic Acid Transport (GO:0015718),1/73,0.701599529720355,0.781996011473787,0,0,0.832483860006796,0.295026043200765,CEACAM1
Positive Regulation Of Secretion By Cell (GO:1903532),1/73,0.701599529720355,0.781996011473787,0,0,0.832483860006796,0.295026043200765,CD2AP
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.701599529720355,0.781996011473787,0,0,0.832483860006796,0.295026043200765,ARHGEF3
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.706511202011538,0.78642264867951,0,0,0.821038079678271,0.285241947218564,NAIP
Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),1/74,0.706511202011538,0.78642264867951,0,0,0.821038079678271,0.285241947218564,SMARCD3
protein-RNA Complex Assembly (GO:0022618),2/150,0.708076531526164,0.787640982209623,0,0,0.809318520974963,0.279379258891899,EIF2S3B;ADAR
Nucleosome Organization (GO:0034728),1/75,0.711342270093639,0.789698485644763,0,0,0.80990164476403,0.275853773756189,SMARCD3
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.711342270093639,0.789698485644763,0,0,0.80990164476403,0.275853773756189,SMARCD3
Regulation Of BMP Signaling Pathway (GO:0030510),1/75,0.711342270093639,0.789698485644763,0,0,0.80990164476403,0.275853773756189,BMPR2
Protein Phosphorylation (GO:0006468),7/500,0.715771940528384,0.793394271657164,0,0,0.848344107220716,0.283680909255559,CDK17;BMPR2;PRKCE;EIF2AK2;TNIK;ACVR1B;TRIB2
Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),1/76,0.716094052721051,0.793394271657164,0,0,0.799062181447503,0.266841831023866,GTF2H2
Positive Regulation Of Protein Secretion (GO:0050714),1/76,0.716094052721051,0.793394271657164,0,0,0.799062181447503,0.266841831023866,CD2AP
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),1/77,0.720767847238718,0.796989166180023,0,0,0.78850796716562,0.258187614261743,NTNG2
Embryonic Organ Development (GO:0048568),1/77,0.720767847238718,0.796989166180023,0,0,0.78850796716562,0.258187614261743,PCSK5
Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),1/77,0.720767847238718,0.796989166180023,0,0,0.78850796716562,0.258187614261743,BMPR2
Epithelium Development (GO:0060429),2/154,0.721644801209327,0.797431804770941,0,0,0.787859218598644,0.257017188245401,DHRS9;STAT1
Regulation Of Cell Cycle (GO:0051726),4/298,0.723139827953296,0.798378636466105,0,0,0.813723020072226,0.263770494368464,PNPT1;MX2;MAP2K6;TNFSF13B
Cellular Response To Lipid (GO:0071396),3/228,0.725177232830161,0.798378636466105,0,0,0.797825641025641,0.256372649179002,CD274;CHMP5;GBP3
Chromatin Remodeling (GO:0006338),3/228,0.725177232830161,0.798378636466105,0,0,0.797825641025641,0.256372649179002,SMARCD3;DTX3L;IFI16
Cellular Response To Nutrient Levels (GO:0031669),1/78,0.725364929724136,0.798378636466105,0,0,0.778227888319631,0.24987372122349,BMPR2
Negative Regulation Of Protein Modification Process (GO:0031400),1/78,0.725364929724136,0.798378636466105,0,0,0.778227888319631,0.24987372122349,OCLN
Proteolysis Involved In Protein Catabolic Process (GO:0051603),1/78,0.725364929724136,0.798378636466105,0,0,0.778227888319631,0.24987372122349,ISG15
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.729886555543636,0.800196728325362,0,0,0.768211401238924,0.241883774192138,HERC5
Negative Regulation Of Cellular Component Organization (GO:0051129),1/79,0.729886555543636,0.800196728325362,0,0,0.768211401238924,0.241883774192138,RUBCN
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.729886555543636,0.800196728325362,0,0,0.768211401238924,0.241883774192138,TNFSF13B
Positive Regulation Of Cytoskeleton Organization (GO:0051495),1/79,0.729886555543636,0.800196728325362,0,0,0.768211401238924,0.241883774192138,PRKCE
Positive Regulation Of Protein Localization To Membrane (GO:1905477),1/79,0.729886555543636,0.800196728325362,0,0,0.768211401238924,0.241883774192138,PRKCE
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),1/79,0.729886555543636,0.800196728325362,0,0,0.768211401238924,0.241883774192138,SEPTIN4
Calcium Ion Transmembrane Transport (GO:0070588),1/80,0.734333959460053,0.804545326900241,0,0,0.758448496109627,0.234202348824293,CACNA1A
Positive Regulation Of Developmental Process (GO:0051094),3/233,0.738612507089489,0.807223435618764,0,0,0.78028093645485,0.236410956339659,BMPR2;SMARCD3;ACVR1B
Activation Of Protein Kinase Activity (GO:0032147),1/81,0.738708356205815,0.807223435618764,0,0,0.748929663608563,0.226814908246585,CAB39L
Cytoskeleton-Dependent Cytokinesis (GO:0061640),1/81,0.738708356205815,0.807223435618764,0,0,0.748929663608563,0.226814908246585,SEPTIN4
Macromolecule Modification (GO:0043412),1/81,0.738708356205815,0.807223435618764,0,0,0.748929663608563,0.226814908246585,UBE2L6
Translation (GO:0006412),3/234,0.741236415892341,0.80945726095815,0,0,0.776863136863137,0.232620522064458,SRBD1;IGF2BP3;GTPBP2
Regulation Of Macromolecule Metabolic Process (GO:0060255),2/162,0.747190528535986,0.813361972373824,0,0,0.748159509202454,0.218039917506634,IGF2BP3;AFF1
Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),1/83,0.747242887948935,0.813361972373824,0,0,0.730588498545536,0.212867914588239,SMAD3
Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),1/83,0.747242887948935,0.813361972373824,0,0,0.730588498545536,0.212867914588239,CACNA1A
Epigenetic Regulation Of Gene Expression (GO:0040029),1/83,0.747242887948935,0.813361972373824,0,0,0.730588498545536,0.212867914588239,IFI16
Regulation Of Cell Division (GO:0051302),1/83,0.747242887948935,0.813361972373824,0,0,0.730588498545536,0.212867914588239,ZFYVE26
Nitrogen Compound Transport (GO:0071705),2/163,0.750238501368187,0.815080106421955,0,0,0.743474450329612,0.213647882038303,SCARB2;SLC26A8
Positive Regulation Of MAPK Cascade (GO:0043410),4/310,0.751101866053744,0.815080106421955,0,0,0.781328169127733,0.223627057368266,CCR1;TRIM5;EIF2AK2;MMP8
Ribosomal Small Subunit Biogenesis (GO:0042274),1/84,0.751405354479196,0.815080106421955,0,0,0.721749382852511,0.206283205449861,IGF2BP3
Positive Regulation Of Double-Strand Break Repair (GO:2000781),1/84,0.751405354479196,0.815080106421955,0,0,0.721749382852511,0.206283205449861,SMARCD3
Positive Regulation Of Protein Ubiquitination (GO:0031398),1/84,0.751405354479196,0.815080106421955,0,0,0.721749382852511,0.206283205449861,SEPTIN4
Negative Regulation Of Programmed Cell Death (GO:0043069),5/381,0.75174453329891,0.815080106421955,0,0,0.794414070219353,0.226692989462357,IFI6;CD38;SERPINB9;IFIT3;NAIP
Regulation Of Kinase Activity (GO:0043549),1/85,0.755499477505386,0.817033371600847,0,0,0.713120722295034,0.199942070312334,NLRC5
Epidermis Development (GO:0008544),1/85,0.755499477505386,0.817033371600847,0,0,0.713120722295034,0.199942070312334,STS
Mitotic Spindle Organization (GO:0007052),1/85,0.755499477505386,0.817033371600847,0,0,0.713120722295034,0.199942070312334,NDC80
Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),1/85,0.755499477505386,0.817033371600847,0,0,0.713120722295034,0.199942070312334,XRN1
Glucose Homeostasis (GO:0042593),1/87,0.763487149918494,0.82513824406566,0,0,0.696465400753858,0.187947446105953,OAS1
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),3/244,0.766338295879222,0.827684938028365,0,0,0.7442451324609,0.19806712348768,CCR1;CEACAM1;GBP1
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.767382882202134,0.828139980010661,0,0,0.688424900699497,0.182273853165666,NAIP
Brain Development (GO:0007420),2/169,0.767870544015554,0.828139980010661,0,0,0.716542375371955,0.189263291569033,AIM2;MATCAP1
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),4/319,0.770619487426212,0.828139980010661,0,0,0.758651773466588,0.197674729778359,FBXO39;FBXO6;PML;TNFSF13B
ERAD Pathway (GO:0036503),1/89,0.771214637690741,0.828139980010661,0,0,0.680567139282736,0.176803554006315,FBXO6
Cellular Response To Chemical Stress (GO:0062197),1/89,0.771214637690741,0.828139980010661,0,0,0.680567139282736,0.176803554006315,PNPT1
Regulation Of Vesicle-Mediated Transport (GO:0060627),1/89,0.771214637690741,0.828139980010661,0,0,0.680567139282736,0.176803554006315,SEPTIN4
Sensory Perception Of Mechanical Stimulus (GO:0050954),1/89,0.771214637690741,0.828139980010661,0,0,0.680567139282736,0.176803554006315,TIMM10
Positive Regulation Of DNA Repair (GO:0045739),1/89,0.771214637690741,0.828139980010661,0,0,0.680567139282736,0.176803554006315,SMARCD3
Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),1/89,0.771214637690741,0.828139980010661,0,0,0.680567139282736,0.176803554006315,TRIM6
Heart Development (GO:0007507),2/171,0.77350325598519,0.829532658502065,0,0,0.707989980760155,0.18182980969278,BMPR2;PCSK5
Metal Ion Transport (GO:0030001),2/171,0.77350325598519,0.829532658502065,0,0,0.707989980760155,0.18182980969278,CCR1;KCNJ2
Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),1/90,0.774983463874677,0.830587658592142,0,0,0.672885956774216,0.171527772743502,CEACAM1
Lymphocyte Differentiation (GO:0030098),1/91,0.778690390974585,0.83349265777382,0,0,0.66537546721033,0.166438187970297,RHOH
Regulation Of Actin Cytoskeleton Organization (GO:0032956),1/91,0.778690390974585,0.83349265777382,0,0,0.66537546721033,0.166438187970297,BST2
Regulation Of Neuron Projection Development (GO:0010975),2/174,0.781729021415175,0.835257722984867,0,0,0.695534313026109,0.171273320343644,SCARB2;NTNG2
Sensory Perception Of Sound (GO:0007605),1/92,0.782336432706089,0.835257722984867,0,0,0.658030043351144,0.161526904601833,TIMM10
Positive Regulation Of Neuron Projection Development (GO:0010976),1/92,0.782336432706089,0.835257722984867,0,0,0.658030043351144,0.161526904601833,SCARB2
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.782336432706089,0.835257722984867,0,0,0.658030043351144,0.161526904601833,TNFSF13B
Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),1/93,0.7859225860449,0.837483112390521,0,0,0.650844302619333,0.156786428539598,TRIM6
Positive Regulation Of Cellular Component Biogenesis (GO:0044089),1/93,0.7859225860449,0.837483112390521,0,0,0.650844302619333,0.156786428539598,SMAD3
Protein O-linked Glycosylation (GO:0006493),1/93,0.7859225860449,0.837483112390521,0,0,0.650844302619333,0.156786428539598,GCNT1
Extracellular Matrix Organization (GO:0030198),2/176,0.787066594346013,0.837635122354249,0,0,0.687469148861152,0.164609274045668,COL9A2;MMP8
Positive Regulation Of Hydrolase Activity (GO:0051345),2/176,0.787066594346013,0.837635122354249,0,0,0.687469148861152,0.164609274045668,AGRN;RASGRP3
Retrograde Transport, Endosome To Golgi (GO:0042147),1/94,0.789449831767018,0.839637360804972,0,0,0.643813093946269,0.152209642459803,HEATR5B
Proteolysis (GO:0006508),4/330,0.792826246083552,0.842692699935059,0,0,0.732636522002575,0.170082441123621,OLR1;FBXO6;MMP8;PCSK5
Regulation Of Macroautophagy (GO:0016241),1/96,0.796331443326904,0.844808183060184,0,0,0.630194752937389,0.143520423033171,LARP1
Regulation Of Protein Metabolic Process (GO:0051246),1/96,0.796331443326904,0.844808183060184,0,0,0.630194752937389,0.143520423033171,INHBA
Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),1/96,0.796331443326904,0.844808183060184,0,0,0.630194752937389,0.143520423033171,SMAD3
Endosomal Transport (GO:0016197),2/180,0.797398766200694,0.845404395344589,0,0,0.671882539463707,0.152114469851536,HEATR5B;ANKFY1
Phosphatidylinositol Biosynthetic Process (GO:0006661),1/98,0.80298879779855,0.850253328301883,0,0,0.61713799300104,0.135409033774384,PI4K2B
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),1/98,0.80298879779855,0.850253328301883,0,0,0.61713799300104,0.135409033774384,IRF4
Negative Regulation Of Apoptotic Process (GO:0043066),6/482,0.805505155530374,0.852378320811079,0,0,0.751448405449136,0.162527526333235,LAMP3;IFI6;CD38;SERPINB9;IFIT3;NAIP
Axon Development (GO:0061564),1/99,0.806235664910559,0.852612052715148,0,0,0.610809461399239,0.131555647642834,NTNG2
Regulation Of Organelle Organization (GO:0033043),1/100,0.809429181545872,0.855448528569958,0,0,0.604608778920706,0.127830011994472,SCARB2
Regulation Of Cell Population Proliferation (GO:0042127),10/766,0.810715601823478,0.856267172885529,0,0,0.786829057269309,0.165106606051547,SMAD3;BMPR2;STAT1;STAT2;CDCA7L;EIF2AK2;IFI35;INHBA;IFIT3;PML
rRNA Processing (GO:0006364),1/101,0.812570221702081,0.857189038806399,0,0,0.598532110091743,0.124227100212837,IGF2BP3
Regulation Of Protein Phosphorylation (GO:0001932),3/265,0.812613159322743,0.857189038806399,0,0,0.683852025836759,0.141899364746958,OCLN;STAT2;TNIK
Calcium Ion Homeostasis (GO:0055074),1/102,0.815659645057505,0.859860482785889,0,0,0.592575771338602,0.12074212078449,CCR1
Chromatin Organization (GO:0006325),3/268,0.81855007021771,0.862364148283519,0,0,0.676005805515239,0.135350362951941,PARP10;CBX5;SMARCD3
Regulation Of Apoptotic Process (GO:0042981),9/705,0.821136164073742,0.864544243231825,0,0,0.769214139011999,0.151586208736864,STAT1;TNFSF10;IFI6;CD38;SERPINB9;SEPTIN4;IFIT3;NAIP;IFIT2
Positive Regulation Of Apoptotic Process (GO:0043065),3/270,0.82241884616693,0.865350144425959,0,0,0.670872947277442,0.131159329851251,TNFSF10;SEPTIN4;IFIT2
Cellular Response To Organonitrogen Compound (GO:0071417),1/105,0.824626602125833,0.866583106379723,0,0,0.575394024935309,0.110950121887606,LARP1
Negative Regulation Of MAPK Cascade (GO:0043409),1/105,0.824626602125833,0.866583106379723,0,0,0.575394024935309,0.110950121887606,GBP1
Protein Localization To Membrane (GO:0072657),2/192,0.825781501334761,0.867252009876369,0,0,0.629060381013884,0.120417925383528,TNIK;AGRN
Response To Calcium Ion (GO:0051592),1/106,0.827517877917913,0.868427854546474,0,0,0.56988495704092,0.107893222862466,CACNA1A
Regulation Of Cell Differentiation (GO:0045595),2/193,0.827978064679919,0.868427854546474,0,0,0.625734750907397,0.118119083462703,SMARCD3;EIF2AK2
Protein Modification Process (GO:0036211),9/711,0.828458371701239,0.868427854546474,0,0,0.762398521019211,0.143474777982855,CDK17;BMPR2;PRKCE;EIF2AK2;DAPP1;UBE2L6;TNIK;ACVR1B;TRIB2
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.830361629462574,0.869877899869059,0,0,0.564479833823784,0.104933400078848,BRCA2
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),3/275,0.831784921496839,0.870823638087742,0,0,0.658371040723982,0.12125968643501,CPLANE1;TNIK;CD2AP
Positive Regulation Of DNA Metabolic Process (GO:0051054),1/108,0.833158635370693,0.871171498109481,0,0,0.559175740947155,0.102067028135158,PML
Positive Regulation Of Metabolic Process (GO:0009893),1/108,0.833158635370693,0.871171498109481,0,0,0.559175740947155,0.102067028135158,IRF4
Cell-Matrix Adhesion (GO:0007160),1/109,0.835909661739373,0.872412267055502,0,0,0.553969872012685,0.0992906414668944,SIGLEC1
Cellular Response To Salt (GO:1902075),1/109,0.835909661739373,0.872412267055502,0,0,0.553969872012685,0.0992906414668944,CACNA1A
Negative Regulation Of Developmental Process (GO:0051093),1/109,0.835909661739373,0.872412267055502,0,0,0.553969872012685,0.0992906414668944,SRGAP2C
Golgi Vesicle Transport (GO:0048193),2/197,0.836517535311052,0.872502391879918,0,0,0.612773320748781,0.109384814971249,COG6;STX17
Anterograde Trans-Synaptic Signaling (GO:0098916),2/199,0.840642305501766,0.874739620937286,0,0,0.606489987854629,0.105280008655962,CNP;CACNA1A
Nervous System Development (GO:0007399),5/433,0.841212292641658,0.874739620937286,0,0,0.696015740285293,0.120348932211236,TMOD2;IGF2BP3;INHBA;ACVR1B;NAIP
Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),1/111,0.841276778295334,0.874739620937286,0,0,0.543842090631081,0.0939947122371001,SMAD3
Mitotic Cell Cycle Phase Transition (GO:0044772),1/111,0.841276778295334,0.874739620937286,0,0,0.543842090631081,0.0939947122371001,ACVR1B
Negative Regulation Of Inflammatory Response (GO:0050728),1/111,0.841276778295334,0.874739620937286,0,0,0.543842090631081,0.0939947122371001,RHBDF2
Regulation Of Cell Migration (GO:0030334),5/434,0.842635762134821,0.875608465870531,0,0,0.694357242344858,0.118888185698568,CCR1;BST2;NTNG2;CEACAM1;RIGI
Protein Deubiquitination (GO:0016579),1/112,0.843894338780943,0.876371960757615,0,0,0.538915061850842,0.0914689665861798,USP18
Organic Substance Transport (GO:0071702),2/201,0.844672781152664,0.876636205253354,0,0,0.600332953109104,0.101339785188834,CCR1;ABCA13
Regulation Of Cytoskeleton Organization (GO:0051493),1/114,0.849001050445388,0.879491490647142,0,0,0.529322616437985,0.0866473891566198,BST2
Protein Modification By Small Protein Removal (GO:0070646),1/114,0.849001050445388,0.879491490647142,0,0,0.529322616437985,0.0866473891566198,USP18
Regulation Of MAP Kinase Activity (GO:0043405),1/114,0.849001050445388,0.879491490647142,0,0,0.529322616437985,0.0866473891566198,TRIB2
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.851491601144259,0.881525648956897,0,0,0.524652610118569,0.0843461139699346,STX17
Cellular Response To Oxidative Stress (GO:0034599),1/117,0.856350505734263,0.885460071751188,0,0,0.515554149530739,0.0799498264523502,PNPT1
Protein Processing (GO:0016485),1/117,0.856350505734263,0.885460071751188,0,0,0.515554149530739,0.0799498264523502,PCSK5
Ribonucleoprotein Complex Biogenesis (GO:0022613),1/118,0.858720191470825,0.88681412366092,0,0,0.511121566167438,0.0778500234180712,IGF2BP3
Positive Regulation Of Cell Projection Organization (GO:0031346),1/118,0.858720191470825,0.88681412366092,0,0,0.511121566167438,0.0778500234180712,SCARB2
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.861050902905208,0.888672523479588,0,0,0.506764111335718,0.0758127500657772,EIF2AK2
Regulation Of Protein Catabolic Process (GO:0042176),1/122,0.867815529193094,0.89406202598738,0,0,0.494123891121389,0.070054963575735,TNFSF13B
Potassium Ion Transport (GO:0006813),1/122,0.867815529193094,0.89406202598738,0,0,0.494123891121389,0.070054963575735,KCNJ2
mRNA Processing (GO:0006397),2/214,0.868691702906865,0.89406202598738,0,0,0.563143882393796,0.0792720686546359,METTL14;CMTR1
Regulation Of GTPase Activity (GO:0043087),2/214,0.868691702906865,0.89406202598738,0,0,0.563143882393796,0.0792720686546359,AGRN;RASGRP3
Positive Regulation Of Protein Phosphorylation (GO:0001934),4/377,0.868944921850257,0.89406202598738,0,0,0.638764770132062,0.0897308239702341,TRIM6;BMPR2;TNIK;INHBA
Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),1/123,0.869996630079714,0.894593953364082,0,0,0.490048628866496,0.0682470833430185,BMPR2
Regulation Of DNA Metabolic Process (GO:0051052),1/124,0.872141849107531,0.896248964101289,0,0,0.486039631038512,0.0664917755443595,HELB
Positive Regulation Of Intracellular Protein Transport (GO:0090316),1/126,0.876326986431868,0.899996960282698,0,0,0.478214067278287,0.0631319013774343,SMAD3
Proteasomal Protein Catabolic Process (GO:0010498),2/220,0.878587253915588,0.901764709080232,0,0,0.547475657117127,0.0708652790656211,PML;TNFSF13B
Synapse Organization (GO:0050808),1/131,0.886201935564962,0.909022586266206,0,0,0.45970359915314,0.0555369922911637,AGRN
Circulatory System Development (GO:0072359),1/132,0.888080498121993,0.91039134396942,0,0,0.456171067068189,0.0541442618560177,PCSK5
Negative Regulation Of Cell Motility (GO:2000146),1/133,0.889928142137973,0.911267391113607,0,0,0.452692058196645,0.0527904845874177,BST2
Protein Transport (GO:0015031),3/313,0.890024457310002,0.911267391113607,0,0,0.576535980148883,0.0671700949133054,STX17;DNAJC15;VAMP5
Regulation Of Protein Kinase B Signaling (GO:0051896),1/136,0.895290594100209,0.916098571210795,0,0,0.442564276815041,0.0489506747739704,AIM2
Potassium Ion Transmembrane Transport (GO:0071805),1/137,0.897019554437497,0.916746313117857,0,0,0.439287641662169,0.047740734223682,KCNJ2
Protein Localization To Plasma Membrane (GO:0072659),1/137,0.897019554437497,0.916746313117857,0,0,0.439287641662169,0.047740734223682,TNIK
Positive Regulation Of GTPase Activity (GO:0043547),2/234,0.899062193627627,0.918272924260695,0,0,0.514068119314576,0.0546984240305175,AGRN;RASGRP3
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),1/140,0.902037515213341,0.920749702838267,0,0,0.42974061118078,0.0443058997430641,RNF213
Cellular Response To Oxygen-Containing Compound (GO:1901701),4/406,0.902825852629386,0.920992470395708,0,0,0.59179411584055,0.060496507618407,CD274;CACNA1A;CHMP5;GBP3
Intracellular Protein Transport (GO:0006886),3/325,0.904261359975988,0.921894732016958,0,0,0.554706163401816,0.05582387838538,STX17;AP4E1;DNAJC15
Protein Localization To Cell Periphery (GO:1990778),1/142,0.905246632333093,0.922337159496508,0,0,0.423601622313315,0.0421686309672915,TNIK
Positive Regulation Of Protein Kinase Activity (GO:0045860),1/145,0.909864843992023,0.926478322579826,0,0,0.41471287801563,0.039173452321997,CAB39L
Cilium Assembly (GO:0060271),2/243,0.910478740373561,0.926539496742681,0,0,0.494641447954586,0.0463898143882878,CPLANE1;RSPH9
Dephosphorylation (GO:0016311),1/147,0.912818279806318,0.928355612228553,0,0,0.408989987851368,0.0373074346199628,DAPP1
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.919786566212016,0.934874195183902,0,0,0.395346011300808,0.0330563147556459,LARP1
Ribosome Biogenesis (GO:0042254),1/155,0.923698031341753,0.938279785327718,0,0,0.387584892172048,0.0307626387282342,IGF2BP3
Peptidyl-Serine Phosphorylation (GO:0018105),1/158,0.927419308290843,0.941488169156906,0,0,0.380120376322094,0.0286418755185306,PRKCE
Negative Regulation Of Cell Migration (GO:0030336),1/163,0.933223637548808,0.946806031303309,0,0,0.368293880016612,0.0254529408981711,BST2
Peptidyl-Serine Modification (GO:0018209),1/166,0.936481623876615,0.949535610148835,0,0,0.361542025762209,0.0237263326165798,PRKCE
Chemical Synaptic Transmission (GO:0007268),2/273,0.940391836379868,0.952922799675057,0,0,0.439204944196681,0.0269929400282659,CNP;CACNA1A
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),1/172,0.942529784072624,0.953741855330823,0,0,0.348749038753867,0.0206416740646439,CEACAM1
Generation Of Neurons (GO:0048699),1/172,0.942529784072624,0.953741855330823,0,0,0.348749038753867,0.0206416740646439,SEPTIN4
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),4/456,0.943439650903519,0.953741855330823,0,0,0.524964492516115,0.03056494424549,CBX5;IFI16;CD38;PML
Neuron Differentiation (GO:0030182),1/173,0.943480436684107,0.953741855330823,0,0,0.346703648389162,0.020171096647448,INHBA
Monoatomic Cation Transmembrane Transport (GO:0098655),2/281,0.946601610636393,0.956319139247998,0,0,0.426435340941575,0.0234014751538944,CACNA1A;KCNJ2
Central Nervous System Development (GO:0007417),2/283,0.948055169343568,0.956871263375558,0,0,0.423356548697684,0.0225829317995314,AIM2;MATCAP1
Inorganic Cation Transmembrane Transport (GO:0098662),2/284,0.948767761700602,0.956871263375558,0,0,0.421833529130227,0.022184743851635,CACNA1A;KCNJ2
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),1/179,0.948863972468649,0.956871263375558,0,0,0.33491392639934,0.0175795745264773,CCR1
RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377),1/180,0.949710141363423,0.957147630422293,0,0,0.333025814497805,0.0171836176026771,METTL14
RNA Processing (GO:0006396),1/183,0.952165799015353,0.959044781308059,0,0,0.327485969687805,0.0160520852762589,ADAR
Axonogenesis (GO:0007409),1/188,0.955995733165635,0.962323021411617,0,0,0.318647892851886,0.014339738035218,NTNG2
Neuron Projection Development (GO:0031175),1/192,0.958838301707232,0.964604016089116,0,0,0.311910594489008,0.0131104848915655,TNIK
Supramolecular Fiber Organization (GO:0097435),2/316,0.967224099584189,0.972455479930498,0,0,0.378218905083819,0.0126041688907203,TMOD2;CD2AP
Protein Stabilization (GO:0050821),1/208,0.968491373536123,0.973144785541101,0,0,0.287565187844406,0.00920660170762623,GLMP
Organelle Assembly (GO:0070925),2/322,0.969885688499804,0.973523453095121,0,0,0.37101226993865,0.0113444649345525,CPLANE1;CHMP5
mRNA Splicing, Via Spliceosome (GO:0000398),1/211,0.970032036048754,0.973523453095121,0,0,0.283413426532693,0.00862318826330885,METTL14
Positive Regulation Of Cell Motility (GO:2000147),1/221,0.97464522282627,0.977566821216037,0,0,0.270391993327773,0.00694413909519851,CCR1
Positive Regulation Of Protein Modification Process (GO:0031401),1/225,0.976285673177755,0.978625483059547,0,0,0.265508955875928,0.00637222488929731,TNIK
Cilium Organization (GO:0044782),1/228,0.977446169801281,0.979202061124277,0,0,0.261959611472605,0.0059758378233228,CPLANE1
Positive Regulation Of Phosphorylation (GO:0042327),1/231,0.978550034055053,0.979721248937225,0,0,0.258502858662412,0.00560521055306138,TNIK
Positive Regulation Of Cell Population Proliferation (GO:0008284),3/483,0.986706313936625,0.98729644929185,0,0,0.369076923076923,0.0049392967063537,BST2;STAT1;CDCA7L
Positive Regulation Of Cellular Process (GO:0048522),4/594,0.98888442840671,0.98888442840671,0,0,0.399288554090814,0.00446317207524401,SMARCD3;CDCA7L;HP;FCGR2B
